{"meta":{"query_hash":"65fff5cca68e","filters":{"venue":"Expert Opinion on Drug Safety"},"cohort_total":120,"direct_labels_cover":0,"predictions_cover":120,"exported":120,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/65fff5cca68e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Drug+Safety"},"results":[{"id":"W1718269887","doi":"10.1517/14740338.2015.1046836","title":"Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Centre for Addiction and Mental Health","funders":"","keywords":"Vortioxetine; Antidepressant; Tolerability; Medicine; Major depressive disorder; Pharmacology; Cognition; Psychiatry; Adverse effect; Anxiety","score_opus":0.02663966568627249,"score_gpt":0.35669402024114133,"score_spread":0.33005435455486887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1718269887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061004313,0.98931694,0.000026026939,0.0010753568,0.00021944202,0.006410468,0.0002773843,0.000082960265,0.0025304065],"genre_scores_gemma":[0.00028020568,0.99735725,0.00012536104,0.00031231146,0.00016678711,0.0005600892,0.000902176,0.00013000864,0.00016582642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944973,0.0009605379,0.001726793,0.0013381692,0.0010260781,0.00045113606],"domain_scores_gemma":[0.9958608,0.0013541532,0.0010463392,0.0010648981,0.00029972784,0.00037409615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000842987,0.0010111481,0.004421646,0.00032106016,0.00008814094,0.000012271909,0.00022807682,0.00038124,0.00014904155],"category_scores_gemma":[0.00088779454,0.00062962057,0.00045810826,0.0005560584,0.00025836538,0.00009267344,0.00018850366,0.000814298,0.000038107617],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038322655,0.0017796372,0.00031730984,0.03237045,0.00034163118,0.00004967339,0.00028347346,8.66386e-7,1.0136854e-7,0.00005006493,0.0008187119,0.9601558],"study_design_scores_gemma":[0.008272661,0.0010203066,0.0012843275,0.42033932,0.00030797123,0.000076301025,0.000039906514,0.000002616983,0.0000055243086,0.000005701112,0.56819206,0.00045330066],"about_ca_topic_score_codex":0.000112371185,"about_ca_topic_score_gemma":0.000017947807,"teacher_disagreement_score":0.9597025,"about_ca_system_score_codex":0.00049354864,"about_ca_system_score_gemma":0.0005895859,"threshold_uncertainty_score":0.9996155},"labels":[],"label_agreement":null},{"id":"W1858597556","doi":"10.1517/14740338.4.4.795","title":"The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance","year":2005,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London","keywords":"Medicine; Guideline; QT interval; Clinical trial; Christian ministry; Cardiology; Internal medicine; Pathology","score_opus":0.0868578007545821,"score_gpt":0.3849547911325002,"score_spread":0.2980969903779181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858597556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78402525,0.016513692,0.00026389243,0.1889894,0.0038685135,0.0047128154,0.000030072617,0.00013952731,0.0014568344],"genre_scores_gemma":[0.99299264,0.004499595,0.00019867926,0.0008305763,0.0009506872,0.000035336085,0.000014389393,0.000022258017,0.00045581677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950586,0.0024582825,0.0014135224,0.00033326188,0.00041210232,0.00032421853],"domain_scores_gemma":[0.99700934,0.0013621515,0.0005006243,0.0009277528,0.00011691701,0.0000832011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039723744,0.00018273,0.0008362478,0.00007463929,0.0001484158,0.000009329106,0.00020373211,0.00017708851,0.00001336589],"category_scores_gemma":[0.002876864,0.00007611821,0.00081138447,0.0004154333,0.000383466,0.00009695746,0.00008301506,0.00051324035,0.0000048609727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018304251,0.0017415307,0.013000862,0.000069431146,0.00070544356,0.0000086002,0.0016638524,0.00066817255,0.033422455,0.011928084,0.07876844,0.8397189],"study_design_scores_gemma":[0.0052755415,0.00065882545,0.1917826,0.00060948345,0.000022633,0.000032071504,0.0002063622,0.0010655569,0.019032642,0.00016803693,0.7808989,0.000247341],"about_ca_topic_score_codex":0.000016374739,"about_ca_topic_score_gemma":0.000017403185,"teacher_disagreement_score":0.8394715,"about_ca_system_score_codex":0.000099856195,"about_ca_system_score_gemma":0.00028589493,"threshold_uncertainty_score":0.34440827},"labels":[],"label_agreement":null},{"id":"W1934513595","doi":"10.1517/14740338.2015.1073710","title":"The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunology; Virus; Virology; Human papilloma virus; Internal medicine; Cancer; Cervical cancer","score_opus":0.048832654778220484,"score_gpt":0.39756835048697386,"score_spread":0.3487356957087534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934513595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006615746,0.9923013,0.0000031140228,0.0008014517,0.0003814106,0.0016181545,0.0002641828,0.000031782598,0.0045920066],"genre_scores_gemma":[0.00036099085,0.998379,0.000010565434,0.00004766099,0.0004168087,0.00013905579,0.00015170153,0.00005968067,0.0004345483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960882,0.00091475295,0.0012543879,0.00042178176,0.0009571982,0.0003636788],"domain_scores_gemma":[0.9959806,0.0018231639,0.0006141608,0.001104913,0.00024180855,0.00023534358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019949882,0.00041977596,0.0022818719,0.0001291305,0.00043551138,0.000023118715,0.00048474813,0.00017542903,0.00033180235],"category_scores_gemma":[0.00056506007,0.00019277023,0.00082741206,0.00036181175,0.0009821573,0.00003789331,0.00033243783,0.0007301078,0.000009689636],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024774799,0.00011147331,0.000010351889,0.00269918,0.0004596994,0.0000015735778,0.00056560873,6.4573464e-7,6.9987726e-7,0.00142013,0.0035216413,0.9887315],"study_design_scores_gemma":[0.0035444165,0.00021624511,0.000937065,0.0034710655,0.00018334096,0.000006517544,0.0002674483,0.000022033659,0.000007798168,0.00007924263,0.99107337,0.00019145383],"about_ca_topic_score_codex":0.0005582214,"about_ca_topic_score_gemma":0.000017154165,"teacher_disagreement_score":0.98854005,"about_ca_system_score_codex":0.00023054752,"about_ca_system_score_gemma":0.00051726773,"threshold_uncertainty_score":0.7860942},"labels":[],"label_agreement":null},{"id":"W1966041444","doi":"10.1517/14740338.2010.485189","title":"Famciclovir: a focus on efficacy and safety","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Health Sciences Centre; University of Toronto; University of Manitoba; Sunnybrook Health Science Centre","funders":"","keywords":"Famciclovir; Penciclovir; Medicine; Tolerability; Herpes simplex virus; Varicella zoster virus; Virology; Dermatology; Adverse effect; Virus; Pharmacology","score_opus":0.04135512242433964,"score_gpt":0.3753422967079179,"score_spread":0.33398717428357827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966041444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000072637863,0.9634903,0.000018680063,0.000820751,0.0019164706,0.0019386995,0.00013559392,0.0001990379,0.0314732],"genre_scores_gemma":[0.00007061332,0.9959574,0.00021616506,0.00039217118,0.0011052721,0.00018963315,0.00035809889,0.00013432445,0.0015763496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726146,0.0002244402,0.00079771376,0.00088438723,0.00040341952,0.00042858644],"domain_scores_gemma":[0.9976634,0.00059944764,0.0002614471,0.0010255687,0.00005077969,0.00039937132],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029734126,0.0007744081,0.0018837505,0.00033365368,0.00033499108,0.00003844928,0.00014539559,0.0006234947,0.0004433342],"category_scores_gemma":[0.00014788163,0.0005346193,0.0005576019,0.00029923554,0.00011728851,0.000053346757,0.00008932776,0.0011980317,0.0010497454],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002597435,0.0007154172,0.0000027344586,0.0005134352,0.00026036284,0.000028298775,0.00011350435,1.5383903e-7,1.9439251e-7,0.0012011635,0.0034748914,0.9934301],"study_design_scores_gemma":[0.0026690506,0.0004153712,0.000060762428,0.0112190535,0.00010123248,0.00013937424,0.000010004721,0.0000020831583,0.0000055171445,0.000014037233,0.9849306,0.00043293394],"about_ca_topic_score_codex":0.000086277476,"about_ca_topic_score_gemma":0.0000075099524,"teacher_disagreement_score":0.99299717,"about_ca_system_score_codex":0.00035163888,"about_ca_system_score_gemma":0.00027672423,"threshold_uncertainty_score":0.999728},"labels":[],"label_agreement":null},{"id":"W1991718710","doi":"10.1517/14740338.2012.712682","title":"Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Institut universitaire en santé mentale de Montréal","funders":"","keywords":"Aripiprazole; Ziprasidone; Quetiapine; Medicine; Risperidone; Akathisia; Extrapyramidal symptoms; Tolerability; Internal medicine; Antipsychotic; Schizophrenia (object-oriented programming); Olanzapine; Side effect (computer science); Psychiatry; Meta-analysis; Adverse effect","score_opus":0.10230004570858303,"score_gpt":0.3839283334062759,"score_spread":0.2816282876976929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991718710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033432918,0.9954256,0.000035571353,0.0003506368,0.00006487305,0.0024938623,0.00007873514,0.000043631455,0.0011727861],"genre_scores_gemma":[0.024549268,0.9724855,0.0017204939,0.000014923726,0.00010074736,0.0006479612,0.00027166697,0.000073087336,0.00013634773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964654,0.00070542534,0.0009804346,0.0008940134,0.0004988365,0.00045588988],"domain_scores_gemma":[0.9977586,0.0005894709,0.0004124353,0.0007941694,0.000058813253,0.00038645702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00082252594,0.00067000906,0.0051126196,0.0008493558,0.000085798034,0.000025207772,0.00013696382,0.00023587959,0.00044526104],"category_scores_gemma":[0.00015092199,0.0004552487,0.0011651888,0.0009319196,0.00024044438,0.000112067326,0.00020294037,0.00058087014,0.000022806951],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004924287,0.0020301891,0.0027062348,0.0049122153,0.06509357,0.000010586618,0.0006410082,0.000003355324,0.0000010409349,0.0014390798,0.00017361289,0.91806483],"study_design_scores_gemma":[0.01656099,0.0012246416,0.0468348,0.004885007,0.08065903,0.000088465145,0.00044172484,0.0004932496,0.000051265695,0.00016846877,0.8465788,0.0020135983],"about_ca_topic_score_codex":0.0010464641,"about_ca_topic_score_gemma":0.001078055,"teacher_disagreement_score":0.9160512,"about_ca_system_score_codex":0.0002069233,"about_ca_system_score_gemma":0.0002107746,"threshold_uncertainty_score":0.99978995},"labels":[],"label_agreement":null},{"id":"W1998398742","doi":"10.1517/14740338.2015.983071","title":"Drug safety assessment of oral formulations of ketoconazole","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Ketoconazole; Drug; Pharmacology; Intensive care medicine; Safety profile; Adverse effect; Dermatology; Antifungal","score_opus":0.052724582042721395,"score_gpt":0.4216115641743533,"score_spread":0.3688869821316319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998398742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015724152,0.9712347,0.0018772084,0.00046775315,0.00086288305,0.0026868647,0.00033738048,0.00006872631,0.022448787],"genre_scores_gemma":[0.0026107454,0.99227387,0.0021139844,0.00012868701,0.00026866415,0.00009121768,0.0010465571,0.000069852395,0.0013964538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99572843,0.00040740034,0.0020514056,0.0006355954,0.00081507006,0.00036211705],"domain_scores_gemma":[0.9965314,0.0007102478,0.0009755794,0.001291609,0.00028503855,0.00020611235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012640654,0.0005472639,0.003300716,0.00024250615,0.00012915694,0.000007860159,0.00031993646,0.0003065416,0.00058698363],"category_scores_gemma":[0.0002152879,0.0004088706,0.0012611308,0.0003658202,0.0001950398,0.000090401394,0.00011815472,0.00055797555,0.000035132878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040849645,0.0009399383,0.0006288102,0.017445024,0.00044251565,0.0000026919113,0.0003960004,0.000009226244,0.000008434905,0.019913634,0.013365294,0.9464399],"study_design_scores_gemma":[0.0010248275,0.00015393534,0.002569082,0.01530191,0.00009317004,0.000004207824,0.00009411793,0.00008590546,0.00001581638,0.000045102945,0.98029226,0.00031964557],"about_ca_topic_score_codex":0.00008731037,"about_ca_topic_score_gemma":0.000026968559,"teacher_disagreement_score":0.966927,"about_ca_system_score_codex":0.00041954467,"about_ca_system_score_gemma":0.0009496817,"threshold_uncertainty_score":0.9998363},"labels":[],"label_agreement":null},{"id":"W1999940036","doi":"10.1517/14740330902797081","title":"Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"University of Ottawa","keywords":"Medicine; Clopidogrel; Perioperative; Aspirin; Coronary artery disease; Regimen; Randomized controlled trial; Platelet aggregation inhibitor; Surgery; Ticlopidine; Artery; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.04322694386965911,"score_gpt":0.32378122526984554,"score_spread":0.28055428140018646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999940036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031823962,0.99538547,0.000029723744,0.0006855096,0.00061017845,0.0019840684,0.00014137792,0.00017545457,0.00066998636],"genre_scores_gemma":[0.00036292273,0.99552554,0.00006283882,0.0012931655,0.000855968,0.00006353211,0.0013259753,0.00014002465,0.00037003425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584395,0.00082091417,0.0010159861,0.0011861201,0.00057748647,0.00055556116],"domain_scores_gemma":[0.99757487,0.00075943524,0.00028464213,0.0008423638,0.000084768195,0.00045393646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006985526,0.0010760155,0.0038858606,0.00030363805,0.0004328658,0.00008630303,0.00016586237,0.00048966834,0.00018395997],"category_scores_gemma":[0.00006304378,0.00078484067,0.0013899752,0.000304362,0.00031614405,0.00016872486,0.00007635363,0.0006753697,0.000042339292],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021619364,0.0003199576,0.000024989138,0.00067496137,0.0017608438,0.0002762068,0.00043932933,5.6868464e-7,0.0000010252697,0.00016258107,0.0021421046,0.9920355],"study_design_scores_gemma":[0.0036938977,0.00032881717,0.0019815653,0.00955516,0.00014666464,0.0016918239,0.000114089664,0.0000057695834,0.000004402621,0.0000029949017,0.98165876,0.0008160532],"about_ca_topic_score_codex":0.000008389657,"about_ca_topic_score_gemma":5.6890605e-7,"teacher_disagreement_score":0.99121946,"about_ca_system_score_codex":0.00012539655,"about_ca_system_score_gemma":0.00037250156,"threshold_uncertainty_score":0.9994603},"labels":[],"label_agreement":null},{"id":"W2003254367","doi":"10.1517/14740338.2015.1040389","title":"Safety of medication options for treating pediatric esophagitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Observational study; Intensive care medicine; Esophagitis; Randomized controlled trial; Reflux esophagitis; Proton-pump inhibitor; Antacid; Internal medicine; Omeprazole; Safety profile; Adverse effect; Disease; Reflux","score_opus":0.05999688029611553,"score_gpt":0.3971398556687936,"score_spread":0.33714297537267807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003254367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002413715,0.9929555,0.0003324039,0.00019191159,0.0010483437,0.0025080491,0.00067801296,0.00009437767,0.0021889838],"genre_scores_gemma":[0.00013334585,0.9877171,0.003310115,0.000056274617,0.0015778616,0.00057212764,0.0053932453,0.00010787251,0.0011320752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968404,0.00019047485,0.0013177918,0.0006344833,0.00063398416,0.00038285155],"domain_scores_gemma":[0.9973452,0.0005192853,0.0008004309,0.00070522714,0.0002642872,0.0003655389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005743371,0.00056554034,0.002096636,0.00040304486,0.00015650973,0.000010843422,0.00021356322,0.00033691822,0.00013008025],"category_scores_gemma":[0.0003507085,0.00042188918,0.00081145274,0.00039173447,0.00006421862,0.00007889183,0.00005998977,0.00029589073,0.00010028858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012713046,0.00049691123,0.000059040845,0.0037504386,0.00029617993,0.000013036356,0.0002180928,0.0000019279694,6.5130266e-8,0.0005969254,0.0077497256,0.9866905],"study_design_scores_gemma":[0.0028805202,0.00051133556,0.0001560164,0.004194342,0.00041671563,0.00004921015,0.000031773612,0.00001653836,0.0000031355285,0.000030304334,0.9915277,0.00018243259],"about_ca_topic_score_codex":0.000014078538,"about_ca_topic_score_gemma":4.795643e-7,"teacher_disagreement_score":0.9865081,"about_ca_system_score_codex":0.00058032846,"about_ca_system_score_gemma":0.00077405525,"threshold_uncertainty_score":0.9998233},"labels":[],"label_agreement":null},{"id":"W2005125564","doi":"10.1517/eods.3.2.113.27343","title":"The safety of antithrombotic therapy during pregnancy","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiovascular Issues in Pregnancy","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Antithrombotic; Warfarin; Pregnancy; Heparin; Anticoagulant; Low molecular weight heparin; Thrombosis; Fetus; Intensive care medicine; Surgery; Obstetrics; Internal medicine","score_opus":0.03836150301545036,"score_gpt":0.35399748430092187,"score_spread":0.3156359812854715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005125564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001190852,0.98866063,0.000055387598,0.00027170937,0.003015324,0.003079562,0.000041251766,0.00015309558,0.0047218595],"genre_scores_gemma":[0.000041431194,0.9973442,0.00025824105,0.000029234172,0.0007574103,0.00020016474,0.00016341041,0.0002172496,0.0009886738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99528277,0.0005054745,0.0016153287,0.00089872896,0.0010925045,0.00060519646],"domain_scores_gemma":[0.9957809,0.00044990392,0.0006327448,0.0027987498,0.0001545742,0.00018316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004904266,0.0008547332,0.0032195004,0.00021898173,0.00038664075,0.000031061376,0.00070164964,0.00043051364,0.00014466132],"category_scores_gemma":[0.00020703353,0.0005305303,0.0027854857,0.0005664217,0.00032577242,0.00008523518,0.00022475586,0.00087647943,0.00013233714],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019827594,0.00022557768,0.0000025730587,0.009552303,0.0014118721,0.00008510296,0.0005819486,0.000009155604,0.0000012809624,0.0010859416,0.00024960408,0.98659635],"study_design_scores_gemma":[0.00196176,0.000105777064,0.00006047916,0.20258637,0.00009176807,0.0005063637,0.00004503178,6.274994e-7,0.000053376534,0.000020570087,0.7941693,0.00039856284],"about_ca_topic_score_codex":0.000019511946,"about_ca_topic_score_gemma":0.0000012293802,"teacher_disagreement_score":0.9861978,"about_ca_system_score_codex":0.0006828413,"about_ca_system_score_gemma":0.000637471,"threshold_uncertainty_score":0.9997146},"labels":[],"label_agreement":null},{"id":"W2010173526","doi":"10.1517/14740338.2014.905540","title":"Do we need to worry about mycophenolate overdose?","year":2014,"lang":"en","type":"letter","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Mycophenolic acid; Pharmacokinetics; Intensive care medicine; Mycophenolate; Drug overdose; Observational study; Pharmacology; Emergency medicine; Transplantation; Internal medicine; Poison control","score_opus":0.028488780113973947,"score_gpt":0.3206889158818539,"score_spread":0.29220013576787995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010173526","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000752562,0.004111807,0.0005302284,0.9713578,0.004309524,0.001345999,0.0001881807,0.00025757236,0.017823623],"genre_scores_gemma":[0.0021926556,0.021018028,0.0013128483,0.94294053,0.007861519,0.0001597828,0.0023495362,0.00022828272,0.021936838],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967171,0.00016077766,0.00071391935,0.0008834927,0.00091026654,0.0006144288],"domain_scores_gemma":[0.99805826,0.00032712068,0.00021736255,0.0009839326,0.00009782977,0.0003155176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015130198,0.00072277576,0.0010156815,0.00038183498,0.00016645005,0.00006577519,0.00027275912,0.0006099459,0.0010512293],"category_scores_gemma":[0.00002958155,0.0005560685,0.00047094503,0.0002678233,0.000041434443,0.000069947346,0.000045672543,0.001122313,0.0022830998],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092605985,0.00012096023,0.00026540007,0.00032186537,0.00035924476,0.0003297636,0.0011953762,0.000025131967,0.000026674186,0.00019780491,0.9867667,0.009465049],"study_design_scores_gemma":[0.003463892,0.00027874537,0.0015755568,0.0046082744,0.00003188155,0.00008172569,0.000045798653,0.000016095059,0.00012658455,0.000046193483,0.9891985,0.00052672165],"about_ca_topic_score_codex":0.00009944385,"about_ca_topic_score_gemma":0.0000011849266,"teacher_disagreement_score":0.0284173,"about_ca_system_score_codex":0.00031654452,"about_ca_system_score_gemma":0.0001069062,"threshold_uncertainty_score":0.99986196},"labels":[],"label_agreement":null},{"id":"W2011083031","doi":"10.1517/14740338.2.5.451","title":"Recent differing expert opinions regarding the safety profile of hepatitis B vaccines: is there really a controversy?","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Medicine; Hepatitis B; Safety profile; Expert opinion; Family medicine; Intensive care medicine; Adverse effect; Virology; Immunology; Pharmacology","score_opus":0.02449876780380497,"score_gpt":0.30239588522140387,"score_spread":0.2778971174175989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011083031","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076700315,0.1450927,0.004937875,0.32928297,0.019415446,0.016353505,0.0017883076,0.001732725,0.40469617],"genre_scores_gemma":[0.70963204,0.27855062,0.0014903819,0.0070172213,0.0008053674,0.0004189098,0.00016067721,0.00015750554,0.0017672883],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966926,0.00038246505,0.0009754752,0.0006370466,0.0007238518,0.00058854074],"domain_scores_gemma":[0.997421,0.0006389081,0.00032078053,0.0010794366,0.00033608652,0.00020378665],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006133359,0.00046980171,0.0008941568,0.00012890999,0.00054961146,0.000025257801,0.00027195836,0.00015103491,0.0012183907],"category_scores_gemma":[0.0010631955,0.00032011024,0.00032243374,0.0003963954,0.00014476258,0.00014106766,0.00013390213,0.00039094995,0.00005588558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005430296,0.0019673873,0.11333637,0.00036359622,0.0021500015,0.00006614642,0.061727066,0.000050263356,0.0040180674,0.05130411,0.565644,0.19394268],"study_design_scores_gemma":[0.0034388609,0.00030554854,0.045753945,0.0008459284,0.000013022705,0.000027884953,0.0018813922,0.00015839309,0.0058834613,0.00006019256,0.9412668,0.00036458255],"about_ca_topic_score_codex":0.0010566548,"about_ca_topic_score_gemma":0.00021474842,"teacher_disagreement_score":0.6329317,"about_ca_system_score_codex":0.0004310942,"about_ca_system_score_gemma":0.00021952331,"threshold_uncertainty_score":0.9999251},"labels":[],"label_agreement":null},{"id":"W2012393743","doi":"10.1517/14740338.5.2.231","title":"Adverse reactions to first-line antituberculosis drugs","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":316,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Ethambutol; Incidence (geometry); Pyrazinamide; Isoniazid; Discontinuation; Adverse effect; Tuberculosis; Hepatitis; Internal medicine; Intensive care medicine; Pathology","score_opus":0.17355412632767034,"score_gpt":0.47612585258496404,"score_spread":0.30257172625729367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012393743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014015217,0.94566315,0.0002727268,0.0028077539,0.014711889,0.003757141,0.00078962947,0.00060103275,0.031382684],"genre_scores_gemma":[0.00009355773,0.9877665,0.00020236833,0.002068165,0.0031543132,0.0010168909,0.0009490897,0.00015531758,0.004593775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99462736,0.0013864421,0.0014950528,0.001183856,0.00044788982,0.00085942907],"domain_scores_gemma":[0.9968774,0.0010392279,0.0005788879,0.00082413777,0.00013093636,0.0005494512],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012944455,0.0010298939,0.001749884,0.000707262,0.0012038953,0.00003826361,0.00064549973,0.001537361,0.0014454171],"category_scores_gemma":[0.00016658485,0.0009647126,0.001039064,0.0010416629,0.00012478988,0.00020963549,0.00020961383,0.0027099594,0.0042883093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018666127,0.0007497972,0.000002693802,0.0020083522,0.00032266777,0.000014696827,0.00077228836,0.00077968516,0.00000784601,0.0009474335,0.063205555,0.9310023],"study_design_scores_gemma":[0.0007311436,0.00010940028,0.0000044085464,0.003565574,0.000110068795,0.00003509745,0.000050767547,0.00010307382,0.00016244927,0.000038213322,0.9940968,0.0009930157],"about_ca_topic_score_codex":0.0005385311,"about_ca_topic_score_gemma":0.000091711576,"teacher_disagreement_score":0.9308912,"about_ca_system_score_codex":0.000965856,"about_ca_system_score_gemma":0.00028668166,"threshold_uncertainty_score":0.99975884},"labels":[],"label_agreement":null},{"id":"W2015413787","doi":"10.1517/14740338.4.3.591","title":"Are rates of gastrointestinal bleeding higher following the introduction of COX-2 inhibitors?","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Population; Drug; Gastrointestinal bleeding; Pharmacology; Internal medicine; Environmental health","score_opus":0.0429082140253849,"score_gpt":0.3567286536502824,"score_spread":0.3138204396248975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015413787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017447576,0.9929236,0.000014078172,0.0011430819,0.0042150794,0.0010826134,0.000016627147,0.000053562435,0.00037688523],"genre_scores_gemma":[0.0007187969,0.98668003,0.00025446428,0.00009449124,0.011608873,0.00007537136,0.00014353858,0.00008938145,0.00033505535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711865,0.00031030885,0.0011887044,0.00045162594,0.00060143176,0.00032929025],"domain_scores_gemma":[0.997308,0.00050139456,0.0013418265,0.0005876397,0.0001388996,0.00012224952],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000996973,0.0004972265,0.0019125313,0.00024808152,0.00011847196,0.000010219126,0.00020774076,0.00018144312,0.00017262415],"category_scores_gemma":[0.00040712793,0.0003074407,0.00091142807,0.0003618669,0.00012658823,0.000082832004,0.000077222125,0.0006307318,0.000032995504],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055422966,0.0004856018,0.00043815712,0.0146548785,0.00058244605,0.000043107855,0.00076566817,0.000017115239,0.00018230232,0.00068472786,0.116158776,0.865433],"study_design_scores_gemma":[0.0006616752,0.00017084804,0.00015885525,0.03536159,0.00010919794,0.00008390788,0.00015407779,0.000009413919,0.00035698724,0.0000017050984,0.9627063,0.00022542253],"about_ca_topic_score_codex":0.0000138994155,"about_ca_topic_score_gemma":9.3747207e-7,"teacher_disagreement_score":0.86520755,"about_ca_system_score_codex":0.00023471305,"about_ca_system_score_gemma":0.00018948215,"threshold_uncertainty_score":0.9999378},"labels":[],"label_agreement":null},{"id":"W2019625594","doi":"10.1517/14740338.2012.643866","title":"Adverse reactions to β-lactam antimicrobials","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Shared Health; St. Boniface Hospital","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Antibiotics; Penicillin; Allergy; Culprit; Desensitization (medicine); Antimicrobial; Cephalosporin; Beta-lactam; Drug allergy; Dosing; Pharmacovigilance; Pharmacology; Immunology; Internal medicine","score_opus":0.09243773285328258,"score_gpt":0.397935331244841,"score_spread":0.30549759839155843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019625594","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.980566e-7,0.91601163,0.00006554741,0.002001696,0.008193583,0.003048682,0.00025015877,0.00049458205,0.06993331],"genre_scores_gemma":[0.000027783959,0.9834865,0.0010082731,0.0011007418,0.0034892338,0.0003175298,0.0010618267,0.00026157903,0.009246552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580365,0.00032706483,0.0014021615,0.0010070293,0.0005916958,0.00086836924],"domain_scores_gemma":[0.99612963,0.0004835751,0.0005568186,0.0017008582,0.00015527147,0.0009738307],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057581277,0.00097159564,0.0025503167,0.00092607987,0.00033718385,0.000025731877,0.00033906096,0.00061008526,0.0004169827],"category_scores_gemma":[0.00029535763,0.0008221033,0.0013368289,0.0009370454,0.00007727126,0.00025538795,0.00018024359,0.0012167837,0.010076385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025148458,0.0006461135,4.985054e-7,0.0018293642,0.00033377396,0.000015343227,0.00039282045,0.0000028858506,0.00004996233,0.0004025985,0.021818394,0.9744831],"study_design_scores_gemma":[0.00055275555,0.000029928842,0.000030109626,0.018133428,0.00022887529,0.00040307213,0.0001518001,7.6103237e-7,0.00003133282,0.0000011399139,0.9797071,0.0007296707],"about_ca_topic_score_codex":0.00011250473,"about_ca_topic_score_gemma":0.0000041486023,"teacher_disagreement_score":0.97375345,"about_ca_system_score_codex":0.0015335164,"about_ca_system_score_gemma":0.0007433973,"threshold_uncertainty_score":0.99942297},"labels":[],"label_agreement":null},{"id":"W2021941886","doi":"10.1517/14740338.2014.896455","title":"Painful decision-making at FDA","year":2014,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Oxycodone; Oxymorphone; Intensive care medicine; Opioid; Hydrocodone; Postmarketing surveillance; Hydromorphone; Risk analysis (engineering); Pharmacology; Adverse effect","score_opus":0.009102172697563944,"score_gpt":0.32075933512620725,"score_spread":0.3116571624286433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021941886","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121809055,0.0077444,0.0003420301,0.0020452612,0.9772003,0.0011633995,0.00022238826,0.00037572728,0.010784655],"genre_scores_gemma":[0.0014363293,0.017049203,0.0021001196,0.0013586142,0.9684561,0.0002455036,0.003950496,0.00034905924,0.0050545707],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99452007,0.00023023957,0.0009785113,0.0013515388,0.0022083686,0.0007112972],"domain_scores_gemma":[0.9929842,0.0041090166,0.00042500914,0.0018283156,0.00030045834,0.00035301453],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00061933143,0.0009393155,0.0013492143,0.0003379834,0.00035490663,0.000051833296,0.00043527017,0.0011067439,0.0012710225],"category_scores_gemma":[0.002289752,0.0007734343,0.0006066061,0.0002266541,0.00009260657,0.00006982185,0.00033932965,0.0010156719,0.0019868566],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002019169,0.00041187438,0.000051375046,0.000108122156,0.00019193107,0.00003586599,0.0011727473,0.000015421443,0.0000038650014,0.00006321333,0.94738734,0.04853907],"study_design_scores_gemma":[0.0036814092,0.00045151066,0.00025406262,0.004064788,0.000029069857,0.00000767026,0.00017000924,0.00008588986,0.00003663766,0.00009650098,0.99045086,0.0006716092],"about_ca_topic_score_codex":0.00009362549,"about_ca_topic_score_gemma":0.000024129426,"teacher_disagreement_score":0.04786746,"about_ca_system_score_codex":0.0018196183,"about_ca_system_score_gemma":0.000570568,"threshold_uncertainty_score":0.99964195},"labels":[],"label_agreement":null},{"id":"W2022539355","doi":"10.1517/14740338.2014.926887","title":"Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Observational study; Cancer; Intensive care medicine; Confounding; Metformin; Clinical trial; Diabetes mellitus; Internal medicine; Oncology","score_opus":0.027585024756647505,"score_gpt":0.3338255132818152,"score_spread":0.3062404885251677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022539355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035553778,0.9939479,0.000008259377,0.00051630114,0.004038644,0.00081506534,0.0005677834,0.000006785238,0.00006370547],"genre_scores_gemma":[0.000021488393,0.9943458,0.000021149152,0.0004867417,0.0043384065,0.00039611824,0.0002994297,0.000033083204,0.000057791407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979383,0.0004454886,0.00050762197,0.0006384975,0.0002688618,0.00020128043],"domain_scores_gemma":[0.9984867,0.00006393347,0.00030491044,0.00092366786,0.00009805384,0.00012271355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055858295,0.00037359528,0.0013241513,0.000042438238,0.00013501068,0.000024689722,0.0002640598,0.00024183435,0.0000120657],"category_scores_gemma":[0.00006870447,0.00024779738,0.00040123952,0.0001737298,0.00032992527,0.0000063001094,0.0001952303,0.0002654462,2.7643463e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004743822,0.000018013809,0.000052373227,0.01852161,0.00049419503,2.252985e-8,0.00023394285,3.4036367e-7,0.00001555016,0.00009809626,0.043586995,0.9369741],"study_design_scores_gemma":[0.0002265946,0.000015821211,0.00011964824,0.06044807,0.00015857597,0.00000558845,0.000014611734,8.2055976e-7,0.00001944382,0.000004001511,0.93873054,0.00025626688],"about_ca_topic_score_codex":0.00009246331,"about_ca_topic_score_gemma":0.00003084419,"teacher_disagreement_score":0.93671787,"about_ca_system_score_codex":0.000022566228,"about_ca_system_score_gemma":0.00021922088,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2024028287","doi":"10.1517/14740338.2014.970164","title":"Antihistamines and birth defects: a systematic review of the literature","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health","keywords":"Medicine; Antihistamine; Systematic review; Pediatrics; Population; Pregnancy; Loratadine; MEDLINE; Pharmacology; Environmental health","score_opus":0.02039990993667317,"score_gpt":0.34534024351459125,"score_spread":0.3249403335779181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024028287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.412401e-7,0.99438316,0.000014237421,0.0008321531,0.00070973864,0.0031166247,0.00006605001,0.000038372607,0.0008394978],"genre_scores_gemma":[0.000007602396,0.99586225,0.000028754728,0.0023031328,0.00026085798,0.00021013671,0.00016314865,0.0000421966,0.001121923],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972185,0.0006729585,0.0011241002,0.00035139374,0.00044761386,0.00018544047],"domain_scores_gemma":[0.99715257,0.0004852183,0.000924471,0.0011702562,0.000111729096,0.00015574486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007945386,0.000408111,0.0030063638,0.00013243548,0.00007650725,0.000011216243,0.0002620824,0.00021036327,0.000034247743],"category_scores_gemma":[0.0020244871,0.00019285841,0.0006565778,0.0004557176,0.00010219269,0.00004124607,0.000071249626,0.0004026491,0.000017540413],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007217564,0.000044184835,8.147644e-7,0.9484025,0.00009789598,0.0000013441764,0.00025987515,3.2049137e-9,1.5174923e-7,0.00028702398,0.0074358913,0.043463074],"study_design_scores_gemma":[0.00015093005,0.000027861342,0.0000038030785,0.5120746,0.00013054299,0.00010459971,0.0000074705636,4.0755265e-7,9.163847e-7,0.0000014425399,0.48740909,0.000088357585],"about_ca_topic_score_codex":0.000002168482,"about_ca_topic_score_gemma":1.633242e-7,"teacher_disagreement_score":0.4799732,"about_ca_system_score_codex":0.00007847036,"about_ca_system_score_gemma":0.00025727367,"threshold_uncertainty_score":0.7864537},"labels":[],"label_agreement":null},{"id":"W2029520632","doi":"10.1517/14740338.2015.1029915","title":"Safety of infliximab for the treatment of inflammatory bowel disease: current understanding of the potential for serious adverse events","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Adverse effect; Intensive care medicine; Disease; Crohn's disease; Current (fluid); Internal medicine","score_opus":0.037470537964966945,"score_gpt":0.3357740852289325,"score_spread":0.2983035472639655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029520632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016444166,0.98711234,0.0015374889,0.000073389245,0.0023515914,0.00558694,0.0031322623,0.000009920708,0.000031636795],"genre_scores_gemma":[0.0014478542,0.9961612,0.0000570643,0.00001532511,0.0005126378,0.00066765863,0.0009584501,0.000079107,0.00010067381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974934,0.00027063597,0.0010890941,0.0004615562,0.00038915823,0.00029614582],"domain_scores_gemma":[0.9972906,0.00012447198,0.0011156149,0.0010988659,0.00022316391,0.00014730172],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040231485,0.0004987611,0.00081871357,0.0000725222,0.0001747476,0.000003693274,0.0005711493,0.00020617389,0.000007802055],"category_scores_gemma":[0.00011236331,0.00030061553,0.0016016829,0.00007790819,0.00021935235,0.0000074207387,0.00014470427,0.00008567213,0.0000010164102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028587958,0.0039553433,0.0002814309,0.0400146,0.0051588276,0.000006805976,0.0019303133,0.004811244,0.00015600854,0.006180555,0.014101016,0.8948159],"study_design_scores_gemma":[0.0026753547,0.0002116387,0.00029930938,0.0025949709,0.00026221832,0.0000012532112,0.00016273146,0.00011947582,0.00008347632,0.00006833032,0.99321485,0.0003063882],"about_ca_topic_score_codex":0.0000034283364,"about_ca_topic_score_gemma":0.0000045457214,"teacher_disagreement_score":0.9791138,"about_ca_system_score_codex":0.00036676053,"about_ca_system_score_gemma":0.001158862,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W2032077631","doi":"10.1517/14740338.5.4.523","title":"The effect of antidepressants on lipid homeostasis: a cardiac safety concern?","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Mirtazapine; Venlafaxine; Medicine; Bupropion; Lipid profile; Internal medicine; Cholesterol; Pharmacology; Endocrinology; Psychiatry; Antidepressant; Anxiety; Pathology","score_opus":0.03599538423764926,"score_gpt":0.40012128186646556,"score_spread":0.3641258976288163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032077631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015972353,0.97063863,0.000002289957,0.0006536669,0.007187373,0.005348077,0.000910708,0.000106298365,0.015136988],"genre_scores_gemma":[0.00019160246,0.9940257,0.00001346099,0.00039659822,0.0030546577,0.00041588064,0.0012217794,0.00014795264,0.00053234276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932916,0.0018807707,0.001887205,0.0008929824,0.0011158588,0.00093156245],"domain_scores_gemma":[0.9936706,0.0032919566,0.0008360284,0.0015316161,0.000082731036,0.00058710633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023046436,0.0009060514,0.0044667018,0.00023502293,0.00048722487,0.00002043387,0.00032761125,0.00048404597,0.00003441218],"category_scores_gemma":[0.00026424762,0.00052786747,0.001979741,0.0004589625,0.00020588652,0.00004399059,0.000120901714,0.0010972851,0.00017742383],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018874333,0.00010078954,0.000025174837,0.011767695,0.00016607992,0.000007370075,0.00008074407,0.0000010118848,1.9802636e-7,0.000093156326,0.06454944,0.9213209],"study_design_scores_gemma":[0.002061333,0.0013857902,0.0001858257,0.03245142,0.0001232984,0.00003079598,0.000044933393,0.000001498818,0.000049593098,7.406299e-7,0.9632911,0.00037365663],"about_ca_topic_score_codex":0.00044761202,"about_ca_topic_score_gemma":0.000004203993,"teacher_disagreement_score":0.92094725,"about_ca_system_score_codex":0.0010220851,"about_ca_system_score_gemma":0.0009395311,"threshold_uncertainty_score":0.9997173},"labels":[],"label_agreement":null},{"id":"W2034607233","doi":"10.1517/14740338.2.2.161","title":"Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Premenstrual dysphoric disorder; Dysphoria; Tolerability; Medicine; Psychiatry; Mood; Population; Affect (linguistics); Clinical psychology; Adverse effect; Menstrual cycle; Psychology; Internal medicine; Anxiety","score_opus":0.04837717828652159,"score_gpt":0.3692788410502523,"score_spread":0.3209016627637307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034607233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022659759,0.94680244,0.0000176662,0.00051202363,0.0016072319,0.0069042766,0.00025450505,0.000120804776,0.043758407],"genre_scores_gemma":[0.000119085926,0.99554455,0.00085953984,0.00023286087,0.00071397587,0.00067939376,0.00070641475,0.00017260533,0.0009715796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946943,0.0005503878,0.0017532025,0.0012191572,0.0009697802,0.00081319804],"domain_scores_gemma":[0.99680287,0.00036266423,0.0009028825,0.001111857,0.00020371113,0.000616047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000340812,0.0011991384,0.0034129457,0.0003911092,0.00023423177,0.000013881609,0.00017533234,0.00058682694,0.00028301065],"category_scores_gemma":[0.00008459416,0.0007877064,0.000633935,0.00069949456,0.00015757086,0.000064762186,0.0000273551,0.000590504,0.000105284686],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047081322,0.0014336586,0.000012992625,0.0032199798,0.0004700233,0.000024207768,0.0012735471,0.0000038340445,3.6359552e-7,0.0008360811,0.0057791313,0.98223805],"study_design_scores_gemma":[0.005892172,0.008880294,0.000025492613,0.017068522,0.00012366063,0.00008396674,0.00046280108,0.0000036336985,0.00010642854,0.000012978796,0.96673423,0.0006058115],"about_ca_topic_score_codex":0.00026885225,"about_ca_topic_score_gemma":0.00003331909,"teacher_disagreement_score":0.98163223,"about_ca_system_score_codex":0.0017896625,"about_ca_system_score_gemma":0.0021149477,"threshold_uncertainty_score":0.99945736},"labels":[],"label_agreement":null},{"id":"W2037388690","doi":"10.1517/14740330903188413","title":"Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Statin; Coronary artery disease; Atrial fibrillation; Internal medicine; Cardiology; Cardiopulmonary bypass; Coronary artery bypass surgery; Artery; Revascularization; Adverse effect; Surgery; Myocardial infarction","score_opus":0.035373376346846425,"score_gpt":0.3393196265184218,"score_spread":0.3039462501715754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037388690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002590453,0.9907402,0.000012042853,0.0038974143,0.0003534457,0.0021388694,0.0001403266,0.000092682894,0.0023660085],"genre_scores_gemma":[0.0002923788,0.9951151,0.00018986185,0.001795383,0.00031917577,0.00007738442,0.0007233187,0.0000793758,0.0014079944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99612737,0.0009229189,0.0010151827,0.0010276895,0.00045126668,0.0004555849],"domain_scores_gemma":[0.99430364,0.0043952027,0.00024043214,0.00045691102,0.00009241384,0.000511408],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000673144,0.0008929528,0.0043108766,0.00025320382,0.00032165673,0.000082768165,0.000083122926,0.00037755398,0.00007596249],"category_scores_gemma":[0.00027538184,0.0006189088,0.00053826586,0.00021695714,0.0003175129,0.00015691006,0.00009516972,0.00063391635,0.000018283068],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009788186,0.0002080172,0.00023701316,0.0009589626,0.00053279864,0.00027781338,0.0021986086,2.7487695e-7,5.2136517e-7,0.0014664276,0.0034792223,0.9896615],"study_design_scores_gemma":[0.0018776418,0.00039162685,0.011753399,0.0071228584,0.00014812524,0.0014526455,0.00027436973,0.0000059179715,0.0000011023129,0.0000033006122,0.9763209,0.00064807775],"about_ca_topic_score_codex":0.000021060503,"about_ca_topic_score_gemma":0.0000032404894,"teacher_disagreement_score":0.98901343,"about_ca_system_score_codex":0.00015291687,"about_ca_system_score_gemma":0.00032088044,"threshold_uncertainty_score":0.9996262},"labels":[],"label_agreement":null},{"id":"W2044795877","doi":"10.1517/14740338.4.2.273","title":"The safety of antidepressant use in pregnancy","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Antidepressant; Pregnancy; Depression (economics); Psychiatry; Drugs in pregnancy; Intensive care medicine; Fetus; Anxiety","score_opus":0.06972261786582652,"score_gpt":0.38779825670822105,"score_spread":0.31807563884239454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044795877","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044610592,0.9933171,0.0000042444353,0.0005469756,0.0017780734,0.0021457395,0.000116992276,0.000046337776,0.0020400484],"genre_scores_gemma":[0.00005242457,0.99653965,0.000118051095,0.00018331752,0.00039522912,0.00019171371,0.00015667554,0.00007517894,0.0022877443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626356,0.0004704425,0.001718496,0.0005306713,0.0004981871,0.00051863183],"domain_scores_gemma":[0.99717164,0.00097341416,0.00060572656,0.0010162722,0.000047229903,0.00018573052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000492121,0.0005099954,0.0017166303,0.0001833493,0.00017231294,0.000019581074,0.00035565518,0.00027779766,0.000098672535],"category_scores_gemma":[0.00012835173,0.00030988306,0.00047101435,0.0002438656,0.00011340459,0.000105960935,0.00013845827,0.0007324728,0.00007695616],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000687339,0.00028162223,0.0001337213,0.01958036,0.00006678163,0.000028294802,0.00026372113,0.000001977976,5.462804e-8,0.0010486979,0.00066662725,0.9772408],"study_design_scores_gemma":[0.0006330852,0.0000837702,0.0007276913,0.29557568,0.000013435412,0.00004477638,0.000012485903,0.000004069411,0.0000068032473,0.0000036836605,0.7027078,0.00018672954],"about_ca_topic_score_codex":0.00013060286,"about_ca_topic_score_gemma":0.00002432617,"teacher_disagreement_score":0.97705406,"about_ca_system_score_codex":0.0002953257,"about_ca_system_score_gemma":0.0002782968,"threshold_uncertainty_score":0.9999353},"labels":[],"label_agreement":null},{"id":"W2055017324","doi":"10.1517/14740338.2011.584531","title":"Adverse drug reactions in newborns, infants and toddlers: pediatric pharmacovigilance between present and future","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacovigilance; Medicine; Drug reaction; Adverse effect; Drug; Adverse drug reaction; Pediatrics; Adverse drug event; Intensive care medicine; Pharmacology","score_opus":0.14124959565047093,"score_gpt":0.4633750617566379,"score_spread":0.322125466106167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055017324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027858018,0.98589206,0.0000027098918,0.0011573457,0.0047128424,0.0018364685,0.00082316704,0.00019994217,0.005096866],"genre_scores_gemma":[0.00032392266,0.9883095,0.000058795376,0.00072744605,0.00867542,0.0004017178,0.00045560475,0.000115653245,0.00093191775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99503624,0.0011702054,0.0013430057,0.0012584171,0.00028973157,0.0009024181],"domain_scores_gemma":[0.9968144,0.0011800412,0.0007138018,0.00051761884,0.00006581867,0.00070828653],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00091951183,0.0010528733,0.0017901344,0.00075016805,0.00051704136,0.000033916585,0.0005178128,0.0007703159,0.0004908829],"category_scores_gemma":[0.00003860518,0.0009644286,0.0003725067,0.0006661071,0.00022719456,0.0005486495,0.00029661343,0.0030996338,0.00021934717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030784204,0.00047826438,0.0013135629,0.0025989169,0.00041667913,0.00005151085,0.001831742,0.000019027257,0.0000035664298,0.00037746652,0.048901506,0.9436999],"study_design_scores_gemma":[0.002059053,0.000031223663,0.00053440535,0.0010978666,0.00026491494,0.000045317647,0.000251851,0.000030920684,0.000017721872,0.000028060489,0.9947115,0.0009271281],"about_ca_topic_score_codex":0.000118952375,"about_ca_topic_score_gemma":0.000007036199,"teacher_disagreement_score":0.94581,"about_ca_system_score_codex":0.00030033902,"about_ca_system_score_gemma":0.00034603555,"threshold_uncertainty_score":0.99928063},"labels":[],"label_agreement":null},{"id":"W2055503279","doi":"10.1517/14740338.6.3.279","title":"The safety and efficacy of IFN-β products for the treatment of multiple sclerosis","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Multiple sclerosis; Adverse effect; Clinical trial; Disease; Dimethyl fumarate; Internal medicine; Intensive care medicine; Immunology","score_opus":0.201271851586892,"score_gpt":0.4185231491944807,"score_spread":0.21725129760758868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055503279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008228368,0.98902565,0.00005264616,0.002124615,0.0006756711,0.007578931,0.00030001707,0.000029800334,0.00020444767],"genre_scores_gemma":[0.00013837042,0.9972943,0.0004080052,0.000031630272,0.0007970221,0.00056194793,0.00015484884,0.000077064826,0.0005367942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965188,0.00028080057,0.001317659,0.0006516444,0.0007121411,0.0005189706],"domain_scores_gemma":[0.98566777,0.011962797,0.0005956447,0.0012776783,0.00036438333,0.00013172197],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013091335,0.00057274045,0.002121573,0.00016050722,0.00055156526,0.000017019463,0.0003432921,0.00017966781,0.000011067462],"category_scores_gemma":[0.0021792045,0.00025404242,0.0007500868,0.00040281596,0.0006551215,0.0000308782,0.00013287652,0.00024835762,0.0000052793234],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017789098,0.00066360884,0.000009492485,0.002723057,0.00088432047,2.8752694e-7,0.0011613814,0.0000015655368,0.000012995422,0.00009097864,0.0032973092,0.98937607],"study_design_scores_gemma":[0.0037885765,0.000844323,0.0016372818,0.008734127,0.00011888392,0.0000030716235,0.00028367623,0.00003677698,0.00025800092,6.198961e-7,0.98409307,0.00020160446],"about_ca_topic_score_codex":0.00012622878,"about_ca_topic_score_gemma":0.000023325305,"teacher_disagreement_score":0.9891745,"about_ca_system_score_codex":0.00035108515,"about_ca_system_score_gemma":0.00029040003,"threshold_uncertainty_score":0.9999912},"labels":[],"label_agreement":null},{"id":"W2063320747","doi":"10.1517/14740338.2014.973846","title":"Is it safe to use smoking cessation therapeutics during pregnancy?","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Varenicline; Smoking cessation; Pregnancy; Nicotine replacement therapy; Bupropion; Addiction; Intensive care medicine; Nicotine; Obstetrics; Psychiatry","score_opus":0.13800878853301513,"score_gpt":0.41268243722773235,"score_spread":0.2746736486947172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063320747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012150011,0.98938316,0.00044009194,0.0021268371,0.0034585805,0.002287681,0.00007590554,0.00022088662,0.0018853851],"genre_scores_gemma":[0.0013254598,0.99258524,0.00012131377,0.0016298528,0.0008943675,0.00025633373,0.00064396654,0.00016417811,0.0023792891],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647856,0.00026806505,0.0010472122,0.00086348486,0.0008922006,0.0004505037],"domain_scores_gemma":[0.9977715,0.0002713652,0.00047449057,0.0011050573,0.00015162032,0.00022597064],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029445815,0.0006763288,0.0014991187,0.00043952884,0.0002825041,0.00010309392,0.0002754047,0.0005371761,0.00048308974],"category_scores_gemma":[0.00009006462,0.0005607016,0.00058252306,0.00045826207,0.000037337744,0.00017741194,0.00009415508,0.0006639569,0.0001072188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000834885,0.0001634006,0.00052113336,0.0034157396,0.0001906375,0.00000981266,0.0025469854,0.0000027333183,0.000003514808,0.00010561049,0.0039248215,0.98903215],"study_design_scores_gemma":[0.0007471974,0.00009070017,0.002188578,0.060848076,0.00017335782,0.000045796383,0.00008606883,0.000005364673,0.000071399896,0.000002539848,0.9352043,0.0005366113],"about_ca_topic_score_codex":0.00005095071,"about_ca_topic_score_gemma":0.0000019254824,"teacher_disagreement_score":0.9884955,"about_ca_system_score_codex":0.0007434756,"about_ca_system_score_gemma":0.00018139131,"threshold_uncertainty_score":0.99968445},"labels":[],"label_agreement":null},{"id":"W2064807159","doi":"10.1517/14740338.2012.705828","title":"Anticonvulsant hypersensitivity syndrome: an update","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lamotrigine; Anticonvulsant; Carbamazepine; Phenobarbital; Phenytoin; Pharmacovigilance; Incidence (geometry); Genetic testing; Drug; Pharmacology; Intensive care medicine; Epilepsy; Internal medicine; Psychiatry","score_opus":0.09170839139657168,"score_gpt":0.39039477450406573,"score_spread":0.29868638310749407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064807159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012629578,0.9757083,0.000021913896,0.00065632054,0.0050786687,0.0016130202,0.00016735311,0.00040498457,0.016336795],"genre_scores_gemma":[0.0009374152,0.9935846,0.00031960694,0.0005547765,0.001689831,0.000100240344,0.0019046541,0.0002468952,0.00066201977],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957831,0.0006192148,0.0009983701,0.0010394753,0.000711048,0.0008487897],"domain_scores_gemma":[0.9963958,0.00031808295,0.00048431102,0.0018374298,0.000112135065,0.00085220416],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007092298,0.0009904553,0.0029444955,0.0005241479,0.00028812612,0.000039702798,0.00027402965,0.0005868891,0.00013810738],"category_scores_gemma":[0.0001064364,0.0007945946,0.0009764479,0.00051390735,0.00015229521,0.00038749294,0.00014922424,0.0013722763,0.003327808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000152154735,0.00079579494,9.818946e-7,0.0015506202,0.0002862207,0.00016927921,0.00016090804,4.5147323e-7,0.0000047518565,0.00068727287,0.0004324268,0.9958961],"study_design_scores_gemma":[0.0006323613,0.0000503418,0.00015030784,0.010348365,0.00026693055,0.004053575,0.00016796483,0.000010185781,0.000006598919,0.0000030602623,0.9835417,0.00076857733],"about_ca_topic_score_codex":0.00007289088,"about_ca_topic_score_gemma":0.000003466422,"teacher_disagreement_score":0.9951275,"about_ca_system_score_codex":0.0008046979,"about_ca_system_score_gemma":0.0005769845,"threshold_uncertainty_score":0.9994505},"labels":[],"label_agreement":null},{"id":"W2068882964","doi":"10.1517/14740338.6.3.315","title":"Managing cardiotoxicity in anthracycline-treated breast cancers","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cardiotoxicity; Medicine; Trastuzumab; Anthracycline; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Cancer; Chemotherapy; Malignancy","score_opus":0.06337415341656599,"score_gpt":0.43531622394368896,"score_spread":0.37194207052712297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068882964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008517177,0.9825141,0.000009303907,0.0008133482,0.0021560113,0.0017163345,0.00017343082,0.00013462853,0.012474328],"genre_scores_gemma":[0.00010867496,0.9949698,0.00004829879,0.0006634575,0.0017311554,0.0002126655,0.0010451603,0.00010781308,0.001113002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699575,0.00025051352,0.0009340526,0.0008309115,0.0003709642,0.00061778974],"domain_scores_gemma":[0.9985443,0.0002989267,0.00028460915,0.0005523081,0.000050676197,0.00026921695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003992557,0.00071290386,0.0025176937,0.0006411263,0.00010459353,0.000013473525,0.00019982416,0.00038798893,0.0005492713],"category_scores_gemma":[0.000014394315,0.00057413836,0.0007202379,0.0007127483,0.00010732336,0.00006191318,0.000074836615,0.0008098571,0.00012495084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061754085,0.0002992102,0.000099519006,0.0017808441,0.00041876113,0.00024617667,0.00019787777,0.000009399229,0.0000012466899,0.000024374156,0.013116576,0.98318845],"study_design_scores_gemma":[0.0024444307,0.00011454512,0.00016739011,0.013956867,0.00011697642,0.00024306162,0.000047687965,0.0000204167,0.000015607748,0.0000022121264,0.98242044,0.0004503708],"about_ca_topic_score_codex":0.0021583128,"about_ca_topic_score_gemma":0.00015270758,"teacher_disagreement_score":0.9827381,"about_ca_system_score_codex":0.0032249587,"about_ca_system_score_gemma":0.0005678636,"threshold_uncertainty_score":0.999671},"labels":[],"label_agreement":null},{"id":"W2072337394","doi":"10.1517/14740331003752694","title":"Interactions between antifungal and antiretroviral agents","year":2010,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Alberta Health Services; University of Alberta","funders":"","keywords":"Fluconazole; Medicine; Intensive care medicine; Drug; Antifungal drug; Antiretroviral therapy; Antifungal; Antifungal drugs; Life expectancy; Amphotericin B; Pharmacology; Human immunodeficiency virus (HIV); Immunology; Viral load; Population; Environmental health","score_opus":0.028559828394123552,"score_gpt":0.3488578652823199,"score_spread":0.3202980368881963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072337394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813252,0.00020399457,0.00014653296,0.0031855544,0.0016678735,0.00030042444,0.000041350995,0.0001099633,0.013019122],"genre_scores_gemma":[0.99541795,0.0005022731,0.00048211933,0.00066975446,0.00085916894,0.000006478205,0.00009170719,0.00002213558,0.0019483891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987204,0.000050322935,0.00029978514,0.00039916366,0.00027857118,0.00025175742],"domain_scores_gemma":[0.9990772,0.00014813586,0.000065907414,0.0004231166,0.000064926906,0.00022069407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024943193,0.00018032348,0.0002997418,0.000089717534,0.00021681,0.000026626956,0.00008554295,0.00009272605,0.0006472642],"category_scores_gemma":[0.00018112354,0.00014991655,0.0001123376,0.00011923674,0.00015067655,0.00015632907,0.000054646636,0.0005466202,0.00011154575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007394383,0.0003136101,0.8770941,0.000040723036,0.00007257944,0.000013899322,0.0009937164,2.2238657e-7,0.02124727,0.0014182451,0.030811604,0.06725457],"study_design_scores_gemma":[0.00081897,0.00015396094,0.7422279,0.000083897314,0.0000048965608,0.000010341079,0.0002457928,0.00006256887,0.0028338318,0.000029715826,0.25337976,0.00014836992],"about_ca_topic_score_codex":0.00006891826,"about_ca_topic_score_gemma":0.000024245437,"teacher_disagreement_score":0.22256814,"about_ca_system_score_codex":0.00004231255,"about_ca_system_score_gemma":0.000057084537,"threshold_uncertainty_score":0.70870894},"labels":[],"label_agreement":null},{"id":"W2081580615","doi":"10.1517/14740338.2015.998197","title":"Labetalol for hypertension in pregnancy","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; B.C. Women's Hospital & Health Centre; British Columbia Centre of Excellence for Women's Health; University of British Columbia","funders":"","keywords":"Labetalol; Medicine; Hypertension in Pregnancy; Pregnancy; Preeclampsia; Obstetrics; Blood pressure; Internal medicine","score_opus":0.11883709888130402,"score_gpt":0.3873821814656408,"score_spread":0.2685450825843368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081580615","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.3788446e-7,0.9865812,0.000022914995,0.0007918894,0.0018338133,0.003521373,0.00011299713,0.0001151755,0.0070204725],"genre_scores_gemma":[0.0000039030906,0.99492556,0.0005558587,0.00035580882,0.0006337669,0.001172254,0.0007857093,0.000105053274,0.0014620753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728227,0.00021409839,0.00089715206,0.000751862,0.00038227052,0.0004723264],"domain_scores_gemma":[0.9981879,0.0004729476,0.0002607085,0.00077269785,0.00012688171,0.00017884694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004295667,0.0006290129,0.002731908,0.00027409274,0.0001104032,0.000011486119,0.00022908844,0.00042539966,0.00003132475],"category_scores_gemma":[0.0002841862,0.00044986745,0.0006347743,0.00030434228,0.00006770426,0.000076055185,0.00013052984,0.0005034112,0.00012126673],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001564056,0.0002295357,0.0000041987014,0.006978532,0.00012407021,0.000022633434,0.00037446292,2.9401332e-7,1.3873212e-7,0.0004077782,0.037151963,0.95454997],"study_design_scores_gemma":[0.001876506,0.00019607272,0.000013807831,0.1411092,0.000053722208,0.000047949234,0.000048755788,0.000009323571,0.0000013138394,0.00006224231,0.8561915,0.00038959904],"about_ca_topic_score_codex":0.000016851367,"about_ca_topic_score_gemma":0.0000059145814,"teacher_disagreement_score":0.9541604,"about_ca_system_score_codex":0.00032380474,"about_ca_system_score_gemma":0.00040711113,"threshold_uncertainty_score":0.9997953},"labels":[],"label_agreement":null},{"id":"W2084298979","doi":"10.1517/14740330903427969","title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toxic epidermal necrolysis; Medicine; Carbamazepine; Pharmacogenetics; Allele; Genetic predisposition; Drug; Drug reaction; Adverse effect; Adverse drug reaction; Human leukocyte antigen; Dermatology; Pharmacology; Epilepsy; Genotype; Psychiatry; Gene; Internal medicine; Genetics; Immunology; Disease","score_opus":0.054149346747096885,"score_gpt":0.3602607732001855,"score_spread":0.30611142645308864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084298979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038371953,0.9739478,0.0001961577,0.000452521,0.0024523665,0.0023173639,0.00010769939,0.0003094929,0.020178176],"genre_scores_gemma":[0.0011507182,0.993952,0.0011916257,0.00015623079,0.0018234713,0.00016132524,0.0007897558,0.00016593379,0.00060895184],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558717,0.0003572476,0.0018326316,0.0009416357,0.00073922414,0.00054206664],"domain_scores_gemma":[0.9966114,0.00038977136,0.0010340181,0.001276296,0.00021105274,0.000477459],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032501147,0.0008252489,0.0026078175,0.000844457,0.00024720907,0.000025955005,0.00027287213,0.0006548971,0.0000700269],"category_scores_gemma":[0.00027139898,0.00072527915,0.001233176,0.00082857464,0.00008359836,0.00017515472,0.00006923653,0.0010936856,0.00027614192],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043619177,0.00059828995,0.0000020148618,0.0020482277,0.00035535754,0.000015610283,0.00021058256,0.0000119053675,0.00010494492,0.0003212251,0.00092045637,0.99536777],"study_design_scores_gemma":[0.0009780469,0.00014737171,0.00074544636,0.028115232,0.00026460216,0.00025986327,0.00014892442,0.000039741,0.00006251877,0.000013988753,0.9686661,0.0005582079],"about_ca_topic_score_codex":0.00013056486,"about_ca_topic_score_gemma":0.0000028047414,"teacher_disagreement_score":0.99480957,"about_ca_system_score_codex":0.0007574475,"about_ca_system_score_gemma":0.00092651846,"threshold_uncertainty_score":0.9995198},"labels":[],"label_agreement":null},{"id":"W2086717153","doi":"10.1517/14740338.6.6.685","title":"The safety of drugs for the treatment of nausea and vomiting of pregnancy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Nausea; Pregnancy; Hyperemesis gravidarum; Vomiting; Adverse effect; Obstetrics; Intensive care medicine; Quality of life (healthcare); Pediatrics; Surgery; Internal medicine; Nursing","score_opus":0.07937431068445187,"score_gpt":0.4155390722052983,"score_spread":0.3361647615208464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086717153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032325147,0.99382526,0.00029574108,0.0006814063,0.0005777409,0.0029596083,0.00017958005,0.000015752168,0.0014617025],"genre_scores_gemma":[0.00019666714,0.99828935,0.0002024395,0.000041928546,0.00027543548,0.00021516699,0.00011776575,0.000040923776,0.0006203511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99754065,0.00014934909,0.0013411054,0.00029623744,0.0003993534,0.00027327676],"domain_scores_gemma":[0.99361134,0.004221824,0.0010924535,0.0008143988,0.00014355787,0.000116415926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076872436,0.00034522457,0.0014781969,0.00011184156,0.00017649685,0.0000038795956,0.00022423166,0.00019164871,0.000019146286],"category_scores_gemma":[0.00036491768,0.00016100655,0.00062687206,0.00020432951,0.00032085535,0.000031189105,0.000033735512,0.00015876928,0.0000012227979],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036924792,0.00024781472,0.000007348853,0.0041092406,0.00039469148,3.2510312e-7,0.0022437489,2.9615217e-7,0.0000010310804,0.0012843448,0.0005095671,0.9908323],"study_design_scores_gemma":[0.0018417804,0.0005063519,0.0000923763,0.05948026,0.00016524518,0.000010544055,0.00040916188,0.0000116663305,0.0001910083,0.00001109225,0.9371624,0.00011810671],"about_ca_topic_score_codex":0.000027892707,"about_ca_topic_score_gemma":0.000002179047,"teacher_disagreement_score":0.99071425,"about_ca_system_score_codex":0.0001471729,"about_ca_system_score_gemma":0.00041929315,"threshold_uncertainty_score":0.65656567},"labels":[],"label_agreement":null},{"id":"W2087313521","doi":"10.1517/14740330903405593","title":"Clinically based evidence of drug–herb interactions: a systematic review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian College of Naturopathic Medicine","funders":"","keywords":"Medicine; Drug; Herb; Drug interaction; Pharmacology; Traditional medicine; Medicinal herbs","score_opus":0.26412354879274036,"score_gpt":0.5583105977799898,"score_spread":0.29418704898724946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087313521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.9822033e-7,0.98559207,0.00006621456,0.0015854737,0.005636941,0.0049114903,0.0001842886,0.00012846374,0.0018947838],"genre_scores_gemma":[0.000020355059,0.98443794,0.00032506848,0.012337929,0.0008764397,0.00089851685,0.0001780486,0.00010668298,0.0008190151],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.985894,0.0070828367,0.0046452214,0.0010452876,0.0006791704,0.0006534661],"domain_scores_gemma":[0.98743665,0.007440384,0.0029064,0.0013612346,0.00034614274,0.00050916715],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005598817,0.0010918406,0.0056019993,0.00039596925,0.00024506688,0.000028051414,0.0015391461,0.0005398318,0.0016424172],"category_scores_gemma":[0.001850269,0.00085275195,0.0020694586,0.0007563804,0.0002063107,0.00015610464,0.0001860712,0.002260773,0.00069026963],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022867792,0.00080323423,4.4953282e-7,0.56937426,0.00054521416,0.000014896428,0.0001935179,0.000021996346,0.0000073987308,0.00019225392,0.03405329,0.3945648],"study_design_scores_gemma":[0.00042245045,0.000058443744,2.3238943e-7,0.40596884,0.00082629424,0.000016895756,0.000011868356,0.00010579294,0.000030387771,0.000010678648,0.5920959,0.00045223004],"about_ca_topic_score_codex":0.000009648374,"about_ca_topic_score_gemma":0.000001429374,"teacher_disagreement_score":0.5580426,"about_ca_system_score_codex":0.0002533138,"about_ca_system_score_gemma":0.00083442224,"threshold_uncertainty_score":0.99939233},"labels":[],"label_agreement":null},{"id":"W2090926478","doi":"10.1517/14740338.4.4.707","title":"The safety of fondaparinux for the prevention and treatment of venous thromboembolism","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Fondaparinux; Medicine; Pulmonary embolism; Antithrombotic; Deep vein; Thrombosis; Venous thrombosis; Regimen; Surgery; Intensive care medicine; Venous thromboembolism; Internal medicine","score_opus":0.06068070712323103,"score_gpt":0.3829024978731514,"score_spread":0.32222179074992036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090926478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005172058,0.9902271,0.00011523576,0.0015943012,0.0010182124,0.0055882954,0.000090401605,0.00002771398,0.0013335787],"genre_scores_gemma":[0.00012101762,0.99687034,0.00022317356,0.000089831905,0.00083104864,0.000855509,0.00020040096,0.00007343799,0.0007352161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741834,0.00018726985,0.0011905,0.00047039468,0.00038858026,0.00034493697],"domain_scores_gemma":[0.996521,0.0015223398,0.0007857909,0.0009744171,0.00010402551,0.00009244866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000609094,0.00049873895,0.00261509,0.00010916715,0.00038255693,0.000019484623,0.00027162282,0.00019093063,0.000048950238],"category_scores_gemma":[0.00007967055,0.00024780416,0.00094046065,0.00016556536,0.00022084772,0.00004055258,0.00009752878,0.00014777406,0.000006843528],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019282784,0.0013707869,4.6525307e-7,0.0014441143,0.0011807578,4.5632436e-7,0.0009707659,0.0000052374867,4.7679015e-7,0.007834213,0.005031654,0.9819682],"study_design_scores_gemma":[0.0014183403,0.0014519439,0.00018350678,0.0056940243,0.0006441352,0.000010280391,0.00028779535,0.000023634777,0.000013872431,0.000055474866,0.9900133,0.00020369198],"about_ca_topic_score_codex":0.00009263671,"about_ca_topic_score_gemma":0.00002958073,"teacher_disagreement_score":0.98498166,"about_ca_system_score_codex":0.00029199623,"about_ca_system_score_gemma":0.00027187468,"threshold_uncertainty_score":0.99999744},"labels":[],"label_agreement":null},{"id":"W2091770334","doi":"10.1517/14740338.5.1.157","title":"The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Fluoxetine; Venlafaxine; Glucose homeostasis; Antidepressant; Desipramine; Serotonergic; Mianserin; Insulin; Phenelzine; Diabetes mellitus; Homeostasis; Internal medicine; Pharmacology; Reuptake inhibitor; Agomelatine; Endocrinology; Insulin resistance; Monoamine oxidase; Serotonin; Receptor; Chemistry","score_opus":0.021629832394163034,"score_gpt":0.3248997841848692,"score_spread":0.30326995179070615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091770334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004723261,0.9972068,0.000018870054,0.0005297256,0.00025633175,0.0013712138,0.00016429757,0.00004134127,0.00036416133],"genre_scores_gemma":[0.004201197,0.99525064,0.0000670427,0.000052618023,0.0001396773,0.00012280831,0.00007043629,0.00006759205,0.00002796481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975532,0.0007647727,0.00048393678,0.00055650267,0.00036957854,0.00027200725],"domain_scores_gemma":[0.9960439,0.0029281222,0.00024429025,0.0006032514,0.000025686573,0.00015471085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007340234,0.0005553288,0.0017721471,0.00015446001,0.00022336691,0.000024273553,0.000074730226,0.00024476755,0.000014749235],"category_scores_gemma":[0.00024362061,0.00030292352,0.0003211595,0.00014024493,0.0001251358,0.000035304987,0.00010027173,0.00032102523,0.00001878542],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003954914,0.00014498115,0.000010384602,0.0014761605,0.00041583375,0.000008907769,0.000082363505,1.118496e-7,0.0000015400733,0.00023468316,0.00015159245,0.99707794],"study_design_scores_gemma":[0.0013531216,0.000694773,0.00040751626,0.0129809445,0.00028681124,0.000118746706,0.000035363075,0.000011596759,0.0009261922,0.000009813677,0.98288906,0.00028606257],"about_ca_topic_score_codex":0.000051207735,"about_ca_topic_score_gemma":0.000013417726,"teacher_disagreement_score":0.9967919,"about_ca_system_score_codex":0.00008801654,"about_ca_system_score_gemma":0.0000575686,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W2096035113","doi":"10.1517/14740338.2010.511611","title":"Everolimus: efficacy and safety in cardiac transplantation","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Everolimus; Tolerability; Transplantation; Heart transplantation; Calcineurin; Immunosuppression; Cardiotoxicity; Malignancy; Basiliximab; Internal medicine; Oncology; Intensive care medicine; Adverse effect; Tacrolimus; Chemotherapy","score_opus":0.045028555899963914,"score_gpt":0.3952464022490669,"score_spread":0.35021784634910297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096035113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020265868,0.9928275,0.00029465804,0.00063439755,0.002189897,0.0017940814,0.00025403162,0.00010206653,0.001883139],"genre_scores_gemma":[0.000017342163,0.99401116,0.0029823713,0.00031397358,0.00073414436,0.000103387974,0.0015197002,0.00009205642,0.00022583919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968181,0.0005905236,0.00106759,0.00073603395,0.0004136659,0.0003740521],"domain_scores_gemma":[0.9976464,0.0013469276,0.0002262931,0.0005071443,0.00003996027,0.00023327667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087965577,0.0006108819,0.0023171224,0.0003965974,0.00012176302,0.000025081032,0.00015076193,0.00057227595,0.00008881461],"category_scores_gemma":[0.00007584148,0.00047081668,0.0004938387,0.00032432255,0.000086262575,0.00010105327,0.000017861212,0.0010698958,0.000050776292],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006396052,0.00010756953,0.00007467868,0.0051056137,0.00009406171,0.00002999067,0.0014668967,9.116565e-7,0.0000032426149,0.0005656823,0.00018770646,0.991724],"study_design_scores_gemma":[0.0027392304,0.00009033798,0.004680725,0.016248906,0.00014657566,0.0000991042,0.000051497434,0.000002915326,0.000009086932,0.000008208309,0.97547835,0.00044507234],"about_ca_topic_score_codex":0.00006328614,"about_ca_topic_score_gemma":0.000015567544,"teacher_disagreement_score":0.99127895,"about_ca_system_score_codex":0.00014567089,"about_ca_system_score_gemma":0.00024528796,"threshold_uncertainty_score":0.99977434},"labels":[],"label_agreement":null},{"id":"W2097906965","doi":"10.1517/14740338.2011.521740","title":"Oral hypoglycemic agents for gestational diabetes mellitus?","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gestational diabetes; Offspring; Pregnancy; Diabetes mellitus; Insulin; Complication; Obstetrics; Gestation; Pediatrics; Endocrinology; Internal medicine","score_opus":0.11112100055468162,"score_gpt":0.4033479606627848,"score_spread":0.2922269601081032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097906965","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001667793,0.99089533,0.00019364084,0.0006057108,0.0009966772,0.003263385,0.00045302737,0.00008989689,0.0035006544],"genre_scores_gemma":[0.0000045340194,0.9809071,0.0023073712,0.00082880125,0.0005789846,0.0015562718,0.008147303,0.00011119796,0.005558429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970004,0.0001883597,0.000766521,0.00071773294,0.00064980413,0.0006771619],"domain_scores_gemma":[0.9979576,0.0006559577,0.00026755707,0.00052373705,0.0002168243,0.00037831234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049280195,0.0005352961,0.0013143107,0.00042308346,0.00016281228,0.000035677476,0.00031874975,0.00020307678,0.0008381714],"category_scores_gemma":[0.00031439663,0.00042406525,0.00071686774,0.00024122598,0.00009333994,0.000101312056,0.00011807956,0.0003507777,0.00061264436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013964203,0.00028016974,0.0000039902857,0.006600682,0.00039114075,0.0000027316107,0.00009381116,0.0000013150012,2.1685852e-7,0.0069665527,0.12147462,0.86404514],"study_design_scores_gemma":[0.0012685433,0.00032921633,0.00011829752,0.007067001,0.000065763365,0.0000022446739,0.000027694909,0.000050068713,0.0000031934244,0.0002716053,0.9904192,0.00037714074],"about_ca_topic_score_codex":0.000012749179,"about_ca_topic_score_gemma":0.0000010576158,"teacher_disagreement_score":0.8689446,"about_ca_system_score_codex":0.00037730395,"about_ca_system_score_gemma":0.00042273928,"threshold_uncertainty_score":0.9998211},"labels":[],"label_agreement":null},{"id":"W2098884513","doi":"10.1517/14740338.4.6.1005","title":"Celecoxib and cardiovascular risks","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Rofecoxib; Celecoxib; Medicine; Valdecoxib; Concomitant; Pharmacology; Drug; Internal medicine; Intensive care medicine; Cyclooxygenase; Enzyme","score_opus":0.06752630300762029,"score_gpt":0.37637547173223196,"score_spread":0.30884916872461166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098884513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035829778,0.9921972,0.000019287658,0.00013552581,0.0018941436,0.0015216331,0.00002615999,0.00013602576,0.0040664333],"genre_scores_gemma":[0.000010744665,0.9938676,0.0001686502,0.00031269388,0.0046325675,0.0001981831,0.00022720388,0.00013234084,0.0004500225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971247,0.00037566057,0.00068915176,0.00077444874,0.00058544317,0.00045061723],"domain_scores_gemma":[0.99810225,0.000265857,0.00017980728,0.0010130688,0.000051569285,0.0003874271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083176873,0.00067550124,0.002739253,0.0002564936,0.00015674921,0.0000232116,0.0001546613,0.000493926,0.00021798095],"category_scores_gemma":[0.00012226944,0.00049842865,0.00136051,0.00019702541,0.00008505612,0.000057769168,0.00008803009,0.0007580758,0.0004093709],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004342841,0.000057899335,0.0000022844006,0.0031847532,0.00051633245,0.000045156852,0.00014830961,0.0000010373954,9.1889795e-8,0.000079845486,0.015222245,0.98069865],"study_design_scores_gemma":[0.00102351,0.000098776625,0.000024102192,0.011223372,0.00017951896,0.00018275893,0.000020686422,0.000010670832,0.0000044163703,0.0000011974093,0.98675716,0.00047385957],"about_ca_topic_score_codex":0.000032274114,"about_ca_topic_score_gemma":0.0000010867076,"teacher_disagreement_score":0.9802247,"about_ca_system_score_codex":0.00022750508,"about_ca_system_score_gemma":0.00028275343,"threshold_uncertainty_score":0.99974674},"labels":[],"label_agreement":null},{"id":"W2106362781","doi":"10.1517/14740338.3.1.25","title":"The safety of antihypertensives for treatment of pregnancy hypertension","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Medicine; Pregnancy; Observational study; Hypertension in Pregnancy; Antihypertensive drug; Ambulatory; Ambulatory blood pressure; Drugs in pregnancy; Blood pressure; Intensive care medicine; Pharmacotherapy; Drug; Fetus; Obstetrics; Preeclampsia; Internal medicine; Pharmacology","score_opus":0.08163984770021554,"score_gpt":0.3625396005674635,"score_spread":0.28089975286724794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106362781","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.007831e-7,0.9924921,0.000059431677,0.0008591851,0.0013160802,0.0036677043,0.00025463503,0.00004735988,0.0013026412],"genre_scores_gemma":[0.00008248272,0.997787,0.00052109733,0.000054130294,0.0002911963,0.00040638784,0.00030412636,0.00008129665,0.00047227283],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708134,0.0001926803,0.0013824463,0.0005825334,0.00038097732,0.00038000237],"domain_scores_gemma":[0.9961477,0.0016172597,0.000765152,0.0010831488,0.0002855952,0.00010112919],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019361157,0.000665233,0.003353192,0.00013898933,0.0003385998,0.0000061141495,0.0002461069,0.00030126894,0.000008845721],"category_scores_gemma":[0.00022910978,0.00034667645,0.001517267,0.00022765272,0.00029985796,0.00004315428,0.00007366867,0.00013583415,0.000007933702],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083954836,0.0005757785,0.000005275932,0.0088836895,0.000964654,0.0000070921296,0.0005965118,0.0000015883519,0.000004657843,0.0020344227,0.0009071422,0.98517966],"study_design_scores_gemma":[0.0026001132,0.0010893935,0.000050904862,0.12913154,0.0002579629,0.000053082404,0.00015583691,0.0000035321727,0.00012999716,0.00006123941,0.8661972,0.00026914058],"about_ca_topic_score_codex":0.000034570574,"about_ca_topic_score_gemma":0.0000034388015,"teacher_disagreement_score":0.9849105,"about_ca_system_score_codex":0.00026031793,"about_ca_system_score_gemma":0.0005150198,"threshold_uncertainty_score":0.99989855},"labels":[],"label_agreement":null},{"id":"W2106887884","doi":"10.1517/14740330902808169","title":"Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Western Ontario; University of Toronto; Western University","funders":"Chinese Academy of Agricultural Sciences","keywords":"Nephrotoxicity; Ifosfamide; Medicine; Pharmacology; Oxidative stress; Toxicity; Fanconi syndrome; Kidney; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.06319356294589396,"score_gpt":0.4022509506249844,"score_spread":0.33905738767909044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106887884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014648332,0.984581,0.0016293592,0.0012185838,0.0005920451,0.011157494,0.0001364603,0.00026741414,0.0002711732],"genre_scores_gemma":[0.00025852444,0.99149495,0.001821541,0.0017644619,0.0015023545,0.0008936104,0.0018690348,0.0001286499,0.00026685483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962002,0.0004503584,0.0012657107,0.0010592947,0.0004878612,0.0005365969],"domain_scores_gemma":[0.99822754,0.00038963626,0.0005090969,0.00053828565,0.0000739728,0.00026145912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00079181156,0.00075918564,0.0020875917,0.00043991447,0.000137191,0.000029146162,0.00027729184,0.00067355525,0.0003663739],"category_scores_gemma":[0.00032235106,0.00065015384,0.000901545,0.00051495666,0.000054449945,0.000096474425,0.00005007127,0.0008562562,0.00008031459],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041354456,0.0012494343,0.0000024499689,0.0012071896,0.00018222115,0.000007756339,0.000111442016,0.0000015926395,0.0003536909,0.0003726514,0.0048216027,0.99127644],"study_design_scores_gemma":[0.005571269,0.00091157283,0.00012547219,0.017233694,0.00017963121,0.00015925043,0.00002447914,0.00016100192,0.0033780246,0.00037735383,0.9709927,0.00088557997],"about_ca_topic_score_codex":0.000013955604,"about_ca_topic_score_gemma":0.0000034301327,"teacher_disagreement_score":0.99039084,"about_ca_system_score_codex":0.0012801292,"about_ca_system_score_gemma":0.0004932153,"threshold_uncertainty_score":0.999595},"labels":[],"label_agreement":null},{"id":"W2111463664","doi":"10.1517/14740338.4.4.779","title":"Safety review of kava (<i>Piper methysticum</i>) by the Natural Standard Research Collaboration","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Medicinal Plant Extracts Effects","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Kava; Medicine; Dosing; Traditional medicine; Pharmacology","score_opus":0.058603490882086155,"score_gpt":0.4599951406542317,"score_spread":0.40139164977214553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111463664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.8607898e-7,0.97155946,0.000038973103,0.011424647,0.0022139023,0.006003763,0.0006143183,0.00007699751,0.008067742],"genre_scores_gemma":[0.000006580923,0.98915887,0.00031313772,0.0026426404,0.0019835797,0.0002715296,0.0030717617,0.00013234382,0.0024195802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890009,0.0037026634,0.0022261448,0.0009726761,0.0033429076,0.00075468695],"domain_scores_gemma":[0.99000496,0.0059093223,0.0009347415,0.0016770307,0.0011018406,0.0003721195],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009030455,0.00084261835,0.0038498242,0.0003828606,0.0003420128,0.000035491455,0.0007124751,0.00047948133,0.00067878724],"category_scores_gemma":[0.00489684,0.00047387427,0.0006631971,0.0017221435,0.00039878953,0.00015957301,0.0001668458,0.002764243,0.0002639566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005515422,0.00009244358,6.496684e-8,0.02986513,0.00014779423,0.000010700861,0.00016165207,2.0968054e-7,0.0000062637887,0.00029400922,0.41657218,0.552298],"study_design_scores_gemma":[0.0007925883,0.0003328365,0.0000010800259,0.2358348,0.00014872334,0.00013634781,0.00011071658,0.0000065535237,0.000041599902,0.0000030039791,0.76227933,0.00031242077],"about_ca_topic_score_codex":0.000057987276,"about_ca_topic_score_gemma":0.000008140159,"teacher_disagreement_score":0.55198556,"about_ca_system_score_codex":0.0013351485,"about_ca_system_score_gemma":0.002115472,"threshold_uncertainty_score":0.9997713},"labels":[],"label_agreement":null},{"id":"W2112690253","doi":"10.1517/14740338.2012.677026","title":"Drug safety evaluation of pregabalin","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pregabalin; Medicine; Adverse effect; Neuropathic pain; Sedation; Peripheral edema; Anesthesia; Anticonvulsant; Intensive care medicine; Pharmacology; Epilepsy; Psychiatry","score_opus":0.11937211517498823,"score_gpt":0.4190687416217234,"score_spread":0.29969662644673517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112690253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000020020952,0.98544574,0.00008783794,0.00027178513,0.0021298092,0.0030639805,0.00016312303,0.00008430401,0.008751441],"genre_scores_gemma":[0.00014262885,0.99402815,0.00077963585,0.00013453866,0.0009438957,0.00034649883,0.0021547384,0.00011654057,0.0013534018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949842,0.0011280767,0.0012762515,0.0006667574,0.001488332,0.00045634367],"domain_scores_gemma":[0.9971904,0.00036769838,0.0007609876,0.0011185886,0.00027011795,0.00029217917],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002894121,0.0007004949,0.0022527787,0.00028940957,0.00013260909,0.000010123817,0.00024121076,0.00037109948,0.0011658577],"category_scores_gemma":[0.00018838956,0.0005061688,0.0008875241,0.00032402342,0.000058358084,0.00010652988,0.00009736889,0.0004213462,0.00038525995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013317722,0.00066570065,0.000004382928,0.0023507115,0.0004668147,0.0000023756336,0.0004824521,0.0000018515497,9.2163793e-7,0.0010508691,0.0029916721,0.99184906],"study_design_scores_gemma":[0.0021858127,0.00010408892,0.00004862576,0.01869307,0.00063548225,0.000028244378,0.00007337091,0.00005741083,0.000038063004,0.00004534385,0.9777141,0.00037638488],"about_ca_topic_score_codex":0.000066532644,"about_ca_topic_score_gemma":0.000003835483,"teacher_disagreement_score":0.99147266,"about_ca_system_score_codex":0.0009003706,"about_ca_system_score_gemma":0.00068539317,"threshold_uncertainty_score":0.9997472},"labels":[],"label_agreement":null},{"id":"W2120113397","doi":"10.1517/14740338.2014.947958","title":"Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Manitoba; Child and Family Research Institute; Dalhousie University; BC Children's Hospital; University of British Columbia; University of British Columbia Hospital","funders":"Canadian Institutes of Health Research; London Health Sciences Centre","keywords":"Medicine; Hazard ratio; Internal medicine; Cohort; Retrospective cohort study; Multiple sclerosis; Liver injury; Drug; Proportional hazards model; Adverse effect; Confidence interval; Pharmacology; Immunology","score_opus":0.11568749489911455,"score_gpt":0.3493558357500897,"score_spread":0.23366834085097515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120113397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99276817,0.0000618466,0.00009407167,0.0007978398,0.0037324168,0.00087560056,0.000334681,0.00018985136,0.0011454945],"genre_scores_gemma":[0.9951046,0.00069740554,0.000060564253,0.0026072962,0.0005046762,0.00015007325,0.000688571,0.000065089196,0.00012169385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961299,0.0016046107,0.0006618517,0.00067433284,0.00034424113,0.00058508094],"domain_scores_gemma":[0.9978616,0.0009944211,0.0003709275,0.00037424613,0.00014461916,0.0002541822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009311533,0.00045455454,0.00053764397,0.00022309323,0.00042160446,0.00004035049,0.00036140264,0.00051389367,0.0002893345],"category_scores_gemma":[0.00032858655,0.00042642048,0.000113868504,0.000322762,0.0001124919,0.000267169,0.00012843581,0.0013954488,0.00022299004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015318362,0.007926819,0.36013582,0.00007459804,0.0005752243,0.000013951431,0.022490924,0.00021103796,0.03609388,0.00054640643,0.012146636,0.5444663],"study_design_scores_gemma":[0.01138181,0.0010689868,0.6910794,0.00089490187,0.0000294728,8.757462e-7,0.00027611858,0.011868782,0.12846881,0.000080012614,0.15343404,0.0014168352],"about_ca_topic_score_codex":0.00067494635,"about_ca_topic_score_gemma":0.00039086063,"teacher_disagreement_score":0.5430495,"about_ca_system_score_codex":0.00046509763,"about_ca_system_score_gemma":0.000056890472,"threshold_uncertainty_score":0.99981874},"labels":[],"label_agreement":null},{"id":"W2127157324","doi":"10.1517/14740338.2014.908182","title":"Serotonergic antidepressants and perioperative bleeding risk: a systematic review","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; McGill University; Jewish General Hospital; Concordia University; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Perioperative; MEDLINE; Context (archaeology); Intensive care medicine; Odds ratio; Meta-analysis; Systematic review; Adverse effect; Odds; Internal medicine; Surgery; Logistic regression","score_opus":0.03918097329417711,"score_gpt":0.4102195454294999,"score_spread":0.37103857213532276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127157324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000014853579,0.98387694,0.000012669802,0.00046758007,0.0011712192,0.011017205,0.00010106079,0.00010136933,0.0032504934],"genre_scores_gemma":[0.000013116236,0.9935838,0.0001006914,0.003265821,0.00075856614,0.0013580355,0.00031209274,0.00010911512,0.0004987606],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945998,0.0014233711,0.0019157748,0.00087330607,0.00059931213,0.0005884381],"domain_scores_gemma":[0.9966844,0.0006154318,0.0009348995,0.0008706418,0.000098144395,0.00079653383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022228665,0.0007591086,0.0066383835,0.0002113704,0.0003667293,0.000029158953,0.0001578023,0.00029194585,0.00006890845],"category_scores_gemma":[0.0005529191,0.00050496287,0.00074958656,0.00030850954,0.00007452848,0.000074245734,0.0001133156,0.0009020892,0.00019529003],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038183938,0.00005522734,0.0000031134227,0.9025383,0.00010237635,0.000008124624,0.00031352378,4.3370267e-8,3.723347e-8,0.00007456226,0.0029819538,0.09388458],"study_design_scores_gemma":[0.0004127348,0.00010816712,0.0000037561492,0.49571037,0.00023582124,0.00024986174,0.00006320517,0.0000071213503,2.8416457e-7,2.9690298e-7,0.50298446,0.00022394014],"about_ca_topic_score_codex":0.000114206116,"about_ca_topic_score_gemma":0.000001950954,"teacher_disagreement_score":0.5000025,"about_ca_system_score_codex":0.00049132184,"about_ca_system_score_gemma":0.0005470432,"threshold_uncertainty_score":0.9997402},"labels":[],"label_agreement":null},{"id":"W2131201627","doi":"10.1517/14740338.4.3.473","title":"Efficacy and safety of basiliximab in kidney transplantation","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondazione Arpa; University of Lethbridge","keywords":"Basiliximab; Medicine; Adverse effect; Transplantation; Kidney transplantation; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.04208344527182806,"score_gpt":0.3744033903799206,"score_spread":0.33231994510809254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131201627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008076684,0.9941428,0.00005909842,0.0004365532,0.00034606247,0.0015431099,0.00035489706,0.00003896995,0.003070473],"genre_scores_gemma":[0.0001391269,0.9960713,0.00056221656,0.00025857973,0.00016668535,0.000063125204,0.002384289,0.000056391433,0.0002982965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755967,0.00019438758,0.0011225864,0.0005109383,0.00036436427,0.00024807564],"domain_scores_gemma":[0.99870265,0.00041427344,0.00028043805,0.00033573507,0.000032958025,0.00023393947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021409757,0.00047754133,0.0017163542,0.0003820212,0.000052338142,0.000008697257,0.00010293447,0.0002506069,0.00015596508],"category_scores_gemma":[0.00003445063,0.00035386966,0.00034498962,0.00028520048,0.00006207543,0.00007809577,0.000011311066,0.00031904984,0.000035048808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015715981,0.00049959286,0.00006455987,0.01148529,0.00021818207,0.000040115676,0.0008593705,0.000003979235,7.5841064e-7,0.00040192445,0.00012672631,0.9847279],"study_design_scores_gemma":[0.008432522,0.00016381056,0.001566874,0.069275506,0.00013697187,0.0001431166,0.00002282707,0.000007567008,0.000011871746,0.000002304968,0.91996,0.00027660382],"about_ca_topic_score_codex":0.00004742571,"about_ca_topic_score_gemma":0.000005196814,"teacher_disagreement_score":0.9844513,"about_ca_system_score_codex":0.00018662191,"about_ca_system_score_gemma":0.00024387964,"threshold_uncertainty_score":0.99989134},"labels":[],"label_agreement":null},{"id":"W2134746903","doi":"10.1517/14740338.4.6.1027","title":"The safety and efficacy of the use of vasopressin in sepsis and septic shock","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vasopressin; Septic shock; Medicine; Sepsis; Intensive care medicine; Shock (circulatory); Internal medicine","score_opus":0.14739981652905867,"score_gpt":0.4014445665321733,"score_spread":0.25404475000311466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134746903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016279105,0.9958098,0.0000011696451,0.0019932592,0.0002752744,0.0014133347,0.00005588892,0.00001111183,0.00027738203],"genre_scores_gemma":[0.0005897962,0.9985505,0.00011748186,0.00023002952,0.00012698464,0.00006794531,0.00004203833,0.000042762054,0.00023246206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976645,0.00036917173,0.00096730003,0.00041838235,0.00035490582,0.0002257006],"domain_scores_gemma":[0.99607223,0.0025424,0.0004396392,0.0008048762,0.000044232314,0.00009662786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032906162,0.00039332622,0.0014744874,0.00010963112,0.00012269283,0.000019174888,0.00016478212,0.00019340501,0.00004127953],"category_scores_gemma":[0.00026756033,0.00018725582,0.000397026,0.00025021168,0.00022882484,0.000047269114,0.00016234072,0.00030092834,0.0000032450364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015984202,0.0004400074,0.00043607617,0.00078776904,0.0002623499,0.000001731841,0.00050853303,0.0000060938337,2.7787866e-7,0.0003096425,0.0027473958,0.9943403],"study_design_scores_gemma":[0.0015969442,0.00009340563,0.010758391,0.018466981,0.00012746196,0.000017221875,0.000053642503,0.000022100052,0.000009332102,0.0000026825758,0.9687003,0.00015154263],"about_ca_topic_score_codex":0.00010038486,"about_ca_topic_score_gemma":0.000027345946,"teacher_disagreement_score":0.9941887,"about_ca_system_score_codex":0.0001636417,"about_ca_system_score_gemma":0.0001400998,"threshold_uncertainty_score":0.7636071},"labels":[],"label_agreement":null},{"id":"W2137748785","doi":"10.1517/14740338.4.2.149","title":"What to do with TNF failures","year":2005,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.010035532026141686,"score_gpt":0.3142949200650003,"score_spread":0.30425938803885866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137748785","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070965034,0.067341715,0.00006031373,0.031112866,0.895858,0.001455796,0.00013330442,0.00022347362,0.003743571],"genre_scores_gemma":[0.00030735775,0.35913432,0.0005872589,0.0006978564,0.6338104,0.00017969125,0.0007519106,0.00012955818,0.004401615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956375,0.00015399972,0.0004766837,0.0008487536,0.002183685,0.0006993841],"domain_scores_gemma":[0.9973592,0.00056161504,0.0001208053,0.00094046904,0.00036972936,0.0006481869],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040795805,0.00056833134,0.00085300516,0.00035221377,0.00023196293,0.00031758865,0.00037422837,0.0004564378,0.00088186486],"category_scores_gemma":[0.00042192687,0.00041307564,0.00020037375,0.00024173757,0.00014112124,0.000351188,0.00011817179,0.0011152303,0.0007879812],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003265736,0.00018078687,0.0000048939296,0.000031855394,0.00014433905,0.000031395182,0.0020770826,0.000007964383,0.000009521217,0.00014539332,0.8870787,0.107022345],"study_design_scores_gemma":[0.0032504925,0.0010287781,0.00004221961,0.0048303306,0.0000010174588,0.000014709896,0.0012073522,0.0000035652276,0.0001790278,0.0000123753125,0.98896265,0.0004674664],"about_ca_topic_score_codex":0.00014975092,"about_ca_topic_score_gemma":0.000104539475,"teacher_disagreement_score":0.29179263,"about_ca_system_score_codex":0.00029966046,"about_ca_system_score_gemma":0.00062542607,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W2138834969","doi":"10.1517/14740338.1.1.71","title":"The gastrointestinal tolerability and safety of oral bisphosphonates","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Bone health and treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Clinical trial; Postmarketing surveillance; Osteoporosis; Intensive care medicine; Dosing; Clinical significance; Internal medicine","score_opus":0.05328660371399697,"score_gpt":0.3657822182065015,"score_spread":0.3124956144925045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138834969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010629488,0.9951685,0.0000064162946,0.0011758865,0.00051940494,0.0014552003,0.0001000276,0.00005282166,0.0015110912],"genre_scores_gemma":[0.00006327565,0.99781054,0.00058883417,0.00012750046,0.00007029523,0.00007952798,0.00022360995,0.000051431165,0.0009849648],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714756,0.00027113289,0.0011818473,0.0005550652,0.00039631064,0.00044807815],"domain_scores_gemma":[0.9973873,0.0009892887,0.0004564473,0.0007298641,0.00010184211,0.00033524996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004928042,0.00053031486,0.0018737498,0.00007690226,0.00032131758,0.000014634079,0.00015929296,0.00015365833,0.00014138158],"category_scores_gemma":[0.00027594197,0.0002899396,0.0004285797,0.00022494659,0.00026659702,0.00003804414,0.00008806582,0.0005233435,0.000039157996],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004516917,0.0003387606,0.0005287174,0.0022750003,0.00008011908,0.000007661358,0.00011482411,1.0944842e-7,3.0927037e-8,0.0003383819,0.0034637772,0.99240094],"study_design_scores_gemma":[0.0011063025,0.0004049917,0.0016156423,0.012554399,0.0000483003,0.00020806833,0.00004415385,0.000012254408,0.0000015627354,0.000013866633,0.9838052,0.00018528657],"about_ca_topic_score_codex":0.00023835893,"about_ca_topic_score_gemma":0.000019275432,"teacher_disagreement_score":0.99221563,"about_ca_system_score_codex":0.0002700191,"about_ca_system_score_gemma":0.00029741268,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2141339944","doi":"10.1517/14740338.3.5.425","title":"The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer’s disease","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Galantamine; Medicine; Rivastigmine; Donepezil; Adverse effect; Cholinesterase; Dementia; Memantine; Disease; Pharmacology; Drug; Internal medicine; Intensive care medicine","score_opus":0.11806681484227145,"score_gpt":0.3888932999723099,"score_spread":0.2708264851300385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141339944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019920536,0.99400544,4.3212225e-7,0.0011013107,0.00045344763,0.0020678062,0.00026559172,0.000071809685,0.000042091466],"genre_scores_gemma":[0.0014188129,0.99499124,0.0000059216472,0.0011049724,0.0007730403,0.00042415303,0.0011008991,0.00012590321,0.00005505174],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971402,0.00041043857,0.00074941915,0.00080543134,0.00048147893,0.00041300527],"domain_scores_gemma":[0.9977896,0.0006459926,0.00032699844,0.0006683733,0.00011854517,0.00045046242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002504266,0.00074681337,0.0013040876,0.0001984818,0.00028666633,0.00008493914,0.00017751697,0.00017352746,0.00001713091],"category_scores_gemma":[0.00021360736,0.0004054887,0.00033779547,0.00041219548,0.00015401887,0.00010587384,0.00006252534,0.00056275044,0.000012505925],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014594035,0.00083568983,0.00027148984,0.00036192808,0.0002977882,0.00012009592,0.00024783012,0.000017469003,3.238202e-7,0.000093837225,0.00069550565,0.9955986],"study_design_scores_gemma":[0.004601438,0.00029366865,0.004211763,0.042950474,0.00014665173,0.000026799116,0.000029853936,0.000008492954,0.000012512707,0.0000040501604,0.9471124,0.00060190633],"about_ca_topic_score_codex":0.00003484052,"about_ca_topic_score_gemma":0.000027914448,"teacher_disagreement_score":0.9949967,"about_ca_system_score_codex":0.00018486804,"about_ca_system_score_gemma":0.0006846856,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W2141490624","doi":"10.1517/14740338.2011.583917","title":"Antidepressant use in pregnancy","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; Antidepressant; Affect (linguistics); Depression (economics); Psychiatry; Drugs in pregnancy; Obstetrics; Intensive care medicine; Family medicine; Anxiety; Fetus","score_opus":0.10990325148139715,"score_gpt":0.38788316994212785,"score_spread":0.27797991846073067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141490624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004911278,0.99081206,0.0000036200995,0.00009524436,0.0025981192,0.0019996376,0.000074751515,0.00010334609,0.004308323],"genre_scores_gemma":[0.000023799817,0.9955462,0.00016032498,0.00033439777,0.00033490654,0.00032841915,0.00026233686,0.00010470595,0.0029049062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698013,0.0003289757,0.0011435247,0.0007099482,0.00029550772,0.0005418869],"domain_scores_gemma":[0.99822456,0.00023768487,0.00034835027,0.00087934826,0.000028706027,0.00028132868],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002202473,0.0005849895,0.0018317755,0.00032340307,0.000081402584,0.000019283383,0.00025107074,0.0003473021,0.0003872604],"category_scores_gemma":[0.000063440064,0.00043909473,0.00041164478,0.00020840437,0.00005202268,0.00013757394,0.00012320398,0.0007690062,0.0004445943],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000447056,0.0006434482,0.0003504224,0.06672974,0.00007389132,0.00022190559,0.0006065054,1.5255446e-7,3.5577294e-8,0.0014163858,0.0014395609,0.9280709],"study_design_scores_gemma":[0.000496668,0.00009403661,0.00046572543,0.3675902,0.000011266776,0.00008148645,0.000004808098,8.016533e-7,0.000004890385,0.00000617951,0.6309965,0.00024739676],"about_ca_topic_score_codex":0.00024442133,"about_ca_topic_score_gemma":0.000009627741,"teacher_disagreement_score":0.9278235,"about_ca_system_score_codex":0.000249964,"about_ca_system_score_gemma":0.00021172738,"threshold_uncertainty_score":0.9998061},"labels":[],"label_agreement":null},{"id":"W2142102791","doi":"10.1517/14740330902778180","title":"Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital","funders":"University of Otago; GlaxoSmithKline","keywords":"Medicine; Anaphylaxis; Heparin; Anaphylactoid reactions; Angioedema; Anesthesia; Immunology; Allergy; Internal medicine","score_opus":0.08887042483451926,"score_gpt":0.3882741692421307,"score_spread":0.2994037444076114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142102791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057162903,0.97833586,0.000021355812,0.00077594264,0.0019445872,0.0024492529,0.0000736601,0.00042902897,0.015398709],"genre_scores_gemma":[0.010931915,0.98548424,0.00034090265,0.0004242422,0.0011843287,0.00020032053,0.0005884468,0.00021439066,0.0006312387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99409974,0.00057539,0.0018032601,0.001769724,0.00077440444,0.0009775056],"domain_scores_gemma":[0.99570906,0.00082281657,0.00085338054,0.0016805296,0.00013445111,0.00079978857],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.000668136,0.001467834,0.0045958566,0.000848589,0.00059805537,0.00015726865,0.00041197267,0.0006775815,0.00027298476],"category_scores_gemma":[0.00041886812,0.001230372,0.0010955553,0.00095506705,0.00015675247,0.0003495691,0.00021964166,0.0017297086,0.00026754374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014420087,0.00053535565,0.00003062183,0.0037335458,0.0007636191,0.000097736716,0.00022922644,2.6051552e-7,0.0000830922,0.0013896513,0.0009934497,0.99199927],"study_design_scores_gemma":[0.0016083765,0.0004786486,0.0019045972,0.021629909,0.00020988833,0.00083465123,0.00013721951,0.000015873053,0.000032390428,0.000058259007,0.9718932,0.0011970012],"about_ca_topic_score_codex":0.00072827114,"about_ca_topic_score_gemma":0.000039733168,"teacher_disagreement_score":0.9908022,"about_ca_system_score_codex":0.0009920208,"about_ca_system_score_gemma":0.00072552206,"threshold_uncertainty_score":0.9998071},"labels":[],"label_agreement":null},{"id":"W2142106904","doi":"10.1517/14740338.2014.867015","title":"Development and application of indicators for the reduction of potentially preventable hospital admissions related to medications","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pharmacy; Performance indicator; Medical emergency; Database; Family medicine; Business","score_opus":0.03065182027426445,"score_gpt":0.3720130291358453,"score_spread":0.34136120886158083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142106904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6272771,0.0061811386,0.06565895,0.26927102,0.0036408831,0.022882406,0.000078213205,0.00020263086,0.0048076888],"genre_scores_gemma":[0.9897868,0.0007141367,0.008412589,0.00031385003,0.000043363223,0.000346097,0.000069203,0.000011499341,0.00030243647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999123,0.000028933731,0.0003829171,0.00015540891,0.00021103215,0.00009874229],"domain_scores_gemma":[0.999172,0.00020288743,0.00018848194,0.000187905,0.000078656536,0.00017006867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024170609,0.00007738782,0.00014257667,0.00008207865,0.00012241224,0.00000367776,0.000074106145,0.000045087632,0.000113409056],"category_scores_gemma":[0.00018045091,0.00005090145,0.000042509346,0.00018468722,0.00004302474,0.00007993607,0.000034420456,0.00008454503,0.0000085331985],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077142596,0.0017884368,0.0041982573,0.00019437971,0.00045791277,9.895689e-8,0.016665803,0.000100187266,0.01738889,0.010185697,0.017097853,0.93115103],"study_design_scores_gemma":[0.001720596,0.00031578724,0.05661294,0.000205818,0.000038854876,0.0000044019325,0.0022528963,0.0015924531,0.027630059,0.00014844898,0.90932715,0.00015059617],"about_ca_topic_score_codex":0.00003322468,"about_ca_topic_score_gemma":3.5223584e-7,"teacher_disagreement_score":0.9310005,"about_ca_system_score_codex":0.00003385924,"about_ca_system_score_gemma":0.000097627526,"threshold_uncertainty_score":0.20757008},"labels":[],"label_agreement":null},{"id":"W2143666642","doi":"10.1517/14740338.2011.533168","title":"Lapatinib for breast cancer: a review of the current literature","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lapatinib; Medicine; Breast cancer; Trastuzumab; Cancer; Oncology; Metastatic breast cancer; Internal medicine; Tyrosine-kinase inhibitor; Disease","score_opus":0.0746250945156274,"score_gpt":0.4797467624904513,"score_spread":0.40512166797482385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143666642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.4219412e-8,0.9748762,0.0000046162418,0.0094596045,0.0051534693,0.0058628363,0.003683892,0.000038121638,0.0009212356],"genre_scores_gemma":[1.736053e-7,0.9921155,0.00010927589,0.001168618,0.0029840115,0.0023048255,0.00058599416,0.00012239246,0.00060918793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626386,0.0004112726,0.0011910924,0.0006904739,0.0009789692,0.00046432315],"domain_scores_gemma":[0.9964885,0.00045163487,0.00065176457,0.0016117644,0.00055707025,0.00023927013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010244773,0.00057578005,0.0024081948,0.00014617902,0.00013190022,0.000021904478,0.0007605343,0.00033490124,0.0005825293],"category_scores_gemma":[0.0004711648,0.00031434087,0.0014814246,0.00075862795,0.0001478959,0.00004169983,0.00019273121,0.0021688489,0.000028527038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005354019,0.00009850595,0.0000010426877,0.16753475,0.00005142424,5.459701e-7,0.00009799214,1.6983154e-8,3.0862142e-7,0.00014556316,0.12029952,0.7117168],"study_design_scores_gemma":[0.00030469388,0.0000362366,0.000007724082,0.42594296,0.000042921398,0.00003432832,0.0000018261425,0.0000012249282,0.000002368562,0.0000035390108,0.57346183,0.00016034313],"about_ca_topic_score_codex":0.000023830158,"about_ca_topic_score_gemma":0.000004381742,"teacher_disagreement_score":0.71155643,"about_ca_system_score_codex":0.00045047828,"about_ca_system_score_gemma":0.0024142782,"threshold_uncertainty_score":0.99993086},"labels":[],"label_agreement":null},{"id":"W2143694203","doi":"10.1517/14740338.6.4.445","title":"Safety considerations with mycophenolate sodium","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Western Ontario; Western University","funders":"","keywords":"Medicine; Mycophenolic acid; Mycophenolate; Bioequivalence; Pharmacokinetics; Ciclosporin; Dosing; Pharmacology; Prodrug; Transplantation; Concomitant; Internal medicine","score_opus":0.0723134514616224,"score_gpt":0.386728963412423,"score_spread":0.31441551195080064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143694203","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.7971018e-7,0.9684398,0.00045647655,0.00061142084,0.0011468665,0.0017545483,0.00018925054,0.00017022439,0.027231121],"genre_scores_gemma":[0.000015431127,0.9902471,0.0022761843,0.0011728471,0.00049299875,0.000104984574,0.0021966759,0.00012310085,0.0033706941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970554,0.00015996452,0.001048089,0.0007045529,0.0005859625,0.00044602802],"domain_scores_gemma":[0.997801,0.0007059105,0.00034660578,0.0006970046,0.00011728555,0.00033216205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002396455,0.0007423203,0.0019151687,0.0003279975,0.0003203946,0.000042048712,0.00011041883,0.0003039003,0.0008080305],"category_scores_gemma":[0.00002911263,0.00046830767,0.0005772406,0.00032074406,0.00009277792,0.00008777344,0.000023210368,0.00055802625,0.0006022896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014963413,0.00081032945,0.000037370744,0.00800408,0.0022250193,0.0006473155,0.0008168316,0.000010426892,2.9409497e-7,0.008550789,0.004997722,0.97240347],"study_design_scores_gemma":[0.002868017,0.00024929352,0.00006839755,0.02721416,0.00019594468,0.00065871625,0.000040082865,0.0000026096916,0.0000047836843,0.000015435708,0.9682351,0.00044750294],"about_ca_topic_score_codex":0.0000391658,"about_ca_topic_score_gemma":0.0000090017475,"teacher_disagreement_score":0.97195596,"about_ca_system_score_codex":0.00036484544,"about_ca_system_score_gemma":0.00053371006,"threshold_uncertainty_score":0.99977684},"labels":[],"label_agreement":null},{"id":"W2144075042","doi":"10.1517/14740338.2014.914168","title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Rivastigmine; Donepezil; Galantamine; Medicine; Memantine; Clinical trial; Disease; Intensive care medicine; Alzheimer's disease; Dementia; Pharmacology; Psychiatry; Internal medicine","score_opus":0.055667495834188986,"score_gpt":0.37620101864618094,"score_spread":0.32053352281199193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144075042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016961389,0.9949702,0.000007056082,0.0009585558,0.0004538749,0.001572724,0.00018438253,0.000073899486,0.00008319138],"genre_scores_gemma":[0.0009776748,0.9952897,0.000066878696,0.0015189823,0.00089761044,0.00016283509,0.0008171408,0.0001390608,0.00013014936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971317,0.00029998634,0.00096979487,0.0008046175,0.00050482474,0.00028906067],"domain_scores_gemma":[0.9976109,0.0003341904,0.00051753403,0.0008840432,0.0001442315,0.0005090835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018147063,0.0008261178,0.0027101939,0.00029997466,0.00010187329,0.000025118261,0.00014411847,0.00013733376,0.000056791996],"category_scores_gemma":[0.000094730036,0.00048064397,0.0006107737,0.0002463155,0.00017868912,0.00009643412,0.00007478615,0.0003056914,0.000015077179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023858352,0.0017024932,0.0016140831,0.005762952,0.0014125752,0.00008492167,0.0003824146,0.0000033232739,0.000011967858,0.0001608218,0.006554248,0.9799244],"study_design_scores_gemma":[0.0027517944,0.000220731,0.001463901,0.0132503,0.0002919093,0.00003038639,0.00001716755,0.0000043495,0.00013912059,8.2921497e-7,0.98132527,0.0005042649],"about_ca_topic_score_codex":0.00001191383,"about_ca_topic_score_gemma":0.0000010567627,"teacher_disagreement_score":0.9794201,"about_ca_system_score_codex":0.000026383763,"about_ca_system_score_gemma":0.00027222445,"threshold_uncertainty_score":0.9997645},"labels":[],"label_agreement":null},{"id":"W2146208080","doi":"10.1517/14740338.2011.586628","title":"The relationship among proton pump inhibitors, bone disease and fracture","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Intensive care medicine; Observational study; Fragility; Disease; Osteoporosis; Internal medicine","score_opus":0.046587861553520085,"score_gpt":0.34863409142449814,"score_spread":0.30204622987097807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146208080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003205453,0.99407446,0.000005173505,0.0005107773,0.0005780448,0.003808705,0.000042452568,0.00008487236,0.00086344837],"genre_scores_gemma":[0.002479609,0.9924858,0.00003895025,0.00016394487,0.0007507957,0.0009800026,0.0006840331,0.0000863271,0.0023305456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783075,0.00026947085,0.0006271304,0.00056906586,0.00036073782,0.000342826],"domain_scores_gemma":[0.99790496,0.00045529753,0.0003528044,0.00075757335,0.000047799193,0.00048155227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002870818,0.000545328,0.0009356371,0.000121409255,0.0004563882,0.000044324333,0.0001288836,0.0002626377,0.000059527065],"category_scores_gemma":[0.00033419178,0.00029184317,0.00040574462,0.00015520972,0.00016315792,0.00009393814,0.00008251263,0.00062547997,0.00009670638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040039397,0.000532838,0.011718111,0.0045752428,0.00044570657,0.00023026622,0.0005526269,1.7296234e-7,1.5307652e-8,0.0010201505,0.012516459,0.96800804],"study_design_scores_gemma":[0.0006863299,0.0001102115,0.0142063685,0.009179478,0.00011803161,0.000022733762,0.00001184914,9.0303314e-7,9.080148e-7,0.00006971692,0.97544545,0.0001480133],"about_ca_topic_score_codex":0.000014641993,"about_ca_topic_score_gemma":9.89955e-7,"teacher_disagreement_score":0.96786,"about_ca_system_score_codex":0.00018033145,"about_ca_system_score_gemma":0.00021624229,"threshold_uncertainty_score":0.9999534},"labels":[],"label_agreement":null},{"id":"W2146324261","doi":"10.1517/14740338.1.3.269","title":"A safety look at currently available statins","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Tolerability; Statin; Adverse effect; Discontinuation; Gemfibrozil; Intensive care medicine; Drug; Pharmacology; Dyslipidemia; Internal medicine; Cholesterol; Disease","score_opus":0.06159846988091728,"score_gpt":0.3495888478837957,"score_spread":0.2879903780028784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146324261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.5293977e-7,0.9580513,0.00007727806,0.0005278517,0.0025630738,0.0032269512,0.000345215,0.00023953621,0.034968525],"genre_scores_gemma":[4.519379e-7,0.96740514,0.00039030527,0.00077250437,0.0027893889,0.00037080637,0.0019079664,0.00022860966,0.026134804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939239,0.00066224096,0.0016280018,0.0013836364,0.001472211,0.00092998595],"domain_scores_gemma":[0.9960125,0.00022471865,0.00054777093,0.002376436,0.00014242208,0.00069613056],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011242885,0.0010420206,0.0038563637,0.000319491,0.00044886596,0.00003776779,0.0003781158,0.0005472928,0.0074975844],"category_scores_gemma":[0.00014061312,0.00078366173,0.0023725468,0.0005406204,0.00011191735,0.00009801513,0.00026537527,0.0011378411,0.008672331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011072132,0.0002663343,0.0000013023621,0.006568552,0.00041545372,0.000034697478,0.00022084714,6.3402445e-7,6.651781e-8,0.00014207287,0.19322486,0.79901445],"study_design_scores_gemma":[0.0018713322,0.00021565957,0.000004506437,0.024108935,0.00014105276,0.0002696047,0.00003822569,0.000018018689,0.000002266114,0.0000019265603,0.9726163,0.0007121413],"about_ca_topic_score_codex":0.00017187679,"about_ca_topic_score_gemma":0.00000890901,"teacher_disagreement_score":0.7983023,"about_ca_system_score_codex":0.00194485,"about_ca_system_score_gemma":0.00081902114,"threshold_uncertainty_score":0.9994614},"labels":[],"label_agreement":null},{"id":"W2154484972","doi":"10.1517/14740338.7.5.547","title":"Efficacy and safety of aromatase inhibitors in early breast cancer","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Tamoxifen; Adjuvant; Breast cancer; Aromatase; Adverse effect; Quality of life (healthcare); Oncology; Clinical trial; Internal medicine; Aromatase inhibitor; Randomized controlled trial; Gynecology; Safety profile; Cancer","score_opus":0.012634255241117436,"score_gpt":0.30578251926398653,"score_spread":0.2931482640228691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154484972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011452736,0.99691904,0.0000017787279,0.000077703866,0.0005176198,0.0007304677,0.00035559092,0.000013567741,0.00023899105],"genre_scores_gemma":[0.0007202974,0.99781007,0.000027638749,0.000040608975,0.00044084122,0.00006918305,0.00075436675,0.00006459763,0.00007238724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795794,0.00026789214,0.0006839159,0.00060841755,0.00018742838,0.00029443065],"domain_scores_gemma":[0.999001,0.00007141734,0.00029437628,0.00046023863,0.000030347284,0.00014260226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014326353,0.0004685461,0.00095943164,0.0001463013,0.000076678065,0.000008509331,0.00021587157,0.00058077107,0.000011108112],"category_scores_gemma":[0.00002775862,0.0003703088,0.00029337013,0.00020484114,0.00014732845,0.0000050142953,0.00015226561,0.00037496389,0.000011102349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000738313,0.0002937145,0.00004529461,0.00090376125,0.0002481649,0.000017465745,0.00023346343,0.000012799101,0.0001871545,0.000039088325,0.008484499,0.9887963],"study_design_scores_gemma":[0.0013064372,0.00014496695,0.00028522225,0.0067830663,0.000013053599,0.00011922198,0.000010658704,0.0000015424456,0.00036850845,6.1244265e-7,0.99055195,0.00041475383],"about_ca_topic_score_codex":0.00013950592,"about_ca_topic_score_gemma":0.0000037423433,"teacher_disagreement_score":0.9883815,"about_ca_system_score_codex":0.00006377831,"about_ca_system_score_gemma":0.0002235265,"threshold_uncertainty_score":0.9998749},"labels":[],"label_agreement":null},{"id":"W2155380597","doi":"10.1517/14740330903311023","title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Nephrotoxicity; Renal function; Adverse effect; Nephritic syndrome; Side effect (computer science); Pharmacology; Drug; Internal medicine; Heart failure; Kidney; Proteinuria","score_opus":0.013915099351497897,"score_gpt":0.3104675364276032,"score_spread":0.29655243707610535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155380597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014203564,0.98997647,0.000023272923,0.00009393918,0.0038178447,0.002885938,0.000030961004,0.00019333958,0.0028361997],"genre_scores_gemma":[0.000094618306,0.99578375,0.00017995128,0.00034809127,0.002479157,0.00014447427,0.00034009907,0.00015628296,0.00047356146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99517316,0.0006383172,0.0016132642,0.0008884955,0.0009996849,0.0006870657],"domain_scores_gemma":[0.9962726,0.00089962257,0.0009301828,0.001269852,0.00012566443,0.0005020466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007806338,0.001073386,0.0038207395,0.0006262577,0.00014593337,0.00001173302,0.00038940873,0.00073675794,0.0001233304],"category_scores_gemma":[0.00024416082,0.0008265316,0.001566292,0.00039569984,0.0001883851,0.00011759027,0.000113001515,0.001024069,0.00040257326],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030616167,0.000361842,0.00001015749,0.024045343,0.00034038874,0.0002580855,0.0007331018,0.0000021684148,0.00003234334,0.00023372589,0.016298324,0.9573784],"study_design_scores_gemma":[0.002313375,0.00040042316,0.000097247554,0.06624389,0.00015676308,0.00008637756,0.000028509854,0.000010137102,0.0005002338,0.0000026842627,0.92951065,0.00064972293],"about_ca_topic_score_codex":0.000008835055,"about_ca_topic_score_gemma":5.238523e-7,"teacher_disagreement_score":0.95672864,"about_ca_system_score_codex":0.00032272292,"about_ca_system_score_gemma":0.00081437174,"threshold_uncertainty_score":0.99941856},"labels":[],"label_agreement":null},{"id":"W2159244051","doi":"10.1517/14740338.2014.942219","title":"Patient reports of the frequency and severity of adverse reactions associated with biological agents prescribed for psoriasis in Brazil","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Medicine; Psoriasis; Adalimumab; Etanercept; Adverse effect; Infliximab; Discontinuation; Odds ratio; Internal medicine; Efalizumab; Intensive care medicine; Dermatology; Rheumatoid arthritis; Disease","score_opus":0.020439595718758717,"score_gpt":0.2603271935728105,"score_spread":0.23988759785405175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159244051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730307,0.00044675937,0.000027053671,0.00024328334,0.0008670788,0.0005234938,0.00011622609,0.000019381088,0.00045362677],"genre_scores_gemma":[0.99921304,0.00029622283,0.0000944017,0.00006737846,0.000014040602,0.00006804413,0.00015428953,0.000007827318,0.00008477234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987772,0.00036821465,0.00040269393,0.0002498301,0.000045116813,0.00015695827],"domain_scores_gemma":[0.99898684,0.00032845815,0.00033819693,0.00027101606,0.000059667036,0.000015833772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029269376,0.00013634267,0.00028189013,0.000050887422,0.000107455686,0.0000010610174,0.00007196464,0.00016082879,0.00003637892],"category_scores_gemma":[0.00034200982,0.00008314828,0.00009246547,0.000115689865,0.00013251898,0.000040831994,0.000036873713,0.00007995962,9.83745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007658828,0.0062008766,0.73490655,0.00009403616,0.001913987,0.000008233149,0.022310441,0.00016160712,0.0860205,0.0038178733,0.0075823376,0.12932475],"study_design_scores_gemma":[0.003116189,0.0005847232,0.941997,0.00022729964,0.000017575152,0.000012023841,0.0005257915,0.00000902007,0.036624916,0.00023771323,0.016466696,0.00018107356],"about_ca_topic_score_codex":0.00018860542,"about_ca_topic_score_gemma":0.0000583558,"teacher_disagreement_score":0.20709045,"about_ca_system_score_codex":0.00004571569,"about_ca_system_score_gemma":0.000032116073,"threshold_uncertainty_score":0.33906886},"labels":[],"label_agreement":null},{"id":"W2160309422","doi":"10.1517/14740338.2011.579899","title":"Drugs with anticholinergic properties: a current perspective on use and safety","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Anticholinergic; Perspective (graphical); Intensive care medicine; Pharmacology; Adverse effect","score_opus":0.07299585514305262,"score_gpt":0.3554412384383344,"score_spread":0.2824453832952818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160309422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016095499,0.98510283,0.000040997074,0.0010603584,0.001163405,0.0034925241,0.00017070338,0.00016671102,0.008786366],"genre_scores_gemma":[0.00014161949,0.99308246,0.00008243235,0.004429824,0.00056004664,0.00026419156,0.00048097502,0.00024717816,0.00071129727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959807,0.00048811722,0.0008476101,0.0014275807,0.0006286462,0.00062736776],"domain_scores_gemma":[0.993561,0.00044903572,0.00044465487,0.0008973125,0.004265371,0.00038260085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027973522,0.001229449,0.0024785933,0.0006396361,0.00025685367,0.00005886868,0.00023427367,0.00032169724,0.00012666256],"category_scores_gemma":[0.001970908,0.00077342056,0.0005866608,0.00046898736,0.0004918889,0.00018338487,0.0001385595,0.0015139246,0.00019829955],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006089056,0.0010946041,0.000009176317,0.005195624,0.0010572197,0.000060316263,0.014447327,8.0165523e-7,6.4225384e-7,0.00734089,0.017843625,0.94686073],"study_design_scores_gemma":[0.0021924574,0.0009055769,0.00003257379,0.07860674,0.00019093434,0.000114213115,0.006277964,0.000006020123,0.0000068189906,0.0000068205272,0.9107947,0.0008652249],"about_ca_topic_score_codex":0.0001565389,"about_ca_topic_score_gemma":0.000005138899,"teacher_disagreement_score":0.9459955,"about_ca_system_score_codex":0.00094281574,"about_ca_system_score_gemma":0.0007160014,"threshold_uncertainty_score":0.99947166},"labels":[],"label_agreement":null},{"id":"W2162939680","doi":"10.1517/14740338.4.2.193","title":"Chemotherapy-induced oral mucositis: new approaches to prevention and management","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Mucositis; Intensive care medicine; Chemotherapy; Dermatology; Internal medicine; Oncology","score_opus":0.27337652476683083,"score_gpt":0.44422378717327093,"score_spread":0.1708472624064401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162939680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002107212,0.97954446,0.000115359886,0.011061077,0.00092036393,0.0052885106,0.000016610678,0.00013649481,0.0029150369],"genre_scores_gemma":[0.0000069204702,0.9798351,0.010383963,0.0018547482,0.001610125,0.0006918631,0.00029044962,0.00012446835,0.005202387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714106,0.00017136679,0.00080145197,0.0009275067,0.0004609653,0.0004976381],"domain_scores_gemma":[0.998372,0.00005260262,0.0002451288,0.0007128342,0.000014510425,0.00060288113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032384638,0.0006408469,0.0015683388,0.00028164036,0.00011714653,0.000028647028,0.00016021004,0.00026456395,0.0001995733],"category_scores_gemma":[0.0000062038766,0.0005095341,0.00033061294,0.0003056159,0.00002173484,0.00006657793,0.000100045225,0.0003127885,0.00020955774],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021248992,0.0003017275,0.0000011295247,0.0039754882,0.00025378235,0.000007705425,0.00032708675,5.06639e-7,3.1258008e-8,0.00048658394,0.018034095,0.97639936],"study_design_scores_gemma":[0.0019519831,0.0005770404,0.00006793234,0.022848874,0.00009177636,0.000043160002,0.000052995245,0.0000054484176,0.0000051598527,0.000015968972,0.9739528,0.00038691662],"about_ca_topic_score_codex":0.00007911433,"about_ca_topic_score_gemma":0.000013797053,"teacher_disagreement_score":0.97601247,"about_ca_system_score_codex":0.0015409368,"about_ca_system_score_gemma":0.00036916157,"threshold_uncertainty_score":0.99973565},"labels":[],"label_agreement":null},{"id":"W2171378113","doi":"10.1517/14740330902933736","title":"Immune mediation of hypersensitivity adverse drug reactions: implications for therapy","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Children’s Health Research Institute; Children's Hospital of Western Ontario","funders":"","keywords":"Medicine; Drug; Immune system; Adverse effect; Hapten; Immunology; Pharmacology; Antibody","score_opus":0.0745449441876453,"score_gpt":0.3937457570854146,"score_spread":0.3192008128977693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171378113","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003967525,0.97691834,0.00024233159,0.0040536076,0.0019383059,0.0049246955,0.0005121913,0.0002659902,0.011140596],"genre_scores_gemma":[0.000203185,0.99271303,0.001087568,0.00024897768,0.0011487182,0.0006750988,0.0029703109,0.00013381657,0.0008192932],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646235,0.00030453148,0.0015644492,0.00081757613,0.0004194445,0.00043165096],"domain_scores_gemma":[0.9953312,0.0013770671,0.0012148253,0.0014276803,0.0004056835,0.00024348644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072955346,0.000687284,0.0022262046,0.0006474111,0.00030512112,0.000011501729,0.00022516253,0.0004265788,0.00002134589],"category_scores_gemma":[0.00047524256,0.0005889586,0.0015636376,0.0006961109,0.00011473187,0.00022120253,0.000038066046,0.00066250825,0.000087251676],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006523937,0.0007635037,6.255453e-7,0.00087482727,0.0003038052,0.0000013509508,0.00027771073,0.000005757133,0.00014917422,0.0017729212,0.0017720796,0.994013],"study_design_scores_gemma":[0.0015449168,0.00006254501,0.0005644614,0.0061645154,0.00011557057,0.000110068875,0.00031547004,0.000012580561,0.00008795547,0.000056556866,0.99051195,0.00045338352],"about_ca_topic_score_codex":0.000093795694,"about_ca_topic_score_gemma":0.0000044163276,"teacher_disagreement_score":0.9935596,"about_ca_system_score_codex":0.0008711584,"about_ca_system_score_gemma":0.00084379537,"threshold_uncertainty_score":0.9996562},"labels":[],"label_agreement":null},{"id":"W2172641990","doi":"10.1517/14740338.2016.1120718","title":"The use of anticoagulants for the treatment and prevention of venous thromboembolism in obese patients: implications for safety","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dosing; Fondaparinux; Warfarin; Intensive care medicine; Low molecular weight heparin; Population; Heparin; Venous thromboembolism; Thrombosis; Internal medicine","score_opus":0.16591350759852055,"score_gpt":0.4171466756494872,"score_spread":0.2512331680509666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172641990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108929824,0.9855748,0.0002716214,0.0010902692,0.00066869095,0.011529256,0.00067988044,0.000016210459,0.000060389604],"genre_scores_gemma":[0.00018552637,0.99633867,0.0003855273,0.00007172207,0.00016617056,0.0019815722,0.0007149306,0.000055971017,0.00009992969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978544,0.00016160631,0.0010919102,0.00039914748,0.0002033001,0.00028964927],"domain_scores_gemma":[0.9966181,0.0015972283,0.0006631122,0.00079491775,0.00024565664,0.00008097518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057045196,0.00036008327,0.0020623475,0.00013388149,0.00021870188,0.000020273188,0.00020727466,0.00014713916,0.000003953649],"category_scores_gemma":[0.00020639441,0.00019020117,0.0004917245,0.00018389305,0.0001287166,0.00006453052,0.00006876125,0.00009830111,0.0000014629394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020411788,0.0023186936,0.000021703938,0.0018910001,0.00053488655,6.2391244e-8,0.00081233145,0.000009748532,2.6515139e-7,0.003223445,0.0072217695,0.98376197],"study_design_scores_gemma":[0.0021724303,0.0011132954,0.0042126635,0.005487106,0.00038862615,0.0000012997745,0.00012636436,0.000030467243,0.0000028158413,0.00022382887,0.98607856,0.00016251637],"about_ca_topic_score_codex":0.00013658796,"about_ca_topic_score_gemma":0.00005655382,"teacher_disagreement_score":0.9835995,"about_ca_system_score_codex":0.00031457745,"about_ca_system_score_gemma":0.00024201605,"threshold_uncertainty_score":0.77561784},"labels":[],"label_agreement":null},{"id":"W2304716045","doi":"10.1517/14740338.2015.1045875","title":"Safety evaluation of olaparib for treating ovarian cancer","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Olaparib; Tolerability; Oncology; Internal medicine; Nausea; Ovarian cancer; Cancer; Adverse effect","score_opus":0.18505262006867182,"score_gpt":0.4859453302992656,"score_spread":0.30089271023059383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304716045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.055003e-7,0.9821776,0.00045475014,0.0007640028,0.0027462586,0.0047762603,0.00087454065,0.0000904991,0.008115355],"genre_scores_gemma":[0.000015924417,0.99045825,0.0011247636,0.00034196718,0.0025469738,0.0025336838,0.0022291944,0.00014946815,0.00059976254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99527967,0.0006285134,0.0015882195,0.00076051673,0.0013536487,0.00038943812],"domain_scores_gemma":[0.9961789,0.0005132541,0.0011097774,0.0008800504,0.0010815288,0.00023649083],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003118448,0.00061391544,0.0025004838,0.00031475027,0.00015012528,0.000014776636,0.00023358526,0.00043417668,0.0008233047],"category_scores_gemma":[0.0003589392,0.00049452425,0.0007945582,0.00042984032,0.000092571456,0.000100487756,0.00004255364,0.00038721264,0.00003262187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068295037,0.00016654501,0.0000011607666,0.0027732446,0.00036662348,4.066887e-7,0.00066572474,0.0000430955,0.000005204514,0.0006355531,0.025465345,0.9691942],"study_design_scores_gemma":[0.0062700408,0.00020175338,0.000007786779,0.030565342,0.00031387698,0.000015271955,0.00009931024,0.0003706587,0.000056108718,0.00008340037,0.96160346,0.00041299147],"about_ca_topic_score_codex":0.00013877435,"about_ca_topic_score_gemma":0.000009538829,"teacher_disagreement_score":0.9687812,"about_ca_system_score_codex":0.0027583905,"about_ca_system_score_gemma":0.0031376537,"threshold_uncertainty_score":0.9997506},"labels":[],"label_agreement":null},{"id":"W2327248001","doi":"10.1517/14740338.2011.579900","title":"Safe use of long-acting β-agonists: what have we learnt?","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Asthma; Adverse effect; Inhaled corticosteroids; Intensive care medicine; B2 receptor; Lung function; Bronchodilator Agents; Fluticasone propionate; Bronchodilator; Internal medicine; Lung","score_opus":0.12358159680523714,"score_gpt":0.38191590711522855,"score_spread":0.25833431030999143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327248001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018920889,0.99378854,0.000059651644,0.00028550441,0.0019683791,0.0011238181,0.00006290394,0.000104153085,0.0026051854],"genre_scores_gemma":[0.000015311523,0.99463826,0.00020446592,0.0004518963,0.0011550598,0.000079881494,0.00040127692,0.00016308656,0.0028907647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965634,0.00042998238,0.0012945182,0.0007912811,0.00045304047,0.00046779565],"domain_scores_gemma":[0.9969366,0.00048433186,0.00085809064,0.0011428727,0.00015204454,0.00042605307],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027725394,0.00076157873,0.0025207407,0.000326716,0.00018542216,0.00006996628,0.0002953093,0.0004713529,0.0009155889],"category_scores_gemma":[0.0002661281,0.00054966717,0.0012643858,0.0002324646,0.00022249026,0.0004008994,0.00016426886,0.00071140076,0.00030465974],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021754041,0.00034549704,0.000014098374,0.00579192,0.00019134005,0.000050696788,0.0005680503,8.2806304e-7,4.129892e-7,0.000119785866,0.0055982503,0.98710155],"study_design_scores_gemma":[0.00052795507,0.00018297807,0.00003242682,0.067233995,0.000090656016,0.000051478273,0.0006611615,0.0000034665393,0.000016972517,0.0000019247032,0.9307284,0.0004686019],"about_ca_topic_score_codex":0.000056323915,"about_ca_topic_score_gemma":0.0000040816003,"teacher_disagreement_score":0.986633,"about_ca_system_score_codex":0.0002580879,"about_ca_system_score_gemma":0.0006460409,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W2418356692","doi":"10.1080/14740338.2016.1199682","title":"Tiotropium for the treatment of asthma: a drug safety evaluation","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Anticholinergic; Salmeterol; Asthma; Bronchodilator; Tiotropium bromide; Clinical trial; Placebo; Intensive care medicine; Adverse effect; Anesthesia; Pharmacology; Internal medicine; Alternative medicine; Lung function; Lung","score_opus":0.060765193412633,"score_gpt":0.4019923326556875,"score_spread":0.34122713924305453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418356692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013074281,0.9887385,0.00035282073,0.0015708215,0.0020140647,0.005741609,0.0005421946,0.00005865567,0.0009800411],"genre_scores_gemma":[0.000018476612,0.9925333,0.00008848078,0.00018848058,0.0026490372,0.0014507856,0.0007130888,0.0000985137,0.0022597837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966648,0.0004908093,0.0010859428,0.00064092566,0.0007593344,0.00035815037],"domain_scores_gemma":[0.9965621,0.0012698097,0.0006299963,0.001050006,0.0002863056,0.00020173601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058961124,0.00062577805,0.0017750827,0.00018125084,0.00027152902,0.000013101444,0.0002370431,0.000227107,0.0005493158],"category_scores_gemma":[0.00017174953,0.0002878889,0.0015799997,0.00019109632,0.00015602376,0.000053278338,0.000033807562,0.00013175402,0.00012633129],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059268955,0.0005895335,0.0000014218542,0.0013468117,0.00033864792,0.0000014104797,0.00032266683,0.0000027480335,7.9677545e-7,0.00025513672,0.015478284,0.98106986],"study_design_scores_gemma":[0.0030108786,0.00068144174,0.000050835795,0.011386231,0.0002604954,0.000009905053,0.00012576394,0.00005027413,0.000016090376,0.000009047145,0.98410654,0.0002925225],"about_ca_topic_score_codex":0.000015781565,"about_ca_topic_score_gemma":0.0000029805506,"teacher_disagreement_score":0.9807773,"about_ca_system_score_codex":0.0008867382,"about_ca_system_score_gemma":0.0011514594,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W2469735602","doi":"10.1080/14740338.2016.1207760","title":"A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Homoharringtonine; Myeloid leukemia; Adverse effect; Pharmacology; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Intensive care medicine; Cancer","score_opus":0.07044490029049531,"score_gpt":0.39386546745387674,"score_spread":0.3234205671633814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469735602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008739287,0.9857046,0.00020400735,0.00067425286,0.0015245968,0.009722006,0.00073280634,0.000057718906,0.0013712632],"genre_scores_gemma":[0.00015503945,0.9930672,0.0001905852,0.000034098706,0.0013998096,0.0021245275,0.0011442134,0.00015887935,0.0017256654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455833,0.00059098593,0.0020039068,0.00093926425,0.0013315587,0.00057595165],"domain_scores_gemma":[0.99369794,0.0021174182,0.0015172295,0.001961194,0.0005262932,0.00017994405],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015409997,0.0009857375,0.0033542465,0.00031527455,0.00018892121,0.000008448289,0.00041257785,0.00044249097,0.00086816185],"category_scores_gemma":[0.00027760037,0.00050320104,0.0018298535,0.00037397255,0.00020645966,0.00007094824,0.00006359416,0.00022119703,0.000078213845],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00078297243,0.0006131878,8.7370455e-7,0.0032989683,0.001964621,0.0000017339913,0.00043287376,0.000029194935,0.000009685721,0.00027912983,0.0020399252,0.9905468],"study_design_scores_gemma":[0.015648818,0.0020038204,0.0000323952,0.022812521,0.0012896678,0.000038954135,0.00004415938,0.00066355406,0.0003647509,0.000017276701,0.9567021,0.0003819524],"about_ca_topic_score_codex":0.00015201986,"about_ca_topic_score_gemma":0.000022073984,"teacher_disagreement_score":0.9901649,"about_ca_system_score_codex":0.022017658,"about_ca_system_score_gemma":0.006756689,"threshold_uncertainty_score":0.999742},"labels":[],"label_agreement":null},{"id":"W2511950217","doi":"10.1080/14740338.2016.1223624","title":"Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Cardiotoxicity; Induced pluripotent stem cell; Medicine; Drug discovery; Stem cell; Drug; Pharmacology; Human Induced Pluripotent Stem Cells; Computational biology; Bioinformatics; Internal medicine; Embryonic stem cell; Cell biology; Biology; Toxicity","score_opus":0.02069101292525807,"score_gpt":0.277245622555107,"score_spread":0.25655460962984894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511950217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77853703,0.011875812,0.18786761,0.0071325814,0.0018893458,0.0046896865,0.0014634206,0.000186381,0.0063581252],"genre_scores_gemma":[0.9927577,0.0022452655,0.00038088256,0.00032206078,0.00047078342,0.00021956876,0.00015111937,0.000067102985,0.0033855606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975832,0.00025491673,0.00035633807,0.00088030956,0.00040048323,0.00052473636],"domain_scores_gemma":[0.9987303,0.00008541456,0.00010719175,0.00073868275,0.00011767904,0.0002207307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005120743,0.00034161194,0.00036105298,0.000084645726,0.0003093495,0.00005675979,0.00032511426,0.00015613728,0.0000067355163],"category_scores_gemma":[0.000014300415,0.00025210954,0.00030477167,0.00006061038,0.00015007952,0.000027040705,0.00023582616,0.0000991509,0.0000068835393],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007212907,0.00011736898,0.000050962408,0.000059380433,0.0000891969,0.0000028478196,0.00015216543,0.0014038688,0.9831904,0.0001643721,0.010417001,0.0036311413],"study_design_scores_gemma":[0.003677583,0.00023730696,0.0002899112,0.00011571062,0.0000050874146,0.0000035073497,0.00017823659,0.0010317885,0.86871904,0.00005965374,0.12516963,0.00051252416],"about_ca_topic_score_codex":0.00005521496,"about_ca_topic_score_gemma":0.000008675956,"teacher_disagreement_score":0.21422061,"about_ca_system_score_codex":0.000114709095,"about_ca_system_score_gemma":0.00011576399,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W2521077651","doi":"10.1080/14740338.2016.1238071","title":"Proton pump inhibitors and risk of<i>Clostridium difficile</i>infection: a multi-country study using sequence symmetry analysis","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Health Canada","funders":"National Health and Medical Research Council","keywords":"Medicine; Clostridium difficile; Internal medicine; Population; Confidence interval; National health insurance; Demography; Proton-pump inhibitor; Environmental health; Microbiology","score_opus":0.04131997720681452,"score_gpt":0.3479490898163622,"score_spread":0.30662911260954767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521077651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99486136,0.00089769927,0.00044005748,0.0005750983,0.000470108,0.002268444,0.00018579734,0.00012105741,0.00018039068],"genre_scores_gemma":[0.9894922,0.009303916,0.00020803427,0.000052560637,0.00054757425,0.00012502105,0.000034037384,0.000057649897,0.00017905378],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99601257,0.00041465025,0.0009258268,0.0009642772,0.0011038372,0.00057884585],"domain_scores_gemma":[0.99756616,0.00042708518,0.00036943593,0.0009243613,0.00033703508,0.00037594055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093935383,0.00047321687,0.0009325333,0.00078995683,0.00033436719,0.00003951718,0.00017194297,0.00020288581,0.00016645201],"category_scores_gemma":[0.0005549954,0.0003253318,0.000363315,0.0018477371,0.00028252933,0.00017192026,0.00021016954,0.00045766198,0.00002157607],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048287357,0.007444765,0.7817264,0.0003097769,0.004247844,0.00009429721,0.002715953,0.00016646988,0.16710827,0.00008688232,0.0006381241,0.03063248],"study_design_scores_gemma":[0.01651765,0.0028159698,0.09420033,0.0013351656,0.0008934459,0.00009400194,0.002760865,0.0048599816,0.8573083,0.000009051812,0.01790971,0.00129549],"about_ca_topic_score_codex":0.0027983352,"about_ca_topic_score_gemma":0.00007038683,"teacher_disagreement_score":0.6902001,"about_ca_system_score_codex":0.000545642,"about_ca_system_score_gemma":0.00026660998,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W2550995488","doi":"10.1080/14740338.2016.1226280","title":"Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions","year":2016,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Agenzia Italiana del Farmaco, Ministero della Salute; Partenariat Canadien Contre Le Cancer; Seconda Università degli Studi di Napoli; World Health Organization","keywords":"Medicine; Drug; Drug reaction; Adverse effect; Contrast (vision); Intensive care medicine; Pharmacology","score_opus":0.0293026674473134,"score_gpt":0.3483644938586854,"score_spread":0.319061826411372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550995488","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38935578,0.0003714911,0.00056763063,0.5640113,0.0042011472,0.009828805,0.0024397697,0.00027941968,0.028944705],"genre_scores_gemma":[0.99623615,0.00047524882,0.00015697295,0.0010196551,0.00035139636,0.00040126912,0.000034879045,0.000039470793,0.0012849901],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951706,0.0015858455,0.00084371434,0.0005982434,0.0013253393,0.00047624804],"domain_scores_gemma":[0.99332803,0.0035834035,0.00031462903,0.002213904,0.00024533612,0.00031468336],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025361206,0.00033207197,0.00051423506,0.00007223518,0.00037495195,0.000010549621,0.0006251974,0.000118903845,0.0021677495],"category_scores_gemma":[0.0019667458,0.00014827399,0.00041129105,0.00035981077,0.0006797917,0.00013887053,0.0002775687,0.00068591366,0.000077569784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009287255,0.010483583,0.10185827,0.00024218808,0.00091821875,0.000008566778,0.011883131,0.000004965896,0.03506863,0.027260745,0.73177814,0.07120629],"study_design_scores_gemma":[0.006981462,0.0005244628,0.6509232,0.0013608147,0.00003741753,0.000022810313,0.003959833,0.00007657642,0.03982179,0.0021133514,0.29375395,0.00042436284],"about_ca_topic_score_codex":0.00036928314,"about_ca_topic_score_gemma":0.000089241534,"teacher_disagreement_score":0.6068803,"about_ca_system_score_codex":0.000966096,"about_ca_system_score_gemma":0.0006236815,"threshold_uncertainty_score":0.9987444},"labels":[],"label_agreement":null},{"id":"W2592568061","doi":"10.1080/14740338.2017.1300251","title":"The safety of vedolizumab for the treatment of ulcerative colitis","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Adverse effect; Internal medicine; Placebo; Population; Natalizumab; Oncology; Gastroenterology; Disease; Pathology","score_opus":0.049647231406416664,"score_gpt":0.37252849525481396,"score_spread":0.3228812638483973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592568061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000042109805,0.9937085,0.00007919148,0.00019632529,0.0011129193,0.0024720817,0.001242475,0.000006121049,0.0011781974],"genre_scores_gemma":[0.00008941327,0.9964274,0.00003876982,0.0000265817,0.0007758046,0.00072665553,0.00064555,0.000052158906,0.0012176288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809587,0.00033578495,0.00071839825,0.00039803784,0.00019099092,0.00026092632],"domain_scores_gemma":[0.99706936,0.00040089502,0.0008084944,0.0014842226,0.00016555749,0.00007149805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033842746,0.00040516106,0.0007926437,0.000028050075,0.00053459045,0.000022074912,0.00064347126,0.00022506413,0.000015577152],"category_scores_gemma":[0.0001636974,0.00021206184,0.0009916394,0.000030235436,0.0003383342,0.000002998174,0.000080600395,0.00007534764,0.000005932115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019141504,0.00014712341,7.6144175e-7,0.00057453726,0.0006098005,0.0000015823252,0.0002526716,0.000005824349,0.0000022592817,0.0017686686,0.0063362573,0.9883864],"study_design_scores_gemma":[0.00091450656,0.0003184545,0.00015590437,0.0010405113,0.000057517274,0.0000031110649,0.000079563455,0.0000072104867,0.00015184206,0.0000124520075,0.9970466,0.00021234456],"about_ca_topic_score_codex":0.000019439529,"about_ca_topic_score_gemma":0.00004364246,"teacher_disagreement_score":0.9907103,"about_ca_system_score_codex":0.000118353724,"about_ca_system_score_gemma":0.000568975,"threshold_uncertainty_score":0.86476314},"labels":[],"label_agreement":null},{"id":"W2729777670","doi":"10.1080/14740338.2017.1351540","title":"Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Rivastigmine; Medicine; Galantamine; Donepezil; Tolerability; Discontinuation; Adverse effect; Pharmacovigilance; Dementia; Pharmacology; Drug; Intensive care medicine; Cognitive decline; Disease; Psychiatry; Internal medicine","score_opus":0.14198100075957254,"score_gpt":0.4582685492821365,"score_spread":0.31628754852256397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729777670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000075882555,0.9894241,0.00011081391,0.0005055562,0.0025664065,0.0057746293,0.000615653,0.00013097508,0.00079595717],"genre_scores_gemma":[0.00015865349,0.98293686,0.00016355223,0.00065459753,0.0050923117,0.0017199963,0.008444169,0.00019774925,0.0006321087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953249,0.0005199936,0.0015468834,0.001259229,0.00082317286,0.0005257953],"domain_scores_gemma":[0.99609464,0.00061835215,0.0010396808,0.0014336278,0.00043320056,0.0003804928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009156352,0.0009898498,0.0023512023,0.0003715937,0.00073360454,0.0001346976,0.0003315366,0.00034752695,0.00017661531],"category_scores_gemma":[0.00097187585,0.0007643011,0.0015250887,0.00018771863,0.00009124488,0.00025021847,0.00011935184,0.00040779094,0.00007916729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005508503,0.00040322077,0.000013412547,0.002952848,0.00048495602,0.00000778872,0.00023385239,0.0000063073526,0.000008961057,0.000045893743,0.010506148,0.98478574],"study_design_scores_gemma":[0.0039536394,0.0001806137,0.000030678057,0.025433341,0.00082007475,0.000043615644,0.000025628186,0.00014395927,0.00008974591,0.0000035883236,0.9686235,0.00065160595],"about_ca_topic_score_codex":0.000015700756,"about_ca_topic_score_gemma":0.000005262909,"teacher_disagreement_score":0.98413414,"about_ca_system_score_codex":0.00046350286,"about_ca_system_score_gemma":0.0009513475,"threshold_uncertainty_score":0.9994808},"labels":[],"label_agreement":null},{"id":"W2735238612","doi":"10.1080/14740338.2017.1351541","title":"Breast cancer treatment-induced cardiotoxicity","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Cardiotoxicity; Breast cancer; Cancer; Oncology; Internal medicine; Intensive care medicine; Chemotherapy","score_opus":0.12144268613943457,"score_gpt":0.4237113256021117,"score_spread":0.3022686394626771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735238612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034210414,0.98471195,0.000008854344,0.0011769425,0.0027948888,0.0025480494,0.0006259745,0.00022074216,0.007878399],"genre_scores_gemma":[0.00042734222,0.9901965,0.000037153877,0.00037594276,0.0052937055,0.0006537788,0.0007485967,0.0001844341,0.0020825106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966076,0.0002969607,0.0008251633,0.001079336,0.0006193472,0.00057158165],"domain_scores_gemma":[0.9968628,0.00015517556,0.0006332162,0.0018077542,0.0001279254,0.00041310207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003177181,0.0010132046,0.003556496,0.0002650889,0.00048024734,0.00008024402,0.00035512797,0.00079128204,0.00029581066],"category_scores_gemma":[0.000039746254,0.0007609831,0.0021708668,0.0001901473,0.00010395424,0.00014515863,0.00006588462,0.00066784874,0.00020613735],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001630266,0.00022417106,0.000003441099,0.0012330409,0.0010148557,0.000023174302,0.00027540998,4.4193908e-7,0.00008224917,0.00005023299,0.0032949573,0.993635],"study_design_scores_gemma":[0.0018822673,0.00015135191,0.00006860523,0.018311638,0.00020397271,0.00046304602,0.000034918765,0.0000033281262,0.00097104814,0.0000033188317,0.9772401,0.0006664133],"about_ca_topic_score_codex":0.00055600534,"about_ca_topic_score_gemma":0.000018996283,"teacher_disagreement_score":0.99296856,"about_ca_system_score_codex":0.0023401321,"about_ca_system_score_gemma":0.001263139,"threshold_uncertainty_score":0.9994841},"labels":[],"label_agreement":null},{"id":"W2766516861","doi":"10.1080/14740338.2018.1397625","title":"A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institut Universitaire de Gériatrie de Montréal; Dalhousie University","funders":"","keywords":"Deprescribing; Medicine; Discontinuation; Polypharmacy; Adverse drug event; Harm; Patient safety; Adverse effect; Continuation; Drug; Narrative review; Beers Criteria; Intensive care medicine; Medical emergency; Psychiatry; Health care; Pharmacology; Psychology; Social psychology","score_opus":0.15349776963131986,"score_gpt":0.47612439269213896,"score_spread":0.32262662306081913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766516861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004455884,0.9911,0.0000115175,0.002715718,0.00085077854,0.0031428395,0.00011335256,0.000010862324,0.0020103462],"genre_scores_gemma":[0.0021962556,0.99647313,0.00005063993,0.00082874566,0.00016167354,0.00007354081,0.00007180336,0.000031364256,0.000112817244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706715,0.00053867314,0.00121765,0.00045871467,0.0004690849,0.00024870495],"domain_scores_gemma":[0.99765134,0.00039885385,0.0009836127,0.0006795404,0.00012296643,0.00016367233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061116996,0.00039514215,0.0020414589,0.000098998666,0.00011609422,0.000017496435,0.0003450924,0.00015246752,0.00013261307],"category_scores_gemma":[0.0004989871,0.00023281359,0.00047294697,0.00017454644,0.00018349291,0.00017791487,0.00023374814,0.0005803023,0.0000049901796],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094691076,0.0002748928,0.000058244714,0.0854986,0.0003157726,0.000011511564,0.009494408,0.0000032262283,0.000002768742,0.00033637122,0.0023943468,0.90066296],"study_design_scores_gemma":[0.001109269,0.000079640165,0.00027193848,0.29957888,0.000086390566,0.000014015557,0.0008435792,0.000015859216,0.000010984759,0.0000029504786,0.6978077,0.00017874337],"about_ca_topic_score_codex":0.00015868137,"about_ca_topic_score_gemma":0.000012660138,"teacher_disagreement_score":0.9004842,"about_ca_system_score_codex":0.000093196955,"about_ca_system_score_gemma":0.00037241232,"threshold_uncertainty_score":0.9493863},"labels":[],"label_agreement":null},{"id":"W2979546650","doi":"10.1080/14740338.2019.1675634","title":"A drug safety review of treating eosinophilic asthma with monoclonal antibodies","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Expert opinion; Asthma; Adverse effect; Nice; Clinical trial; Intensive care medicine; European commission; Eosinophilic; European union; Immunology; Pharmacology; Pathology","score_opus":0.035632735430708364,"score_gpt":0.35501349510202185,"score_spread":0.31938075967131346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979546650","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000543392,0.98941815,0.000020200583,0.0006846237,0.00061210233,0.002660249,0.0003392944,0.00011654973,0.0061434265],"genre_scores_gemma":[0.000008343346,0.99370426,0.00037843137,0.0012135024,0.00090875354,0.00013238053,0.0017577278,0.00017246975,0.001724103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99500376,0.0005890949,0.0018277263,0.0010348606,0.0010078759,0.0005366843],"domain_scores_gemma":[0.9962754,0.00054598093,0.001229102,0.0013299104,0.00025908134,0.00036047088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057132187,0.0010709194,0.0047250325,0.00032820075,0.00019662081,0.000016976692,0.00038323566,0.00026207307,0.0005234826],"category_scores_gemma":[0.00019745741,0.00066136656,0.0014327429,0.0005581081,0.0002458852,0.00011949504,0.00015005321,0.0006503394,0.00021364287],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038171822,0.00036161035,0.00004073008,0.13837823,0.00034590028,0.000035122855,0.00018135192,0.0000015407719,9.293813e-7,0.0001406524,0.010123057,0.85000914],"study_design_scores_gemma":[0.0007368593,0.00025896038,0.000082857485,0.33762324,0.00016211596,0.00009181831,0.00007268878,0.0000035026737,0.000004655718,6.089564e-7,0.66052306,0.00043966886],"about_ca_topic_score_codex":0.000028784027,"about_ca_topic_score_gemma":0.0000017970076,"teacher_disagreement_score":0.8495695,"about_ca_system_score_codex":0.0003110658,"about_ca_system_score_gemma":0.0013335177,"threshold_uncertainty_score":0.9995838},"labels":[],"label_agreement":null},{"id":"W2989937144","doi":"10.1080/14740338.2020.1698545","title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; McMaster University; University of Toronto; Centre for Addiction and Mental Health","funders":"National Research Foundation of Korea; Lundbeckfonden","keywords":"Clozapine; Medicine; Pharmacology; Internal medicine; Intensive care medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.07745435242841285,"score_gpt":0.45906443011764303,"score_spread":0.38161007768923016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989937144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002922396,0.9717724,0.0000785387,0.01579793,0.0015648664,0.010251535,0.0002897219,0.000043079945,0.00017270294],"genre_scores_gemma":[0.000023482542,0.9932906,0.0012654436,0.0021122992,0.00093766634,0.0008700678,0.00017799008,0.00008299176,0.0012394352],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913444,0.002925972,0.0025009275,0.0013467688,0.0012334129,0.0006485434],"domain_scores_gemma":[0.99159944,0.0034105962,0.0009528147,0.0028340353,0.0004484294,0.00075465994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034770337,0.00090076914,0.0042231157,0.0001593646,0.00045175798,0.000036864305,0.0008339574,0.0002765938,0.00021581443],"category_scores_gemma":[0.006826376,0.00042615455,0.0015206428,0.0011276065,0.00034479063,0.000055093504,0.0006300813,0.0012387572,0.00028714404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041020983,0.0004566847,0.0000152140765,0.0056040613,0.00068593957,0.0000028972393,0.00040258712,2.3218828e-7,3.871101e-7,0.00024891377,0.03165452,0.95682645],"study_design_scores_gemma":[0.0028406535,0.0005896554,0.0021552138,0.06460624,0.00029058696,0.000021101767,0.000060364026,0.0000058234236,0.000020786303,0.0000065089616,0.9290619,0.00034114748],"about_ca_topic_score_codex":0.000072797295,"about_ca_topic_score_gemma":0.00003360059,"teacher_disagreement_score":0.95648533,"about_ca_system_score_codex":0.00019131399,"about_ca_system_score_gemma":0.0014179792,"threshold_uncertainty_score":0.99981904},"labels":[],"label_agreement":null},{"id":"W3011295729","doi":"10.1080/14740338.2020.1744562","title":"An update on the safety of apremilast for the treatment of plaque psoriasis","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Apremilast; Medicine; Psoriasis; Adverse effect; Dermatology; Thalidomide; Drug; Intensive care medicine; Pharmacology; Psoriatic arthritis; Internal medicine","score_opus":0.036359056662185425,"score_gpt":0.33205896088783493,"score_spread":0.2956999042256495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011295729","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010848656,0.99339783,0.0009773738,0.0015969034,0.0014254651,0.0016499846,0.0006560761,0.0000131082925,0.0002723973],"genre_scores_gemma":[0.00028500188,0.9965742,0.00007201404,0.00024834689,0.0008067914,0.00023243456,0.0015692755,0.00004216417,0.00016976036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845296,0.000247615,0.00056811335,0.00041454067,0.0001693638,0.00014741176],"domain_scores_gemma":[0.99842024,0.00026051237,0.00042291675,0.00077076413,0.0000663498,0.0000592203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019972997,0.00034786985,0.0006607677,0.00003426659,0.00015969218,0.00000983524,0.00030242375,0.00021426585,0.00004553932],"category_scores_gemma":[0.000039456554,0.0001699237,0.00060043426,0.00009982043,0.000094459785,0.0000029005075,0.000030486817,0.00008143028,0.0000070608285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001310764,0.00031955214,5.6364115e-7,0.00028720105,0.00044778571,1.6895363e-7,0.00031869535,0.00012311552,0.00014660614,0.0013084849,0.011365129,0.98437196],"study_design_scores_gemma":[0.0005653474,0.0008647799,0.0000057225175,0.00059714966,0.000042543827,0.0000019584613,0.00009509666,0.00006501079,0.004295409,0.000005667952,0.99329066,0.00017067647],"about_ca_topic_score_codex":0.000010078103,"about_ca_topic_score_gemma":0.0000051206953,"teacher_disagreement_score":0.98420125,"about_ca_system_score_codex":0.00006607196,"about_ca_system_score_gemma":0.0001355478,"threshold_uncertainty_score":0.6929288},"labels":[],"label_agreement":null},{"id":"W3034357715","doi":"10.1080/14740338.2020.1776699","title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Tolerability; Ketamine; Medicine; Adverse effect; Nausea; Anesthesia; Blood pressure; Dissociative; Psychiatry; Internal medicine","score_opus":0.01756774449392825,"score_gpt":0.25818466346288543,"score_spread":0.24061691896895718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034357715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9064645,0.019365817,0.000041992997,0.066387445,0.00026884887,0.0034134868,0.0028731672,0.00006313139,0.001121581],"genre_scores_gemma":[0.9875514,0.010919418,0.00040490847,0.00044813476,0.0000969915,0.000037491547,0.00045524872,0.000027517237,0.00005888523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782413,0.00022900116,0.0006798072,0.0006169073,0.00038081128,0.00026935857],"domain_scores_gemma":[0.99813366,0.0005770176,0.000252005,0.0006480709,0.0000797867,0.00030948874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015092133,0.00030645748,0.00062387646,0.0000726676,0.00011877702,0.0000071380946,0.00016172545,0.000103787665,0.00012899216],"category_scores_gemma":[0.00024283273,0.00016190945,0.00008170009,0.00021640374,0.00019680918,0.00008016309,0.000060824757,0.00016917159,0.0000034152522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17185923,0.0028664074,0.49674553,0.00020295619,0.00047056688,0.00011699909,0.05305793,0.00017152942,0.00058716367,0.00004497977,0.0018753622,0.27200133],"study_design_scores_gemma":[0.05037119,0.003694477,0.78644115,0.0028225016,0.000039907496,0.000012645955,0.0025399767,0.0010468363,0.0074793156,0.000004892484,0.14518462,0.00036246466],"about_ca_topic_score_codex":0.12679556,"about_ca_topic_score_gemma":0.09161541,"teacher_disagreement_score":0.28969562,"about_ca_system_score_codex":0.00024693838,"about_ca_system_score_gemma":0.00026867588,"threshold_uncertainty_score":0.92496026},"labels":[],"label_agreement":null},{"id":"W3130785468","doi":"10.1080/14740338.2021.1889513","title":"A safety review of approved intrathecal analgesics for chronic pain management","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Chronic pain; Adverse effect; Discontinuation; Opioid; Morphine; Analgesic; Anesthesia; Intensive care medicine; Pharmacology; Internal medicine; Physical therapy","score_opus":0.04108772081446854,"score_gpt":0.36668461784210266,"score_spread":0.3255968970276341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130785468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.4375e-9,0.97855467,0.0070810723,0.0021056563,0.0009280929,0.0063750427,0.00009676789,0.000092207854,0.0047664866],"genre_scores_gemma":[1.0448179e-7,0.98541933,0.0030128998,0.0027061305,0.0011202598,0.00092802313,0.0039629517,0.0001308028,0.0027194803],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951119,0.0008202956,0.0018631491,0.0009838718,0.0006739276,0.0005468796],"domain_scores_gemma":[0.9966444,0.00076057063,0.0007498123,0.0014712833,0.00016695434,0.00020700005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003377973,0.00078842544,0.0036371604,0.00028960244,0.00012096567,0.000019267924,0.00048544747,0.00027544703,0.00035778116],"category_scores_gemma":[0.00040876365,0.000623585,0.0017815897,0.000713857,0.00008606761,0.00005047821,0.00023652877,0.00046168844,0.000035162197],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006735063,0.00021983775,2.8579018e-7,0.20302469,0.0006349091,0.000011888795,0.000035957484,4.5093387e-7,6.7049406e-8,0.0046963193,0.12028036,0.6710279],"study_design_scores_gemma":[0.00096464605,0.0001890709,0.0000028010763,0.28370467,0.0003363224,0.0000024561593,0.000047548434,0.00007393989,8.909752e-7,0.000010854642,0.7142828,0.00038398374],"about_ca_topic_score_codex":0.0000049462315,"about_ca_topic_score_gemma":0.0000014044226,"teacher_disagreement_score":0.6706439,"about_ca_system_score_codex":0.0007837338,"about_ca_system_score_gemma":0.000457758,"threshold_uncertainty_score":0.99962157},"labels":[],"label_agreement":null},{"id":"W3160031138","doi":"10.1080/14740338.2021.1912010","title":"Newer formulations of intravenous iron: a review of their chemistry and key safety aspects – hypersensitivity, hypophosphatemia, and cardiovascular safety","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Hypophosphatemia; Ferumoxytol; Intravenous iron; Iron deficiency; Safety profile; Anemia; Adverse effect; Intensive care medicine; Internal medicine","score_opus":0.0212790669287603,"score_gpt":0.29322410819075895,"score_spread":0.27194504126199864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160031138","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014517465,0.98679364,0.00009779221,0.00039654938,0.00034019176,0.0015238032,0.0003507675,0.00003783757,0.010444921],"genre_scores_gemma":[0.00011055469,0.9973401,0.0006029226,0.00031197997,0.00032509404,0.000037159843,0.0010343147,0.000094684,0.00014319262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961496,0.0004044222,0.0015269633,0.0008831341,0.0006482209,0.00038766005],"domain_scores_gemma":[0.9971659,0.00043404737,0.0005677465,0.0012877595,0.0002603224,0.0002841981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010713865,0.0007525835,0.0048644478,0.00010040563,0.00014859696,0.000011913475,0.00015741929,0.0004225632,0.00017536616],"category_scores_gemma":[0.00031987415,0.00059543154,0.0013549544,0.00045432008,0.00027827825,0.00008958215,0.00023989569,0.00053414976,0.000004121537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010108327,0.0002120403,0.0000021881945,0.09420581,0.00050401746,0.00001959583,0.0005282604,0.0000019049553,0.000008128408,0.0010511936,0.0007376471,0.9026281],"study_design_scores_gemma":[0.0013811624,0.000054018667,0.00007957061,0.08755905,0.00059507496,0.00031117964,0.00031804646,0.0000034326456,0.00006455351,0.000013012788,0.90916246,0.00045845268],"about_ca_topic_score_codex":0.000093506984,"about_ca_topic_score_gemma":0.0000018212864,"teacher_disagreement_score":0.9084248,"about_ca_system_score_codex":0.000114421244,"about_ca_system_score_gemma":0.0006399228,"threshold_uncertainty_score":0.9996497},"labels":[],"label_agreement":null},{"id":"W3169367773","doi":"10.1080/14740338.2021.1919620","title":"A drug safety evaluation of enzalutamide to treat advanced prostate cancer","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Oncology; Clinical trial; Cancer; Internal medicine; Androgen receptor","score_opus":0.08988337752740705,"score_gpt":0.46237497673581374,"score_spread":0.3724915992084067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169367773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045643235,0.9848222,0.0000066615853,0.002782234,0.00129261,0.0064004827,0.00069866556,0.00008168562,0.003869792],"genre_scores_gemma":[0.000041612937,0.9845607,0.00025769274,0.00025435633,0.000613441,0.0025627248,0.002805081,0.00015558761,0.008748771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99377906,0.0009755063,0.0013511728,0.0012171121,0.0019886247,0.0006885397],"domain_scores_gemma":[0.9965809,0.00041353915,0.0004784618,0.0011553077,0.00090604596,0.00046572599],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014691419,0.00082074915,0.0028582336,0.0004936741,0.0001902102,0.00002853157,0.0002969889,0.0002576621,0.0010842071],"category_scores_gemma":[0.00032964323,0.0005870562,0.00083798106,0.001064175,0.000109164386,0.00012293886,0.00019152038,0.00059057807,0.0001033653],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011775736,0.00036501014,0.000009672245,0.004366165,0.00037763777,0.000017756307,0.0017574352,0.0000739261,0.00001715709,0.000058835816,0.013004851,0.97877395],"study_design_scores_gemma":[0.0041776155,0.00023213902,0.0000348295,0.048095375,0.00030382155,0.00001926251,0.00033596373,0.000025984797,0.0004581563,0.0000066345697,0.94581735,0.00049286307],"about_ca_topic_score_codex":0.00026026735,"about_ca_topic_score_gemma":0.00003592382,"teacher_disagreement_score":0.97828114,"about_ca_system_score_codex":0.0030905101,"about_ca_system_score_gemma":0.0038117378,"threshold_uncertainty_score":0.99982893},"labels":[],"label_agreement":null},{"id":"W3181815039","doi":"10.1080/14740338.2021.1950138","title":"A systematic review on pediatric medication errors by parents or caregivers at home","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Innovation and Advanced Education","keywords":"Medicine; Medical prescription; Scopus; Dosing; MEDLINE; Pediatric hospital; Intervention (counseling); Family medicine; Pediatrics; Intensive care medicine; Medical emergency; Nursing; Pharmacology","score_opus":0.09589084297413045,"score_gpt":0.4528886906321413,"score_spread":0.3569978476580109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181815039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.274251e-7,0.97884345,0.000056103097,0.0034801185,0.0075748963,0.007976481,0.0005665351,0.00021943354,0.0012826265],"genre_scores_gemma":[0.0000024851215,0.97227,0.000025569087,0.0045357654,0.0007652164,0.004648141,0.0093152225,0.00013967082,0.008297893],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9872592,0.005413884,0.003514874,0.0012534441,0.0017240094,0.0008345714],"domain_scores_gemma":[0.9901811,0.0031072395,0.0039390544,0.0018590648,0.00024103744,0.0006724936],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002005573,0.0009674479,0.004407324,0.00039640098,0.0010854924,0.000003265899,0.0009478458,0.00084258,0.0021789332],"category_scores_gemma":[0.0029334738,0.0006504215,0.0008337888,0.0010998964,0.000080158155,0.00011926142,0.00027846414,0.0015282724,0.0039737667],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003755967,0.00016664101,0.0000036217584,0.5925602,0.00014904219,0.0000055276164,0.0016042255,4.364264e-7,6.9740898e-9,0.000089118555,0.39767233,0.0077112955],"study_design_scores_gemma":[0.00040561368,0.000053813837,0.0000015624174,0.43644318,0.00022393081,0.0000040536333,0.00059941533,0.0000011359348,2.9204656e-8,5.0798576e-7,0.56190234,0.00036441113],"about_ca_topic_score_codex":0.000033502714,"about_ca_topic_score_gemma":0.000009882827,"teacher_disagreement_score":0.16423002,"about_ca_system_score_codex":0.0025409476,"about_ca_system_score_gemma":0.0019384191,"threshold_uncertainty_score":0.9995947},"labels":[],"label_agreement":null},{"id":"W3185792067","doi":"10.1080/14740338.2021.1962283","title":"Evaluating safety in hyaluronic acid lip injections","year":2021,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Canadian Institute of Mining, Metallurgy and Petroleum; McGill University Health Centre","funders":"","keywords":"Medicine; Soft tissue; Filler (materials); Narrative review; Clinical trial; Adverse effect; Intensive care medicine; Randomized controlled trial; Patient safety; Surgery; Dentistry; Pathology; Health care; Internal medicine","score_opus":0.13835687824297893,"score_gpt":0.4747249426467594,"score_spread":0.3363680644037805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185792067","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010155195,0.980742,0.00013670247,0.0023847842,0.0018739082,0.0013820106,0.000049011458,0.00030767138,0.013122905],"genre_scores_gemma":[0.000010337177,0.9936267,0.0009809475,0.0014530944,0.0003594569,0.00037349213,0.0012030905,0.00010852128,0.0018843719],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99542594,0.000925958,0.0015556989,0.00085700117,0.00076747837,0.0004679414],"domain_scores_gemma":[0.9977798,0.0006191579,0.00036618864,0.00084037485,0.00018154622,0.00021297317],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016455073,0.0005986812,0.00232944,0.000746281,0.00020820914,0.00003784987,0.00021399607,0.0005212803,0.0012322834],"category_scores_gemma":[0.0014118787,0.00051940384,0.0009432967,0.0011449163,0.00006606652,0.00009636567,0.00013826221,0.001219479,0.00017577181],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005398827,0.00023038361,0.000003829224,0.0006362214,0.00006749503,0.00002207383,0.00025269165,0.000002967165,0.0000027694507,0.0012183494,0.012790531,0.9847187],"study_design_scores_gemma":[0.0005313613,0.00013894698,0.000016662889,0.027869478,0.000021227153,0.00007825442,0.00010742816,0.00007094564,0.000018675022,0.000012546895,0.97070473,0.00042976008],"about_ca_topic_score_codex":0.00006648822,"about_ca_topic_score_gemma":0.000018373517,"teacher_disagreement_score":0.98428893,"about_ca_system_score_codex":0.0013832396,"about_ca_system_score_gemma":0.0016469776,"threshold_uncertainty_score":0.99972576},"labels":[],"label_agreement":null},{"id":"W4214898817","doi":"10.1080/14740338.2022.2047928","title":"Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; British Columbia Centre on Substance Use; University of Calgary","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Medicine; Ketamine; Placebo; Depression (economics); Adverse effect; Meta-analysis; Internal medicine; Confidence interval; Relative risk; Randomized controlled trial; Major depressive disorder; Anesthesia","score_opus":0.09425174148257835,"score_gpt":0.39450474612543573,"score_spread":0.30025300464285737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214898817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012425497,0.98841107,0.000071829345,0.0008739034,0.0000991298,0.009956437,0.00040094974,0.000059316913,0.00012611794],"genre_scores_gemma":[0.000021886144,0.9941009,0.0007000761,0.0003507044,0.00006104293,0.002157427,0.0012352056,0.000100093195,0.00127266],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.994827,0.0008992155,0.0021085395,0.0011971303,0.00065876334,0.0003093789],"domain_scores_gemma":[0.99378735,0.0030670832,0.0014244048,0.0013451301,0.00008221216,0.0002937931],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013846785,0.00091863534,0.012053661,0.00051468954,0.00022335188,0.000020702153,0.0002133506,0.00023609593,0.00048544435],"category_scores_gemma":[0.0007917224,0.0005495335,0.001828233,0.0006054924,0.0001222112,0.00008364974,0.00034885848,0.00037908275,0.0000024909623],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004503922,0.00039954987,0.0000035211076,0.84293383,0.087077364,0.000010772527,0.00017245891,6.982182e-7,7.528531e-7,0.000048818634,0.0013729521,0.06752886],"study_design_scores_gemma":[0.0023117594,0.00025925488,0.00001928293,0.07035465,0.37621707,0.00016577136,0.000030688017,0.000014061066,0.0000019846827,0.0000016205021,0.55024016,0.00038368892],"about_ca_topic_score_codex":0.000013087806,"about_ca_topic_score_gemma":0.0000012895927,"teacher_disagreement_score":0.7725792,"about_ca_system_score_codex":0.00014002644,"about_ca_system_score_gemma":0.000092804046,"threshold_uncertainty_score":0.9996956},"labels":[],"label_agreement":null},{"id":"W4223456429","doi":"10.1080/14740338.2022.2063274","title":"Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?","year":2022,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Higher Education Funding Council for England","keywords":"Medicine; Serotonergic; Psychiatry; Pharmacology; Serotonin; Internal medicine","score_opus":0.05152653116104238,"score_gpt":0.3701219538538488,"score_spread":0.3185954226928064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223456429","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00842427,0.016102279,0.00000644751,0.023943346,0.92626894,0.005512024,0.01168948,0.000111200956,0.007941999],"genre_scores_gemma":[0.04543252,0.1833616,0.00016925589,0.0052377754,0.7174134,0.021221075,0.01312375,0.00088252244,0.0131580345],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960642,0.00036493555,0.00088275207,0.0012469229,0.0007801232,0.00066106644],"domain_scores_gemma":[0.9968156,0.0011900722,0.0005682006,0.0011025532,0.00012270169,0.00020085383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072004634,0.0008299048,0.0010526795,0.00020246654,0.00081759377,0.0000473482,0.00076389493,0.00038136906,0.00044581742],"category_scores_gemma":[0.000114486,0.00059625116,0.00046038232,0.0002652384,0.00016228508,0.000048126076,0.00038288464,0.0005660622,0.000024437604],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024588942,0.000527199,0.000027645878,0.000037258207,0.00089607073,4.2866827e-7,0.03069607,0.000006386906,0.000016402953,0.001352323,0.9215543,0.04242701],"study_design_scores_gemma":[0.0031629363,0.00087639,0.0007620721,0.00018757525,0.0000304369,0.0000015581004,0.009426171,0.0000052528335,0.000030469037,0.00026694857,0.9846684,0.00058181904],"about_ca_topic_score_codex":0.0025293895,"about_ca_topic_score_gemma":0.00013826681,"teacher_disagreement_score":0.2088555,"about_ca_system_score_codex":0.00026144506,"about_ca_system_score_gemma":0.00012123556,"threshold_uncertainty_score":0.99964887},"labels":[],"label_agreement":null},{"id":"W4226209427","doi":"10.1080/14740338.2022.2058488","title":"The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Major depressive disorder; Treatment-resistant depression; Depression (economics); Placebo; Suicidal ideation; Internal medicine; Meta-analysis; Adjunctive treatment; Randomized controlled trial; Anesthesia; Poison control; Injury prevention; Emergency medicine","score_opus":0.05097786294773289,"score_gpt":0.3585261489271402,"score_spread":0.3075482859794073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226209427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015641293,0.9873929,0.000012918451,0.0016339672,0.00009820039,0.010323662,0.0003249948,0.000036842914,0.00017492854],"genre_scores_gemma":[0.00004233018,0.99486405,0.00006439054,0.0001454706,0.00003349605,0.0034503718,0.0007589022,0.00007699649,0.00056397123],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936853,0.002121237,0.0020932937,0.0010343707,0.00071150286,0.00035431658],"domain_scores_gemma":[0.9930232,0.004027279,0.0012593725,0.0014382935,0.000058115187,0.00019373899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009339976,0.0009659656,0.010155181,0.00045410293,0.00029452855,0.000022989461,0.00027486327,0.00017668647,0.00031158974],"category_scores_gemma":[0.0004670371,0.00046559528,0.0020132563,0.0009143109,0.00017327115,0.00006682536,0.00023271693,0.0004263903,0.0000036711197],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011562858,0.002164913,0.000023219298,0.4480684,0.3084256,0.00007841245,0.001274248,0.000009413162,1.3065777e-7,0.00026230037,0.00046343388,0.2380736],"study_design_scores_gemma":[0.004131863,0.0006111417,0.000090592985,0.044447828,0.43803856,0.00006976754,0.00017749154,0.000012878007,0.0000010135839,0.000003944973,0.51195353,0.00046136466],"about_ca_topic_score_codex":0.00020742763,"about_ca_topic_score_gemma":0.00007986093,"teacher_disagreement_score":0.5114901,"about_ca_system_score_codex":0.00050748285,"about_ca_system_score_gemma":0.00017325016,"threshold_uncertainty_score":0.9997796},"labels":[],"label_agreement":null},{"id":"W4245658224","doi":"10.1517/eods.2.2.161.21387","title":"Treatment of premenstrual dysphoria with selective serotonin re-uptake inhibitors: focus on safety","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Menstrual Health and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Dysphoria; Serotonin; Psychiatry; Pharmacology; Internal medicine; Receptor; Anxiety","score_opus":0.02238667350330823,"score_gpt":0.31324809314630525,"score_spread":0.290861419642997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245658224","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4430367,0.00556285,0.0004371548,0.0147909485,0.004938008,0.012694166,0.00027001344,0.00058246974,0.5176877],"genre_scores_gemma":[0.9932448,0.0024719888,0.0021975006,0.0006160169,0.0003499861,0.0001990323,0.00010585475,0.000070125425,0.00074464286],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732214,0.0002171501,0.00068446645,0.0006145,0.0006249811,0.0005367658],"domain_scores_gemma":[0.99846476,0.00016728813,0.00023478964,0.0005688902,0.00015611044,0.00040815008],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023323315,0.0004268513,0.0006637363,0.00015944864,0.00019857657,0.000007737852,0.00007136578,0.0001622497,0.00027018288],"category_scores_gemma":[0.000100677644,0.00030294585,0.00013748009,0.0003643829,0.000109401524,0.000068298505,0.000010138687,0.00020843654,0.000047393176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17087753,0.018331245,0.021041239,0.0006424954,0.001522371,0.00015555319,0.05644899,0.0006681285,0.0021351997,0.060102317,0.046602182,0.6214728],"study_design_scores_gemma":[0.036256324,0.03228989,0.014724191,0.0012659873,0.00003672915,0.00009737026,0.007984415,0.00012895123,0.12058521,0.00025642445,0.78545547,0.0009190141],"about_ca_topic_score_codex":0.0003342561,"about_ca_topic_score_gemma":0.000055564902,"teacher_disagreement_score":0.73885334,"about_ca_system_score_codex":0.0006380123,"about_ca_system_score_gemma":0.00057269563,"threshold_uncertainty_score":0.99994224},"labels":[],"label_agreement":null},{"id":"W4251134584","doi":"10.1517/eods.3.1.25.25270","title":"The safety of antihypertensives for treatment of pregnancy hypertension","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Medicine; Pregnancy; Observational study; Hypertension in Pregnancy; Drugs in pregnancy; Ambulatory; Intensive care medicine; Ambulatory blood pressure; Blood pressure; Antihypertensive drug; Pharmacotherapy; Drug; Fetus; Obstetrics; Preeclampsia; Internal medicine; Pharmacology","score_opus":0.04079530696978833,"score_gpt":0.309136369948734,"score_spread":0.26834106297894567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251134584","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09023915,0.7528541,0.0043438813,0.104033574,0.008290428,0.0134721575,0.0005796861,0.00046064978,0.025726372],"genre_scores_gemma":[0.870208,0.12724799,0.0015644584,0.0002910837,0.00019437095,0.00011636093,0.00005192921,0.000031805193,0.00029395192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864817,0.00005137699,0.00052416924,0.00028555075,0.00024728948,0.00024343298],"domain_scores_gemma":[0.99846685,0.0005142903,0.00019038728,0.0005390623,0.00022316385,0.00006625994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011350469,0.0002274647,0.0006158712,0.00005507213,0.0002852669,0.0000033110246,0.00010532129,0.00007894651,0.0000053328918],"category_scores_gemma":[0.00014870461,0.00012851495,0.00030991904,0.00011791396,0.00021012615,0.000048200793,0.0000323968,0.000046302546,0.000003700364],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03921376,0.008021258,0.0069854404,0.0009537935,0.0029959935,0.000049209164,0.02818745,0.00053109153,0.04444072,0.09094051,0.008449995,0.7692308],"study_design_scores_gemma":[0.039430793,0.008881977,0.07930875,0.013495406,0.00013627476,0.00011971567,0.0050338055,0.00020163564,0.29412526,0.002619692,0.55586326,0.00078340125],"about_ca_topic_score_codex":0.00005838913,"about_ca_topic_score_gemma":0.000008660854,"teacher_disagreement_score":0.7799689,"about_ca_system_score_codex":0.00009204863,"about_ca_system_score_gemma":0.00010946913,"threshold_uncertainty_score":0.5240688},"labels":[],"label_agreement":null},{"id":"W4286110999","doi":"10.1080/14740338.2022.2103536","title":"Safety and tolerability of spesolimab in patients with ulcerative colitis","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Boehringer Ingelheim","keywords":"Medicine; Tolerability; Ulcerative colitis; Adverse effect; Intensive care medicine; Internal medicine; Gastroenterology; Disease","score_opus":0.009818968218653348,"score_gpt":0.23554349803142818,"score_spread":0.22572452981277483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286110999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342144,0.0014351379,0.000012905935,0.00056461827,0.00083401235,0.00068048766,0.00066901144,0.000032028376,0.0023503362],"genre_scores_gemma":[0.9985211,0.00039074206,0.000052900188,0.00013887676,0.000015965454,0.00006068808,0.00053019205,0.000012838905,0.00027669518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844825,0.0005680185,0.00033980235,0.00034715008,0.00007504214,0.00022175955],"domain_scores_gemma":[0.99937934,0.00018794762,0.00012251678,0.00024744959,0.000041021038,0.000021724081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002561048,0.00017589769,0.00036567196,0.00009075939,0.00024711026,0.0000032612124,0.000110563364,0.000061499064,0.0007797341],"category_scores_gemma":[0.000019958623,0.00014643792,0.000048553873,0.00015792156,0.00012404719,0.000059550064,0.0001043597,0.00016087701,0.000010943955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09987021,0.006441468,0.5878582,0.00004838502,0.00073548243,0.000009944728,0.03094836,0.00035005275,0.0005922557,0.008066001,0.0038105268,0.26126912],"study_design_scores_gemma":[0.008325857,0.00083699875,0.9210948,0.000029549397,0.000004332939,0.0000033372164,0.0008851117,0.0000034083346,0.0014942366,0.00003188625,0.06709475,0.00019576814],"about_ca_topic_score_codex":0.000174946,"about_ca_topic_score_gemma":0.00005452255,"teacher_disagreement_score":0.33323658,"about_ca_system_score_codex":0.00016417353,"about_ca_system_score_gemma":0.00005082038,"threshold_uncertainty_score":0.8537542},"labels":[],"label_agreement":null},{"id":"W4293834588","doi":"10.1080/14740338.2022.2120607","title":"Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Carleton University; University of British Columbia; University of Ottawa","funders":"","keywords":"Medicine; Pediatrics; Adverse effect; Internal medicine","score_opus":0.05542161233639507,"score_gpt":0.37158030379435447,"score_spread":0.3161586914579594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293834588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95221883,0.000523009,0.00019017368,0.04603482,0.000089341855,0.00066618033,0.00004778409,0.00003979094,0.00019008471],"genre_scores_gemma":[0.96649253,0.0002256502,0.000039782528,0.032952223,0.000069486785,0.00013861319,0.000059393627,0.000012006858,0.000010305198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997848,0.00045734036,0.00038199726,0.00042385765,0.00066487165,0.00022393769],"domain_scores_gemma":[0.9984769,0.0007516475,0.00016964063,0.0004710437,0.00006673027,0.00006399903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012232974,0.00017651489,0.00033019503,0.00057849515,0.00050669396,0.000011843264,0.0002178046,0.000053283195,0.00005944918],"category_scores_gemma":[0.00023780341,0.00009429603,0.00011889141,0.0025776462,0.00020101691,0.000051915296,0.00012817436,0.0005066128,4.610115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009676356,0.0015426193,0.96850556,0.000083951316,0.00058300316,0.000055661432,0.0036994128,0.0007889581,0.00063744944,0.010116442,0.002202656,0.0021079346],"study_design_scores_gemma":[0.0019070604,0.00058144395,0.5280313,0.000010829491,0.00008045106,0.00007449012,0.0029573953,0.0027892278,0.000031859963,0.00007388489,0.46333385,0.00012824615],"about_ca_topic_score_codex":0.0018691424,"about_ca_topic_score_gemma":0.00025212683,"teacher_disagreement_score":0.4611312,"about_ca_system_score_codex":0.00007530129,"about_ca_system_score_gemma":0.00016047113,"threshold_uncertainty_score":0.38971317},"labels":[],"label_agreement":null},{"id":"W4303633844","doi":"10.1080/14740338.2022.2134342","title":"How do safety warnings on medicines affect prescribing?","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"National Health and Medical Research Council; Canadian Institutes of Health Research","keywords":"Medicine; SAFER; Transparency (behavior); Patient safety; Intervention (counseling); Affect (linguistics); Access to medicines; Public relations; Public health; Family medicine; Health care; Nursing","score_opus":0.18995852560681586,"score_gpt":0.48312188938221584,"score_spread":0.2931633637754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303633844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000036931988,0.9512653,0.0000120704535,0.0046410747,0.016818518,0.0022236404,0.00086458714,0.0005086707,0.023662481],"genre_scores_gemma":[0.00010087461,0.9807789,0.000015196128,0.005749319,0.003908585,0.00093390536,0.0018044984,0.00021307534,0.0064956797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992743,0.0027199993,0.0010819182,0.0015102649,0.00084233517,0.0011024788],"domain_scores_gemma":[0.9934319,0.004029616,0.0009291273,0.00093588606,0.00006414482,0.0006093078],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016878935,0.0013809262,0.002421565,0.00062315667,0.001524385,0.00008266917,0.0011963424,0.00078991946,0.006718571],"category_scores_gemma":[0.0004461596,0.0011404342,0.0013071503,0.00078417023,0.00027843268,0.0002858113,0.00036784352,0.00513712,0.00069637975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054925727,0.0005540203,0.000004290543,0.0012329553,0.00062041177,0.00007752846,0.0011031973,0.000092308124,0.000010469266,0.00073755067,0.25015095,0.7448671],"study_design_scores_gemma":[0.0018083184,0.00022682421,0.0000026483447,0.003105534,0.00022494185,0.00008471399,0.0003781635,0.00007323219,0.000058344634,0.000015111785,0.9929224,0.0010997177],"about_ca_topic_score_codex":0.000016053073,"about_ca_topic_score_gemma":0.0000014524659,"teacher_disagreement_score":0.7437673,"about_ca_system_score_codex":0.0010424919,"about_ca_system_score_gemma":0.00048811073,"threshold_uncertainty_score":0.99989414},"labels":[],"label_agreement":null},{"id":"W4317871119","doi":"10.1080/14740338.2023.2172158","title":"Can COVID-19 have a clinically significant effect on drug metabolism?","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Drug; 2019-20 coronavirus outbreak; Drug metabolism; Pharmacology; Internal medicine; Intensive care medicine; Virology; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.020936756237832307,"score_gpt":0.3709943633978683,"score_spread":0.350057607160036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317871119","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016972587,0.0011924068,0.0000800545,0.06731271,0.9203633,0.0055332696,0.0016373007,0.0017361086,0.0019751284],"genre_scores_gemma":[0.0020224582,0.008758019,0.00024143273,0.018297061,0.94998944,0.0014379689,0.00876591,0.0009129547,0.009574776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848831,0.00283039,0.002526088,0.0032729993,0.004788325,0.0016990744],"domain_scores_gemma":[0.9326041,0.059429813,0.0012151769,0.0034611847,0.00043590268,0.00285383],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006447737,0.0021233577,0.0040141703,0.0010924444,0.0006034689,0.00019235339,0.0015805907,0.002203198,0.0004116166],"category_scores_gemma":[0.06638984,0.0017155947,0.0018210345,0.00069046207,0.0005089903,0.00014020172,0.0005627001,0.0045615765,0.0015886351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013770002,0.0006006801,0.00008910306,0.0013614541,0.0006827673,0.00068595924,0.0021314952,0.00009202437,0.00009474009,0.00017212867,0.97605795,0.0042617153],"study_design_scores_gemma":[0.013067433,0.0026071933,0.0002222174,0.0027023787,0.00016790193,0.000006166788,0.00017056556,0.00009566673,0.00033750775,0.00011232149,0.9789249,0.0015857774],"about_ca_topic_score_codex":0.0033096888,"about_ca_topic_score_gemma":0.00015459693,"teacher_disagreement_score":0.0599421,"about_ca_system_score_codex":0.0027099762,"about_ca_system_score_gemma":0.006253857,"threshold_uncertainty_score":0.99937975},"labels":[],"label_agreement":null},{"id":"W4321003910","doi":"10.1080/14740338.2023.2181340","title":"Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"ZonMw","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Drug reaction; Drug; Adverse drug reaction; Rheumatology; Pharmacology","score_opus":0.01145086819823524,"score_gpt":0.25840616164251806,"score_spread":0.24695529344428283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321003910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618137,0.0015212037,0.0000020868908,0.0012270018,0.0001543225,0.00053344097,0.00006368982,0.00010684785,0.00021004074],"genre_scores_gemma":[0.9708221,0.028418697,0.000032459873,0.00008814859,0.000036921105,0.00009711686,0.00028743056,0.000025383148,0.0001917734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830943,0.0001867348,0.0003685054,0.00034263727,0.00048229127,0.00031040524],"domain_scores_gemma":[0.9990602,0.00036188783,0.000065064196,0.000279679,0.000034388933,0.00019875437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015194547,0.00019398617,0.0003699616,0.00033047367,0.000108338965,0.000020210076,0.00008602669,0.00004590505,0.00019044138],"category_scores_gemma":[0.000121332625,0.00014715815,0.000041212457,0.0003036248,0.00013512974,0.00019780171,0.000053797146,0.00023208451,0.000059295995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017146087,0.00045834752,0.9611211,0.000046452562,0.0000603396,0.000027959797,0.010442518,0.000024468623,0.00001989894,0.0001353898,0.0015097479,0.024439178],"study_design_scores_gemma":[0.006270955,0.00012776299,0.9821641,0.0014717223,6.17552e-7,9.940015e-7,0.004730085,0.00045617018,0.000017550414,0.00011791212,0.0044686543,0.00017349515],"about_ca_topic_score_codex":0.0006743702,"about_ca_topic_score_gemma":0.00031008612,"teacher_disagreement_score":0.026897494,"about_ca_system_score_codex":0.00009836185,"about_ca_system_score_gemma":0.0000858823,"threshold_uncertainty_score":0.6000935},"labels":[],"label_agreement":null},{"id":"W4385658077","doi":"10.1080/14740338.2023.2244421","title":"Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a National Referral Hospital, Uganda","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; International Development Research Centre; Wellcome Trust; Health Research","keywords":"Medicine; Antithrombotic; Epidemiology; Drug; Drug reaction; Referral; Diabetes mellitus; Adverse effect; Pharmacoepidemiology; Intensive care medicine; Adverse drug reaction; Emergency medicine; Medical prescription; Pharmacology; Internal medicine; Family medicine","score_opus":0.19431172838170033,"score_gpt":0.4919582185759955,"score_spread":0.2976464901942951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385658077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012138899,0.9547171,0.000022137003,0.005797362,0.015264475,0.0049617346,0.0040494134,0.0005537346,0.0024951536],"genre_scores_gemma":[0.0052929088,0.9884488,0.00013821597,0.0020441625,0.00059555616,0.00048814213,0.0014725842,0.000111145746,0.0014084812],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99466723,0.0012808571,0.0017828447,0.0010678759,0.00046698187,0.0007342282],"domain_scores_gemma":[0.99396867,0.0033011555,0.0011004942,0.0005147525,0.00049764017,0.000617281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011566124,0.00073200994,0.0021274388,0.0007952312,0.00071393134,0.000003758875,0.00048592154,0.0006119907,0.00031236262],"category_scores_gemma":[0.0014555377,0.0006601735,0.0005339638,0.0009677281,0.00061978033,0.0002369609,0.00034205356,0.0013389655,0.0007526392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010120018,0.006651149,0.030880604,0.016626274,0.010294926,0.00012669554,0.011040856,0.0023457177,0.00019653903,0.008811075,0.7667407,0.14527349],"study_design_scores_gemma":[0.0011398991,0.00009402498,0.0036325438,0.0043012663,0.00024945487,0.00002427975,0.00026415373,0.0003466396,0.00004417564,0.000049944323,0.9891832,0.0006704482],"about_ca_topic_score_codex":0.00014945224,"about_ca_topic_score_gemma":0.000024110628,"teacher_disagreement_score":0.2224425,"about_ca_system_score_codex":0.0005072369,"about_ca_system_score_gemma":0.000432724,"threshold_uncertainty_score":0.999585},"labels":[],"label_agreement":null},{"id":"W4385827303","doi":"10.1080/14740338.2023.2248883","title":"Serotonin 5-HT <sub>2B</sub> receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Psilocybin; Medicine; Serotonin; Agonism; 5-HT receptor; Pharmacology; Lysergic acid diethylamide; Receptor; Serotonin Antagonists; Hallucinogen; Internal medicine","score_opus":0.04017881504522608,"score_gpt":0.3698573903593072,"score_spread":0.3296785753140811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827303","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015931824,0.024986198,0.00019539103,0.021319982,0.94577557,0.0032195519,0.002102152,0.00021757693,0.0005904091],"genre_scores_gemma":[0.018613022,0.18399714,0.0037452492,0.002198738,0.72845376,0.026029974,0.01907783,0.0016868071,0.016197463],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970788,0.00019040176,0.0008988466,0.00093947665,0.0004191211,0.00047337578],"domain_scores_gemma":[0.9960558,0.002364675,0.00037503993,0.00077450444,0.00022006214,0.00020992332],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092221535,0.0004932313,0.00061820186,0.0001529606,0.00076622196,0.00004237773,0.00033893535,0.00046680262,0.00003502342],"category_scores_gemma":[0.0004383371,0.00039407262,0.00017772807,0.00023052703,0.00021012954,0.000043827426,0.0002458534,0.00044722046,0.00006449923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039115586,0.0001459832,0.000044401815,0.00006805327,0.00044388312,3.2901934e-7,0.0056516365,0.0000038911526,0.00015096476,0.0009572662,0.98336977,0.008772691],"study_design_scores_gemma":[0.0014740299,0.00006308658,0.012403594,0.0002746284,0.000023090404,5.4057836e-7,0.0006419725,0.000014609235,0.00009645274,0.00033777385,0.9842591,0.0004110984],"about_ca_topic_score_codex":0.00003359387,"about_ca_topic_score_gemma":0.000012157825,"teacher_disagreement_score":0.21732178,"about_ca_system_score_codex":0.0001157136,"about_ca_system_score_gemma":0.00023628796,"threshold_uncertainty_score":0.9998511},"labels":[],"label_agreement":null},{"id":"W4386084010","doi":"10.1080/14740338.2023.2247976","title":"An update on the safety of long-term vedolizumab use in inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Allergan; Biogen; Pfizer; Amgen","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Ulcerative colitis; Pouchitis; Clinical trial; Internal medicine; Crohn's disease; Disease; Intensive care medicine; Immunology","score_opus":0.0758371502196532,"score_gpt":0.38842080031011567,"score_spread":0.31258365009046246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386084010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001578099,0.9924841,0.00002649567,0.0021365325,0.0014434508,0.0028024958,0.00037977408,0.00018788695,0.00038148765],"genre_scores_gemma":[0.0006353818,0.9952104,0.000012025974,0.0009797794,0.0005701448,0.00030449126,0.0017330897,0.00013072777,0.00042392834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958677,0.0007786895,0.0014198247,0.00069112977,0.0007798673,0.0004627603],"domain_scores_gemma":[0.9958118,0.00091668166,0.00062065065,0.0020208124,0.00007108278,0.00055893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091533724,0.0006058378,0.0013921822,0.0004642136,0.00012466284,0.00002649916,0.00056653126,0.00030044417,0.0002801808],"category_scores_gemma":[0.0008730985,0.0003835508,0.0005647959,0.00043496527,0.00019751496,0.00018781127,0.000105403145,0.00087199983,0.00032962076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002321059,0.0010377489,0.000769312,0.011515628,0.00034052634,0.00023725229,0.0011776653,0.000017141992,8.3159404e-7,0.004159062,0.0104315085,0.96799225],"study_design_scores_gemma":[0.0014024025,0.00012685037,0.026712662,0.11434677,0.000065985776,0.000015177588,0.000047815924,0.000026459253,0.000004504994,0.000013232916,0.856837,0.00040117936],"about_ca_topic_score_codex":0.000022019392,"about_ca_topic_score_gemma":0.000008734925,"teacher_disagreement_score":0.9675911,"about_ca_system_score_codex":0.0004346476,"about_ca_system_score_gemma":0.0011541646,"threshold_uncertainty_score":0.99986166},"labels":[],"label_agreement":null},{"id":"W4386209201","doi":"10.1080/14740338.2023.2253144","title":"Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Psychedelics and Drug Studies","field":"Psychology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Psilocybin; Serotonergic; Medicine; Lysergic acid diethylamide; Psychotherapist; Hallucinogen; Pharmacology; Neuroscience; Psychology; Serotonin; Internal medicine","score_opus":0.051419392729938396,"score_gpt":0.4360025776403967,"score_spread":0.3845831849104583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386209201","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16685234,0.010835905,0.00037286617,0.0083869565,0.80324817,0.0075411326,0.0018210412,0.00014273023,0.000798839],"genre_scores_gemma":[0.91824186,0.012590255,0.00015214451,0.0006116963,0.058698215,0.006557,0.0015805569,0.0003346136,0.0012336657],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964923,0.0004919249,0.0011148218,0.00093787233,0.00054119964,0.0004218479],"domain_scores_gemma":[0.9960556,0.0018028889,0.0008464727,0.0010128567,0.00019880456,0.00008337124],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009363757,0.00053811126,0.00069086853,0.00012455639,0.00062308455,0.000057198184,0.0006422065,0.0003766233,0.00005164427],"category_scores_gemma":[0.0001036356,0.00033643068,0.00022824564,0.00036418752,0.00059690746,0.000117781805,0.00020645407,0.0003492956,0.000004439127],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012787589,0.00032130882,0.00095745106,0.0001553256,0.001030205,2.498308e-7,0.12301311,0.000009950498,0.00053026946,0.010764142,0.84383076,0.018108455],"study_design_scores_gemma":[0.007859781,0.0011080921,0.03592444,0.0004881619,0.00011510862,0.000004156356,0.02526887,0.000068461646,0.004186881,0.0011232643,0.9228363,0.0010165094],"about_ca_topic_score_codex":0.00034162094,"about_ca_topic_score_gemma":0.000089995054,"teacher_disagreement_score":0.7513895,"about_ca_system_score_codex":0.00008421647,"about_ca_system_score_gemma":0.0001400259,"threshold_uncertainty_score":0.99990875},"labels":[],"label_agreement":null},{"id":"W4386820153","doi":"10.1080/14740338.2023.2248872","title":"Janus kinase inhibitor—Tofacitinib associated with pemphigus: an analysis of the FDA adverse event reporting system data","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Chinese Pharmaceutical Association","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Adverse effect; Janus kinase; Adverse Event Reporting System; Pemphigus; Dermatology; Safety profile; Pharmacology; Internal medicine","score_opus":0.0475409499849269,"score_gpt":0.33562638444909326,"score_spread":0.28808543446416635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386820153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937457,0.00050408184,0.000059661605,0.001634059,0.0008803847,0.0010277362,0.000641884,0.00060767133,0.0008988494],"genre_scores_gemma":[0.9947103,0.00010073449,0.000045694786,0.00020549867,0.0001581422,0.000042499883,0.004318972,0.000056671863,0.00036147036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583626,0.00036890214,0.001547749,0.00074864156,0.00109769,0.0004007749],"domain_scores_gemma":[0.99476737,0.0002574584,0.0018079719,0.002735098,0.00023571309,0.00019637319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016368255,0.00030631016,0.00084942905,0.00033928655,0.00028286193,0.000014956093,0.0005299297,0.0001089762,0.0001105711],"category_scores_gemma":[0.0023269118,0.00020512269,0.0003482096,0.0021090566,0.00013238186,0.00016013715,0.0003894265,0.00022972407,0.000026399428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073209177,0.0065252883,0.8422714,0.0009860507,0.016830683,0.0017515338,0.025924679,0.029623704,0.0035006702,0.001267609,0.043854516,0.020142943],"study_design_scores_gemma":[0.0028594527,0.00023241596,0.926661,0.0028529114,0.0006268605,0.000028478662,0.016553557,0.03429496,0.0013211387,0.0000022537129,0.014117794,0.00044917036],"about_ca_topic_score_codex":0.0005041872,"about_ca_topic_score_gemma":0.00006439837,"teacher_disagreement_score":0.0843896,"about_ca_system_score_codex":0.00038132348,"about_ca_system_score_gemma":0.00036611134,"threshold_uncertainty_score":0.836466},"labels":[],"label_agreement":null},{"id":"W4387362397","doi":"10.1080/14740338.2023.2267971","title":"The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministerie van Volksgezondheid, Welzijn en Sport","keywords":"Medicine; Vaccination; Rheumatoid arthritis; Comorbidity; Cohort; Adverse effect; Malaise; Logistic regression; Coronavirus disease 2019 (COVID-19); Pediatrics; Odds ratio; Internal medicine; Disease; Immunology; Infectious disease (medical specialty)","score_opus":0.027165265555898085,"score_gpt":0.3680216653711588,"score_spread":0.3408563998152607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387362397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949087,0.0002635598,0.000010720379,0.0018563708,0.00005548395,0.0016069051,0.000011839163,0.000021083428,0.0012653177],"genre_scores_gemma":[0.9953425,0.00005065813,0.000020843641,0.0036477197,0.000024716388,0.00085100695,0.000036629655,0.000014917862,0.000011030195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768835,0.0003933812,0.0005627213,0.000252492,0.00082655123,0.00027651322],"domain_scores_gemma":[0.99867433,0.0006595308,0.00014440328,0.00041625596,0.0000835346,0.000021928552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023416174,0.00015153649,0.00028099437,0.00025524676,0.000104820516,0.000015978001,0.0002311295,0.00006022038,0.000010295006],"category_scores_gemma":[0.00030887086,0.00007046199,0.000045790097,0.00071867,0.00006467649,0.00007712391,0.000043058502,0.00025480767,0.0000032675696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002058412,0.0004925846,0.8749865,0.000025883277,0.000038062124,0.000024298351,0.11891638,0.0000060081447,0.00010050091,0.0002038106,0.00010555706,0.0030419673],"study_design_scores_gemma":[0.0025085912,0.0002504957,0.9211098,0.00007352242,0.0000020997666,0.000004726152,0.046356697,0.00026583573,0.0036703171,0.00014106528,0.025527645,0.00008918254],"about_ca_topic_score_codex":0.0004853601,"about_ca_topic_score_gemma":0.0027388143,"teacher_disagreement_score":0.072559685,"about_ca_system_score_codex":0.00024967536,"about_ca_system_score_gemma":0.0004790359,"threshold_uncertainty_score":0.28733566},"labels":[],"label_agreement":null},{"id":"W4388132398","doi":"10.1080/14740338.2023.2274416","title":"Risk of serious skin and subcutaneous tissue disorders for nimesulide among the pediatric population: a jeopardy identified through the analysis of global individual case safety reports","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Nimesulide; Double jeopardy; Population; Subcutaneous tissue; Dermatology; Intensive care medicine; Surgery; Internal medicine; Environmental health","score_opus":0.04328827465123892,"score_gpt":0.42146180062452104,"score_spread":0.37817352597328213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388132398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909496,0.0017131062,0.00012943396,0.0016505781,0.0021269056,0.0011628052,0.0018025533,0.00008652313,0.00037852413],"genre_scores_gemma":[0.9919755,0.0068540736,0.000030249746,0.0002336026,0.00027934232,0.00010361618,0.00036432897,0.00001884733,0.00014043332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975502,0.0005612514,0.00082211476,0.00042872358,0.0002876878,0.0003500613],"domain_scores_gemma":[0.9971338,0.0015421839,0.0007195665,0.00042220874,0.00008437061,0.00009787594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010638818,0.00025427216,0.00045087875,0.000125449,0.00079586613,0.000019239018,0.00023375922,0.00016340558,0.00010485632],"category_scores_gemma":[0.00015934922,0.00017919812,0.00030556112,0.0015362719,0.00024304558,0.0001533696,0.000120886674,0.00035812572,0.0000060259877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047621424,0.0012137617,0.65397424,0.00016941255,0.011250088,0.00076114055,0.048017133,0.1609229,0.00023375115,0.0029729789,0.044293214,0.07142924],"study_design_scores_gemma":[0.0041294154,0.0002714991,0.8024619,0.00003310977,0.0045934045,0.0009530104,0.021792563,0.01051646,0.001198818,0.0013271283,0.15175363,0.0009690295],"about_ca_topic_score_codex":0.0013722546,"about_ca_topic_score_gemma":0.00044312002,"teacher_disagreement_score":0.15040644,"about_ca_system_score_codex":0.00006568419,"about_ca_system_score_gemma":0.000058524318,"threshold_uncertainty_score":0.7307487},"labels":[],"label_agreement":null},{"id":"W4388376519","doi":"10.1080/14740338.2023.2280137","title":"The safety of oral antifungals for the treatment of onychomycosis","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Medicine; Itraconazole; Fluconazole; Terbinafine; Ketoconazole; Adverse effect; Posaconazole; Griseofulvin; Pharmacology; Liver function; Antifungal; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.11716897643670479,"score_gpt":0.43305810991604665,"score_spread":0.3158891334793419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388376519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019666913,0.99168265,0.000016375609,0.0009795931,0.0013169625,0.0043153805,0.0013121361,0.00004380936,0.00033113826],"genre_scores_gemma":[0.000028749648,0.9956776,0.00007178223,0.000042642077,0.00031753173,0.00084614207,0.0007299692,0.0000952683,0.0021903205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975094,0.00018277139,0.0011036416,0.00043416102,0.0004368317,0.00033315635],"domain_scores_gemma":[0.9953326,0.0026913558,0.0006097031,0.0011158802,0.00012369535,0.00012674982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937266,0.0005028916,0.0019161967,0.00010601233,0.00030349047,0.000013159417,0.00028025007,0.00016013038,0.00005592473],"category_scores_gemma":[0.00011738676,0.00021389715,0.0018949081,0.00034004854,0.0001471126,0.000022673668,0.000042698553,0.00010454385,0.000046082463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000938884,0.00090731995,0.00001934847,0.0018509636,0.0024167248,0.000002696658,0.00020545274,0.0000011171196,1.8419033e-7,0.00075828005,0.008230745,0.98466825],"study_design_scores_gemma":[0.0022596982,0.0008388038,0.00020751831,0.007494094,0.00064567145,0.000004192954,0.00015196957,0.000011288168,0.000014581283,0.000017769646,0.9881913,0.00016310056],"about_ca_topic_score_codex":0.00013556864,"about_ca_topic_score_gemma":0.000010165036,"teacher_disagreement_score":0.9845052,"about_ca_system_score_codex":0.00031485013,"about_ca_system_score_gemma":0.00034823196,"threshold_uncertainty_score":0.8722473},"labels":[],"label_agreement":null},{"id":"W4389677779","doi":"10.1080/14740338.2023.2294924","title":"Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Korea Health Industry Development Institute","keywords":"Medicine; Lung cancer; Cancer; Gefitinib; Lung; Internal medicine; Intensive care medicine; Oncology; Epidermal growth factor receptor","score_opus":0.009137389951940248,"score_gpt":0.31485448300877644,"score_spread":0.3057170930568362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389677779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947504,0.0013669933,0.0001600313,0.0008212918,0.0008432325,0.0012390547,0.00006233927,0.000088724984,0.0006679475],"genre_scores_gemma":[0.9962437,0.00081331056,0.00056156935,0.000577451,0.000100999845,0.0004010195,0.0002516111,0.000067556466,0.0009827444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985918,0.000031797354,0.00028106864,0.00043369245,0.00028627104,0.00037540344],"domain_scores_gemma":[0.9993369,0.00004610924,0.00008491278,0.0003109071,0.00008136086,0.00013984123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000061136874,0.0002436217,0.0003058848,0.00021636343,0.000099187186,0.000017522403,0.00006916827,0.00006808282,0.000219967],"category_scores_gemma":[0.000006463495,0.0001876829,0.00006975026,0.0004862993,0.000028387009,0.00013997837,0.000040257335,0.00015116394,0.000035620033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016159035,0.0012218105,0.96279234,0.00030336255,0.00023276814,0.0005452828,0.012959174,0.004919391,0.000081686776,0.000011040643,0.002356431,0.0129608335],"study_design_scores_gemma":[0.009289672,0.0001987501,0.98133314,0.0018241215,0.00003072568,0.000008593243,0.000505005,0.001288975,0.00025150142,0.0000015927819,0.004950244,0.0003176927],"about_ca_topic_score_codex":0.00044698679,"about_ca_topic_score_gemma":0.00008124845,"teacher_disagreement_score":0.018540813,"about_ca_system_score_codex":0.00066409394,"about_ca_system_score_gemma":0.00019721026,"threshold_uncertainty_score":0.7653487},"labels":[],"label_agreement":null},{"id":"W4389681767","doi":"10.1080/14740338.2023.2295397","title":"The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Medicine; Adverse Event Reporting System; Suicidal ideation; Liraglutide; Adverse effect; Odds ratio; Internal medicine; Poison control; Pharmacology; Psychiatry; Suicide prevention; Emergency medicine; Endocrinology; Diabetes mellitus","score_opus":0.02239137260098223,"score_gpt":0.3025923590626875,"score_spread":0.28020098646170527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389681767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90192395,0.0012175408,0.00006249426,0.08519384,0.003723155,0.0037001956,0.000043908036,0.00054018555,0.0035946982],"genre_scores_gemma":[0.9913294,0.001067655,0.000077854405,0.00052304997,0.0006394724,0.0002495214,0.00036471654,0.00003609238,0.0057122596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969943,0.00021618223,0.0011346266,0.0005641606,0.0006869462,0.00040379434],"domain_scores_gemma":[0.9975878,0.00046850753,0.0010460798,0.0005853133,0.000107784814,0.00020453603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036703576,0.00026091587,0.00039332767,0.000091744485,0.0007147008,0.000104729086,0.0000858812,0.00008036574,0.0000061804744],"category_scores_gemma":[0.0007200663,0.00016796461,0.0001282274,0.00030781835,0.000038918133,0.00011298317,0.00015403582,0.00016269073,0.00003963595],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012105536,0.00043521044,0.29772297,0.00066005724,0.0029727626,0.00018763836,0.021576526,0.000085351865,0.0004114086,0.0045874007,0.5012256,0.1689245],"study_design_scores_gemma":[0.0011644257,0.00043018343,0.1619805,0.0005558938,0.00009050243,0.000016086358,0.009544909,0.000109438486,0.0012235999,0.000029157181,0.8245617,0.00029356798],"about_ca_topic_score_codex":0.00008480977,"about_ca_topic_score_gemma":0.0000857908,"teacher_disagreement_score":0.32333612,"about_ca_system_score_codex":0.0005236121,"about_ca_system_score_gemma":0.000088909335,"threshold_uncertainty_score":0.6849398},"labels":[],"label_agreement":null},{"id":"W4390403997","doi":"10.1080/14740338.2023.2299391","title":"A safety evaluation of ruxolitinib for the treatment of polycythemia vera","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministry of Health, British Columbia","keywords":"Ruxolitinib; Polycythemia vera; Medicine; Myelofibrosis; Myeloproliferative neoplasm; Haematopoiesis; Disease; Immunology; Thrombocytosis; Stem cell; Internal medicine; Bone marrow; Platelet","score_opus":0.07678855501728588,"score_gpt":0.3890195278381949,"score_spread":0.312230972820909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390403997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80620706,0.028673194,0.00082058215,0.11020383,0.006071401,0.025131598,0.0021768468,0.00046057324,0.020254906],"genre_scores_gemma":[0.9770863,0.019469922,0.00032160967,0.00026041004,0.00045802273,0.001252421,0.0005440897,0.00003694361,0.0005702915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982669,0.000121577286,0.00049416727,0.0002889305,0.0006072311,0.00022120422],"domain_scores_gemma":[0.99786067,0.0011421671,0.00017882668,0.0004621968,0.00027847564,0.00007764299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006158293,0.00020645311,0.00043817065,0.00010494902,0.00014212172,0.0000047681533,0.00007288566,0.00006385936,0.00025675312],"category_scores_gemma":[0.00015687305,0.000121346406,0.00028139178,0.00023315451,0.00007082492,0.000030300374,0.000014938579,0.00004387946,0.000027659924],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015276053,0.00675284,0.009993894,0.00018093023,0.0023709666,0.000005444887,0.03018537,0.0018056153,0.002592446,0.024303934,0.036580097,0.8699524],"study_design_scores_gemma":[0.027291931,0.00481704,0.12580398,0.0005882,0.00023021479,0.000009870574,0.002835911,0.014367079,0.14101118,0.0003604782,0.6823662,0.00031795359],"about_ca_topic_score_codex":0.000089878464,"about_ca_topic_score_gemma":0.000009218809,"teacher_disagreement_score":0.86963445,"about_ca_system_score_codex":0.0003248953,"about_ca_system_score_gemma":0.00021861558,"threshold_uncertainty_score":0.4948363},"labels":[],"label_agreement":null},{"id":"W4393114465","doi":"10.1080/14740338.2024.2335215","title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Receptor; Glucagon; Peptide; Agonist; Endocrinology; Pharmacology; Internal medicine; Biochemistry; Insulin; Chemistry; Diabetes mellitus; Type 2 diabetes","score_opus":0.008898181884863885,"score_gpt":0.2885847164336534,"score_spread":0.2796865345487895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393114465","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006342575,0.31949055,0.0000028004497,0.024894144,0.65190625,0.0011394317,0.00022347638,0.00025589662,0.0020240357],"genre_scores_gemma":[0.000032128846,0.57471734,0.00016808849,0.0005288665,0.40560102,0.00014011863,0.002450025,0.00013487002,0.016227549],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583584,0.00016358292,0.0006795038,0.0015241613,0.0011551835,0.00064172305],"domain_scores_gemma":[0.9977825,0.00047027948,0.00022765866,0.00089489215,0.00015636075,0.0004682936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005399607,0.0009896485,0.0012313102,0.0003423069,0.00025361014,0.00064623944,0.00022103889,0.0008138267,0.00036727928],"category_scores_gemma":[0.00008283876,0.00079592265,0.00029020023,0.00024900504,0.00019825659,0.0003466951,0.0004031877,0.00096923433,0.0002816779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005945816,0.00020820847,0.000008301099,0.000722454,0.00055571384,0.00003423336,0.0014169223,1.02993546e-7,0.000011457963,0.00049713167,0.74016374,0.25578716],"study_design_scores_gemma":[0.0029555832,0.0005449617,0.00003371158,0.0053992616,0.0001457338,0.0000038487274,0.0021678617,0.000008541936,0.000057643338,0.00007753925,0.9878928,0.0007124917],"about_ca_topic_score_codex":0.0000622224,"about_ca_topic_score_gemma":0.000016110678,"teacher_disagreement_score":0.25522676,"about_ca_system_score_codex":0.00048026728,"about_ca_system_score_gemma":0.0002373635,"threshold_uncertainty_score":0.9994492},"labels":[],"label_agreement":null},{"id":"W4399076922","doi":"10.1080/14740338.2024.2361300","title":"Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Adverse Event Reporting System; Medicine; Food and drug administration; Adverse effect; Orexin receptor; Orexin; Association (psychology); Adverse drug event; Pharmacovigilance; Pharmacology; Environmental health; Internal medicine; Medical emergency; Receptor","score_opus":0.045348961043192734,"score_gpt":0.34622012807160324,"score_spread":0.3008711670284105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399076922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96583617,0.0003232693,0.00025250908,0.030180078,0.0017736044,0.00096306857,0.00016316552,0.0002836442,0.0002245019],"genre_scores_gemma":[0.9979031,0.00040927235,0.000034566223,0.00041275582,0.00051394163,0.000094715026,0.00021266523,0.000035137135,0.00038381768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960247,0.000683971,0.0010998497,0.0008453426,0.00093884766,0.00040729064],"domain_scores_gemma":[0.99752814,0.0011913499,0.0005491093,0.00039659932,0.00010471665,0.00023011044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033052529,0.00024245307,0.00028742544,0.00021164543,0.00060451095,0.00030151985,0.00011993626,0.00009757482,0.00001860474],"category_scores_gemma":[0.0024031338,0.00018260108,0.00007395529,0.0006779087,0.000066959954,0.00024629338,0.00016010417,0.00033872543,0.000020807223],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039309165,0.0013390076,0.22366382,0.0029979816,0.0015673188,0.0024081848,0.15093058,0.002378555,0.0337473,0.030266942,0.3148472,0.2319222],"study_design_scores_gemma":[0.0011727675,0.00080437417,0.019583106,0.0016502634,0.000040417155,0.00033289223,0.018542426,0.0064486265,0.2154064,0.00028372477,0.73449904,0.0012359428],"about_ca_topic_score_codex":0.00032055393,"about_ca_topic_score_gemma":0.000060978004,"teacher_disagreement_score":0.41965187,"about_ca_system_score_codex":0.00042283203,"about_ca_system_score_gemma":0.00013986633,"threshold_uncertainty_score":0.7446256},"labels":[],"label_agreement":null},{"id":"W4399747109","doi":"10.1080/14740338.2024.2368827","title":"The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Adverse Event Reporting System; Medicine; Ketamine; Food and drug administration; Adverse effect; Drug; Pharmacovigilance; Emergency medicine; Administration (probate law); Anesthesia; Pharmacology; Intensive care medicine; Internal medicine; Medical emergency","score_opus":0.02108355986093473,"score_gpt":0.3166153105612791,"score_spread":0.2955317507003444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399747109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91468704,0.011655928,0.00014907731,0.069106415,0.0014330203,0.0017533338,0.000031893498,0.00027121452,0.00091209507],"genre_scores_gemma":[0.99637413,0.0011291153,0.00010939048,0.00018170933,0.0006239506,0.00008383132,0.00009597291,0.00003105421,0.001370866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973435,0.0002107933,0.0010190121,0.0005768811,0.00060087885,0.00024897198],"domain_scores_gemma":[0.99791193,0.00077318295,0.0005925036,0.00045681078,0.00007596771,0.00018959667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027512074,0.00024014285,0.0003485723,0.00007525248,0.0004516075,0.00011264009,0.000048103193,0.00009184188,0.0000032849055],"category_scores_gemma":[0.0009157191,0.00013788193,0.000078210236,0.00015886419,0.000043796914,0.0001295748,0.00010583597,0.00022178839,0.0000039347333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017160545,0.00043123314,0.5020978,0.0014154552,0.0022243715,0.00073757075,0.021809867,0.000032505526,0.0019323489,0.004214134,0.043256164,0.42013252],"study_design_scores_gemma":[0.0016692065,0.00082958373,0.6339623,0.0025735334,0.00018620054,0.0006887359,0.005665476,0.00065982173,0.004828656,0.000058055197,0.3484655,0.00041299663],"about_ca_topic_score_codex":0.00007539898,"about_ca_topic_score_gemma":0.000060008053,"teacher_disagreement_score":0.41971955,"about_ca_system_score_codex":0.00033890354,"about_ca_system_score_gemma":0.000081605314,"threshold_uncertainty_score":0.56226623},"labels":[],"label_agreement":null},{"id":"W4401715832","doi":"10.1080/14740338.2024.2393274","title":"Considerations for practical use of tree-based scan statistics for signal detection using electronic healthcare data: a case study with insulin glargine","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Health care; Detection theory; SIGNAL (programming language); Statistics; Tree (set theory); Health records; Data mining; Insulin; Computer science; Internal medicine; Detector; Mathematics; Telecommunications","score_opus":0.33295204115155824,"score_gpt":0.5283326762861714,"score_spread":0.19538063513461318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401715832","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21506733,0.0027287414,0.72491163,0.015837472,0.005452919,0.0124832075,0.022922928,0.00056067115,0.000035116387],"genre_scores_gemma":[0.98843104,0.00031543718,0.008695133,0.0010700563,0.00048243988,0.00034964754,0.00057678396,0.00005172593,0.000027734424],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979508,0.00041394727,0.00049495534,0.00054079766,0.00017568258,0.00042384732],"domain_scores_gemma":[0.99482876,0.0042878077,0.00016369123,0.000302855,0.00024730057,0.00016959553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007121643,0.00025434847,0.00031214792,0.00018881985,0.0006013667,0.00005198367,0.000087708715,0.00012533157,0.0000767233],"category_scores_gemma":[0.0002181623,0.00022980962,0.00007355868,0.0002448509,0.00010648136,0.0004214167,0.000030994073,0.0005947631,0.0000030499016],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10212176,0.031977355,0.0029832765,0.003408149,0.010000394,0.004289252,0.022905279,0.2656313,0.114924915,0.062932804,0.09649951,0.282326],"study_design_scores_gemma":[0.005503629,0.001508867,0.000028669452,0.00008412867,0.00019447948,0.00044778612,0.0019270527,0.7086232,0.012129559,0.00016359164,0.2690373,0.00035175786],"about_ca_topic_score_codex":0.000349268,"about_ca_topic_score_gemma":0.0011531735,"teacher_disagreement_score":0.7733637,"about_ca_system_score_codex":0.00029577326,"about_ca_system_score_gemma":0.0015014485,"threshold_uncertainty_score":0.9371364},"labels":[],"label_agreement":null},{"id":"W4402194288","doi":"10.1080/14740338.2024.2396396","title":"Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec; Ottawa Hospital; Dalhousie University; Université Laval; University of Ottawa","funders":"Cilag; National Health and Medical Research Council; H. Lundbeck A/S; Lundbeckfonden; Servier; Bristol-Myers Squibb; Eli Lilly and Company; Shire; QuantIC; Gedeon Richter; Canadian Institutes of Health Research; Sunovion; Teva Pharmaceutical Industries; Novo Nordisk; Sanofi","keywords":"Medicine; Psychiatry; Weight gain; Intensive care medicine; Internal medicine; Body weight","score_opus":0.12679275899886266,"score_gpt":0.42275965345624095,"score_spread":0.2959668944573783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402194288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019757268,0.99382836,0.0000068994673,0.00044034293,0.0002160068,0.0029581445,0.00054586923,0.00001446739,0.000014168133],"genre_scores_gemma":[0.0006055075,0.9984153,0.00014467615,0.000018787141,0.000049579132,0.000070019145,0.00028228003,0.00004422041,0.0003696539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645317,0.0012410365,0.0010913668,0.00047939556,0.0005278062,0.00020721482],"domain_scores_gemma":[0.9967993,0.0013522158,0.00089755276,0.0007002403,0.00011254417,0.00013816687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006242848,0.00042044916,0.0021367867,0.00010536239,0.000068080095,0.000012688768,0.0001154453,0.000127946,0.000017740444],"category_scores_gemma":[0.00032657792,0.00016754669,0.0006219306,0.0003148901,0.00030611307,0.0000454858,0.000072024515,0.00031470828,0.0000025790457],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017926377,0.001384778,0.003002665,0.0068952786,0.0034281178,0.000009343384,0.00022726641,2.9609507e-7,1.429957e-7,0.000032646127,0.008072703,0.9751541],"study_design_scores_gemma":[0.003086709,0.0021144466,0.012982332,0.14402513,0.0016147224,0.00001777978,0.000016745584,0.00002140579,0.000015406498,0.000019329218,0.8358858,0.0002001507],"about_ca_topic_score_codex":0.00005256727,"about_ca_topic_score_gemma":0.000040798794,"teacher_disagreement_score":0.97495395,"about_ca_system_score_codex":0.00009995502,"about_ca_system_score_gemma":0.00035564,"threshold_uncertainty_score":0.6832356},"labels":[],"label_agreement":null},{"id":"W4402455942","doi":"10.1080/14740338.2024.2401024","title":"Comparative risk of infection of medications used for type 2 diabetes","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Dapagliflozin; Type 2 diabetes; Food and drug administration; Diabetes mellitus; Drug; Urinary system; Canagliflozin; Randomized controlled trial; Intensive care medicine; Pharmacology; Internal medicine; Endocrinology","score_opus":0.08427157789930105,"score_gpt":0.4222656409577348,"score_spread":0.3379940630584337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402455942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025001267,0.99425954,0.000047369176,0.00017724968,0.0014368928,0.002164712,0.00016718886,0.000058062607,0.0016639826],"genre_scores_gemma":[0.00025787743,0.99639183,0.00030393782,0.000024420307,0.00025402257,0.00039272703,0.001627148,0.00003764579,0.00071039266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852395,0.00010850881,0.00066028093,0.00031143782,0.000242009,0.0001538325],"domain_scores_gemma":[0.99852264,0.0004298591,0.00046364206,0.00039708972,0.00011886488,0.0000678883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028370644,0.0002916366,0.0016072869,0.00031835845,0.000042492236,0.0000054101442,0.00007973869,0.00012568825,0.00007161819],"category_scores_gemma":[0.00007178897,0.00019842919,0.0005595663,0.0003773396,0.00007694083,0.000033102842,0.00004725084,0.00015656697,0.00005792113],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087354936,0.0011506295,0.00015655183,0.024331039,0.0072393822,4.467884e-7,0.0014574358,0.000004601509,0.0000027654098,0.0042998814,0.11923815,0.8420318],"study_design_scores_gemma":[0.00054462405,0.00046576708,0.00006933674,0.014660695,0.0012367003,1.805293e-7,0.000029480198,0.0000478278,0.000055408844,0.000041012245,0.98271203,0.00013692954],"about_ca_topic_score_codex":0.000024282408,"about_ca_topic_score_gemma":0.0000042726633,"teacher_disagreement_score":0.8634739,"about_ca_system_score_codex":0.00013558757,"about_ca_system_score_gemma":0.00015608736,"threshold_uncertainty_score":0.8091708},"labels":[],"label_agreement":null},{"id":"W4404474075","doi":"10.1080/14740338.2024.2430306","title":"Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Brain and Cognition Discovery Foundation; University of Toronto","funders":"","keywords":"Medicine; Accidental; Population; Pharmacology; Glucagon-like peptide-1; Internal medicine; Endocrinology; Environmental health; Diabetes mellitus","score_opus":0.07159680861154213,"score_gpt":0.4388225693700137,"score_spread":0.3672257607584716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404474075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861784,0.0011384934,0.0001082932,0.0014099068,0.0054376903,0.0013788589,0.00023160645,0.00051290484,0.0036038535],"genre_scores_gemma":[0.99621516,0.00035403884,0.0001741178,0.0014803445,0.0005982639,0.00016238369,0.0004467101,0.00006419356,0.0005047678],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967099,0.00044964932,0.0013239586,0.0006553917,0.0004404449,0.0004206691],"domain_scores_gemma":[0.9978239,0.00070817344,0.00072494865,0.00038489938,0.00010770629,0.00025040517],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011640567,0.00038408162,0.00051390525,0.00026855938,0.00041130144,0.000047106656,0.0002516377,0.00015611737,0.0013296666],"category_scores_gemma":[0.00018651025,0.00032602824,0.00022265207,0.00055031443,0.00008373611,0.00032200888,0.000061814826,0.00078586506,0.000119638804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01713931,0.014939379,0.67566895,0.0006321043,0.003488375,0.0008668372,0.018202085,0.026106441,0.08711215,0.0026899267,0.11629763,0.036856808],"study_design_scores_gemma":[0.0081153,0.00071013405,0.058776107,0.0007620465,0.00013345943,0.000055883334,0.0057801446,0.010135397,0.04104143,0.00003715458,0.87328786,0.0011651118],"about_ca_topic_score_codex":0.00072710356,"about_ca_topic_score_gemma":0.000056005654,"teacher_disagreement_score":0.7569902,"about_ca_system_score_codex":0.00035774775,"about_ca_system_score_gemma":0.00035095928,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W4405065092","doi":"10.1080/14740338.2024.2438751","title":"Safety assessment of tafamidis: a real-world adverse event analysis from the FAERS database","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adverse Event Reporting System; Medicine; Adverse effect; Quarter (Canadian coin); Pharmacovigilance; Database; MEDLINE; Pharmacology","score_opus":0.016010363082259983,"score_gpt":0.343212526316856,"score_spread":0.327202163234596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405065092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6450256,0.10843447,0.051272318,0.09516298,0.016805882,0.008723069,0.029348738,0.0011267384,0.044100203],"genre_scores_gemma":[0.95446104,0.037336856,0.001114187,0.0009838301,0.0004091999,0.00015471563,0.0048360648,0.000049720198,0.00065441156],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975285,0.00031348105,0.00062560115,0.00079805177,0.00042778678,0.0003065727],"domain_scores_gemma":[0.99807805,0.00031336342,0.00018362477,0.0012364436,0.00005702773,0.00013151616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043485215,0.0003568718,0.0004199215,0.00015272018,0.00015361024,0.000027561086,0.0004281879,0.00010044438,0.00041750443],"category_scores_gemma":[0.00006314725,0.00025110462,0.0006250588,0.0006008321,0.000119229386,0.000014710349,0.000272551,0.00017144847,0.000031054515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031083405,0.0045311037,0.36233932,0.00020566468,0.035879806,0.000111568355,0.006305905,0.018036924,0.0624539,0.016264196,0.42572382,0.06503946],"study_design_scores_gemma":[0.0017088209,0.00021850997,0.25379074,0.00032230778,0.00038056812,0.0000014566605,0.0019948075,0.0025037425,0.026308909,0.000028151362,0.7120572,0.00068483496],"about_ca_topic_score_codex":0.0018298653,"about_ca_topic_score_gemma":0.0008388433,"teacher_disagreement_score":0.3094354,"about_ca_system_score_codex":0.00020287267,"about_ca_system_score_gemma":0.0001871048,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W4405790898","doi":"10.1080/14740338.2024.2447072","title":"Is Duchenne gene therapy a suitable treatment despite its immunogenic class effect?","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Genetic enhancement; Weakness; Cardiomyopathy; Intensive care medicine; Disease; Bioinformatics; Internal medicine; Gene; Surgery; Heart failure; Genetics","score_opus":0.03765620373132751,"score_gpt":0.36017075118431663,"score_spread":0.32251454745298913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405790898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031129687,0.9956963,0.000007671462,0.00020560216,0.0016163342,0.0011817924,0.00019891007,0.00005487594,0.00072718115],"genre_scores_gemma":[0.00021405348,0.992101,0.00002115884,0.00053544866,0.0009269997,0.00069869927,0.0025113334,0.0001334442,0.0028578257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972069,0.00045509313,0.00053571636,0.001121258,0.00015735556,0.00052363763],"domain_scores_gemma":[0.99857515,0.00007605802,0.00018468154,0.0009927887,0.000039656727,0.00013166817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024282785,0.00086574553,0.0011933887,0.00011283122,0.00018428577,0.000036934605,0.000418675,0.0007080895,0.00017184675],"category_scores_gemma":[0.000025661586,0.0005982585,0.0012085491,0.00019000721,0.00007301885,0.0000049392215,0.0001547947,0.00029125868,0.0005503546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007461732,0.00037044546,0.000001398823,0.001161409,0.0018821056,0.000006537232,0.0002545247,0.00000443689,0.0037687696,0.00008893165,0.030226616,0.96148866],"study_design_scores_gemma":[0.00094805803,0.0011408303,0.0000030024635,0.0010056123,0.000059911214,0.000014937741,0.000013280499,0.0000047588933,0.0061347918,0.0000096899,0.9900754,0.00058969465],"about_ca_topic_score_codex":0.00002807203,"about_ca_topic_score_gemma":0.0000025738984,"teacher_disagreement_score":0.96089894,"about_ca_system_score_codex":0.00014442451,"about_ca_system_score_gemma":0.00030837723,"threshold_uncertainty_score":0.9996469},"labels":[],"label_agreement":null},{"id":"W4407267045","doi":"10.1080/14740338.2025.2460454","title":"Association of ocular adverse events with varenicline solution use: a population-based study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Varenicline; Adverse effect; Population; Pharmacology; Intensive care medicine; Environmental health; Internal medicine; Nicotine","score_opus":0.013241548894679567,"score_gpt":0.29976375839986685,"score_spread":0.2865222095051873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407267045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897934,0.00022279183,0.0030602966,0.004655316,0.00057522947,0.0012825143,0.000019472725,0.000095634714,0.00029530464],"genre_scores_gemma":[0.9967861,0.000063116386,0.0005602318,0.0006575245,0.00005864919,0.00002928816,0.00022787912,0.000016551217,0.001600619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984725,0.00017388842,0.0003887593,0.00027797255,0.00051168614,0.00017520343],"domain_scores_gemma":[0.99899644,0.00014783886,0.00020273803,0.0003912315,0.00020595443,0.000055828274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003475943,0.00016177783,0.00032988423,0.00015220097,0.00010006232,0.000004181485,0.000062874446,0.00008663191,0.00006367327],"category_scores_gemma":[0.0001766149,0.00013437615,0.00012056201,0.00032190586,0.000006658311,0.00011172535,0.000019824207,0.00014510714,0.00001292439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014758805,0.0012736743,0.9942618,0.000026660911,0.0002644632,0.0000030549693,0.0003232504,0.0006930406,0.00020472775,0.00013661371,0.00039543735,0.00094139157],"study_design_scores_gemma":[0.006795498,0.0004579346,0.97667813,0.00047082093,0.000051432573,1.5722613e-7,0.00041782093,0.0018241747,0.00066416635,0.000007892386,0.012488711,0.00014325808],"about_ca_topic_score_codex":0.0007240325,"about_ca_topic_score_gemma":0.00016071004,"teacher_disagreement_score":0.017583672,"about_ca_system_score_codex":0.0004056441,"about_ca_system_score_gemma":0.00015577386,"threshold_uncertainty_score":0.54797006},"labels":[],"label_agreement":null},{"id":"W4407700738","doi":"10.1080/14740338.2025.2465870","title":"Evaluating bowel obstruction and ileus events in patients on GLP-1 receptor agonists: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Ileus; Systematic review; Bowel obstruction; Internal medicine; Tegaserod; Intensive care medicine; Gastroenterology; MEDLINE; Irritable bowel syndrome; Surgery","score_opus":0.07329668357785438,"score_gpt":0.3981136809968496,"score_spread":0.32481699741899517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407700738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003741733,0.9911605,0.0000032720754,0.0004892046,0.00030689436,0.0074550705,0.0000809293,0.00004025415,0.00046012882],"genre_scores_gemma":[0.000009279615,0.99325,0.00023546703,0.0008235167,0.000037039234,0.0018638114,0.0013274533,0.00003713674,0.0024162885],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958751,0.0008781476,0.0014602813,0.00088133354,0.00063038437,0.00027473085],"domain_scores_gemma":[0.9978783,0.00039695788,0.0007338502,0.0007762425,0.000086367894,0.00012827785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087653514,0.00067155156,0.006235987,0.00065736327,0.00010730478,0.000025469542,0.0001343884,0.00015577821,0.00014828898],"category_scores_gemma":[0.00045744135,0.0004388027,0.0011724834,0.0007425119,0.00002730438,0.00007490348,0.00012956632,0.00025009812,0.0000325729],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005443681,0.00048280015,0.000024414441,0.80403185,0.06145709,0.0000016208711,0.00014302939,0.0000013611594,7.448913e-9,0.00011227722,0.0013782785,0.13231286],"study_design_scores_gemma":[0.0019400902,0.000541471,0.000130095,0.35882595,0.43994513,0.0000013744378,0.000057591824,0.000014091418,2.3472256e-7,0.000011446536,0.19788983,0.0006426901],"about_ca_topic_score_codex":0.00002444912,"about_ca_topic_score_gemma":0.0000030625638,"teacher_disagreement_score":0.44520587,"about_ca_system_score_codex":0.0005376675,"about_ca_system_score_gemma":0.00006583237,"threshold_uncertainty_score":0.9998064},"labels":[],"label_agreement":null},{"id":"W4409390867","doi":"10.1080/14740338.2025.2493351","title":"Does the use of generative AI chatbots by patients introduce risk of adverse drug events?","year":2025,"lang":"en","type":"editorial","venue":"Expert Opinion on Drug Safety","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Drug; Adverse effect; Intensive care medicine; Pharmacology","score_opus":0.009750782252618122,"score_gpt":0.2941775190829544,"score_spread":0.2844267368303363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409390867","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027803372,0.0008784287,0.0070026387,0.009588271,0.9789707,0.0013252038,0.0017567266,0.00012784137,0.00007216875],"genre_scores_gemma":[0.0065296576,0.029603226,0.018582191,0.0035141008,0.9194451,0.00064301817,0.005813932,0.00030655848,0.015562226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99290824,0.0024110174,0.0012185988,0.0011863135,0.0018301171,0.00044569036],"domain_scores_gemma":[0.99228334,0.0028034833,0.0015357891,0.00222054,0.0010256842,0.0001311844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010313173,0.00058666506,0.0008473098,0.00023924053,0.00036382358,0.000035918973,0.0023111808,0.00042687688,0.000033998505],"category_scores_gemma":[0.0033874116,0.0003446819,0.00031973587,0.0005193441,0.00014175923,0.00040004094,0.00096655614,0.0017505964,0.000011113981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001303141,0.00022133406,0.0008881539,0.00011067564,0.000102034304,3.2365472e-7,0.004855639,0.0011572959,0.0000019538902,0.0004360922,0.9820684,0.01002777],"study_design_scores_gemma":[0.0008291709,0.00013667016,0.00091149705,0.00058318186,0.000006482549,6.193058e-8,0.000055621313,0.004102509,0.00028962173,0.0000621679,0.9926679,0.00035512625],"about_ca_topic_score_codex":0.002840968,"about_ca_topic_score_gemma":0.000079095495,"teacher_disagreement_score":0.059525598,"about_ca_system_score_codex":0.00029837582,"about_ca_system_score_gemma":0.0006159968,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W4411253013","doi":"10.1080/14740338.2025.2517232","title":"Analysis of the relationship between histamine H1 receptor antagonists and broad dementia events using the FAERS, JADER, and CVAR databases","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Mast cells and histamine","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CVAR; Medicine; Database; Pharmacology; Computer science; Risk management","score_opus":0.03665619841939237,"score_gpt":0.3101971100633989,"score_spread":0.2735409116440065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411253013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9225102,0.06261874,0.0014393801,0.008810085,0.002052237,0.00074123935,0.0009799505,0.000046726873,0.00080145936],"genre_scores_gemma":[0.99588346,0.0015815403,0.00013968116,0.00019797296,0.000029528666,0.000005646149,0.00051898573,0.000007737694,0.0016354495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884224,0.00031868153,0.00034625074,0.00027799266,0.000053974953,0.0001608744],"domain_scores_gemma":[0.9988093,0.0005704185,0.00016804198,0.00040233688,0.000033700228,0.00001622994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003105946,0.00014708185,0.00027984133,0.00014129096,0.0005538441,0.000009153339,0.00017228712,0.00007865529,0.00015955708],"category_scores_gemma":[0.00010586087,0.00009400252,0.00008659195,0.0003872595,0.00027404376,0.000053918488,0.00018271804,0.00017717404,0.0000028447287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025292957,0.00014881219,0.953876,0.000051077765,0.0018979467,1.7341566e-7,0.0018083288,0.000025606683,0.016479198,0.008261326,0.010762876,0.0064357305],"study_design_scores_gemma":[0.00073957426,0.000018868235,0.61351377,0.00010228721,0.00019227373,9.608601e-7,0.00049107184,0.000032893702,0.0022136476,0.000019659668,0.3825597,0.000115306924],"about_ca_topic_score_codex":0.0005229018,"about_ca_topic_score_gemma":0.00008500288,"teacher_disagreement_score":0.37179682,"about_ca_system_score_codex":0.000037557325,"about_ca_system_score_gemma":0.000038371396,"threshold_uncertainty_score":0.4259777},"labels":[],"label_agreement":null},{"id":"W4411778543","doi":"10.1080/14740338.2025.2526787","title":"Use of medroxyprogesterone acetate and risk of meningiomas: a comparative safety study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of British Columbia","keywords":"Medicine; Medroxyprogesterone acetate; Environmental health; Internal medicine; Pharmacology; Estrogen","score_opus":0.055066350056986714,"score_gpt":0.34371568104549627,"score_spread":0.28864933098850953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411778543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925026,0.0015811163,0.0005715827,0.0008378165,0.0003261577,0.0015335135,0.0000329668,0.000047531725,0.0025666573],"genre_scores_gemma":[0.99637985,0.0006697947,0.0018555102,0.000057014462,0.000029798617,0.000043264947,0.000028648057,0.000014143552,0.0009219942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978985,0.000334064,0.0007633924,0.0004125118,0.00038814527,0.00020334565],"domain_scores_gemma":[0.99856627,0.00034943965,0.00030691648,0.0005427132,0.00013216086,0.00010247543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005954387,0.0002422886,0.00077622046,0.00028834437,0.00011187343,0.000013165245,0.00011414887,0.000052005893,0.000038439448],"category_scores_gemma":[0.00010067683,0.00019450657,0.00010812875,0.00035879388,0.00013850772,0.00011377381,0.00017274937,0.00015814643,0.0000036848398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055838726,0.015818126,0.5628275,0.0014060591,0.01456652,0.0003448712,0.20873243,0.0011334958,0.011412773,0.029124174,0.03549648,0.063298814],"study_design_scores_gemma":[0.0188704,0.003706774,0.8423596,0.0019995987,0.00031517536,0.000032133164,0.021816237,0.0037114487,0.018877668,0.00012407318,0.08755621,0.0006307039],"about_ca_topic_score_codex":0.00021906172,"about_ca_topic_score_gemma":0.00001164875,"teacher_disagreement_score":0.27953205,"about_ca_system_score_codex":0.000060133876,"about_ca_system_score_gemma":0.00005100014,"threshold_uncertainty_score":0.79317474},"labels":[],"label_agreement":null},{"id":"W4414613758","doi":"10.1080/14740338.2025.2568242","title":"Auditory system adverse events with sacubitril/valsartan: an active-comparator restricted disproportionality analysis using the FDA adverse event reporting system database","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Adverse effect; Event (particle physics); Auditory event; Lisinopril; MEDLINE; Adverse Event Reporting System; Risk assessment; Warrant","score_opus":0.037236860189816076,"score_gpt":0.34145001000881675,"score_spread":0.30421314981900066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414613758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93999565,0.00027457185,0.045911968,0.00062132505,0.008239477,0.002432831,0.00047568922,0.0008006668,0.0012477951],"genre_scores_gemma":[0.9984927,0.000034655786,0.00025789617,0.00023924498,0.0005225511,0.00009718305,0.000189131,0.00003561551,0.00013100672],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99406904,0.0013935507,0.0016062952,0.0012562579,0.0011616822,0.00051317184],"domain_scores_gemma":[0.9957442,0.00034440105,0.0019922224,0.0015021141,0.00018401523,0.0002330225],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0010594821,0.00046504292,0.00081791624,0.0003547608,0.001347551,0.00003377442,0.0005967105,0.00010611654,0.000032437536],"category_scores_gemma":[0.0006424045,0.00032962058,0.00033621618,0.0021008267,0.00018874355,0.00058533036,0.00016101469,0.00041195392,0.00002496423],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008308478,0.0036140275,0.04255909,0.0011258338,0.00234486,0.0006443716,0.0049045915,0.838825,0.07522181,0.012109766,0.008457792,0.0018843819],"study_design_scores_gemma":[0.00950394,0.00049545587,0.17777543,0.006814867,0.0015212914,0.000280141,0.07714313,0.58295023,0.089914195,0.000029480287,0.049500164,0.00407169],"about_ca_topic_score_codex":0.00027052194,"about_ca_topic_score_gemma":0.000036681813,"teacher_disagreement_score":0.25587478,"about_ca_system_score_codex":0.0008212526,"about_ca_system_score_gemma":0.0005535194,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W4416292676","doi":"10.1080/14740338.2025.2588634","title":"Utility and limitations of the FDA adverse events reporting system public dashboard for safety analyses: a case study with vesicular monoamine transporter 2 inhibitors","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Drug Safety","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Neurocrine Biosciences","keywords":"Pharmacovigilance; Adverse Event Reporting System; Dashboard; Adverse effect; Postmarketing surveillance; Quality (philosophy); Public health; MEDLINE","score_opus":0.22096002355757186,"score_gpt":0.4648317167819514,"score_spread":0.24387169322437954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416292676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98828423,0.00035641354,0.0011638696,0.003050346,0.001928671,0.0029232593,0.00018795885,0.00012969605,0.0019755806],"genre_scores_gemma":[0.9982626,0.0003263887,0.00010727505,0.0006543245,0.00011703699,0.00025784443,0.0000579651,0.000020221523,0.00019634244],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972306,0.00050867914,0.0012105198,0.0005073402,0.00021612839,0.00032676416],"domain_scores_gemma":[0.9975896,0.0008295454,0.0007786212,0.00043988953,0.00021088167,0.00015147061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011325162,0.00029241864,0.00047778233,0.00017033055,0.00081726635,0.00000828933,0.00019057038,0.00012938537,0.000018986591],"category_scores_gemma":[0.000247598,0.00020826909,0.00023777502,0.0005504785,0.00015580257,0.0002208899,0.00005768175,0.0004441898,0.0000017742559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020838248,0.019616988,0.65559983,0.0021081711,0.013432245,0.00150877,0.064978056,0.032637503,0.020900099,0.005170411,0.012832696,0.150377],"study_design_scores_gemma":[0.022897229,0.0005932417,0.07106954,0.000853012,0.0010401206,0.00054462755,0.12662268,0.030102719,0.024440177,0.00004182605,0.720599,0.0011958455],"about_ca_topic_score_codex":0.00010741637,"about_ca_topic_score_gemma":0.00013557599,"teacher_disagreement_score":0.7077663,"about_ca_system_score_codex":0.00013026272,"about_ca_system_score_gemma":0.00023062326,"threshold_uncertainty_score":0.8492967},"labels":[],"label_agreement":null}]}